Publications
Books
Menzies, RG & Menzies, RE 2019, Tales from the Valley of Death Reflections from Psychotherapy on the Fear of Death, Australian Academic Press, Australia.
View description>>
These intimate personal tales reveal fears ranging from sudden death by fire to assassins in the shadows, from anaphylactic shock to a multitude of diseases, from being attacked by dinosaurs lurking in kitchen cupboards to being pushed off ...
Chapters
Abbott, M & Norton, A 2019, 'Negative automatic thoughts and mental health: Building on Wenzlaff, Wegner and Klein (1991)' in Clinical Psychology: Revisiting the Classic Studies, Sage.
Garcia-Cardenas, V, Rossing, C & Benrimoj, SI 2019, 'Pharmaceutical Care and Implementation Strategies' in The Pharmacist Guide to Implementing Pharmaceutical Care, Springer International Publishing, Germany, pp. 203-212.
View/Download from: Publisher's site
View description>>
Implementation of pharmaceutical care through professional pharmacy services is a complex process, in which multilevel implementation factors interact and affect implementation processes and outcomes. This process has traditionally been approached in an ad hoc manner, and assuming that positive benefits and diffusion of information through key stakeholders would ensure the service’s integration into routine practice. It is now known that this traditional approach is not sufficient to effectively integrate innovations into routine practice of pharmacy, and that more complex, tailored, and evidence-based approaches are needed. The application of implementation science to the implementation of professional pharmacy services will facilitate this complex process and will assist in ensuring their long-term sustainability.
Klein, WMP, Biesecker, BB & Turbitt, E 2019, 'Judgment and Decision Making in Genome Sequencing' in Clinical Genome Sequencing, Elsevier, pp. 57-73.
View/Download from: Publisher's site
View description>>
© 2019 Elsevier Inc. All rights reserved. Genome sequencing involves a host of decisions on the part of the provider and client, including whether to be tested, when and how to receive sequencing results, whether to inform biological relatives, and whether to take protective actions to reduce risk. In this chapter, we consider the relevance of research in the decision sciences to decisions in the genome sequencing context. We review the role of cognitive factors (e.g., use of heuristics, low numeracy), affective factors (e.g., incidental emotions, affective forecasting), and motivational factors (e.g., regarding oneself positively, adhering to social norms) in judgment and decision-making. In so doing, we consider how knowledge of these factors might inform practice toward the end of improving preference-based decision-making regarding the results of genome sequencing.
Lowe, R & O'Brian, S 2019, 'Posttreatment Relapse in Stuttering' in Damico, JS & Ball, MJ (eds), The SAGE encyclopedia of human communication sciences and disorders, SAGE Publications, Inc., Thousand Oaks, CA, pp. 1437-1438.
View/Download from: Publisher's site
Lowe, R & O'Brian, S 2019, 'Stuttering and Adolescence' in Damico, JS & Ball, MJ (eds), The SAGE encyclopedia of human communication sciences and disorders, SAGE Publications, Inc., Thousand Oaks, CA, pp. 1852-1855.
View/Download from: Publisher's site
Lowe, R, Carey, B, Amato Maguire, M & Onslow, M 2019, 'Designing therapy for adolescents' in Tomaiuoli, D (ed), Proceedings of the 3rd International Conference on Stuttering, Erickson, Trento, Italy, pp. 234-235.
Odgaard, L, Harsløf, I & Stubbs, P 2019, 'Return to Work After Severe Traumatic Brain Injury in Diverse Labour Market and Welfare State Contexts' in Harslof, I, Poulsen, I & Larsen, K (eds), New Dynamics of Disability and Rehabilitation: Interdisciplinary Perspectives, Palgrave Macmillan, Singapore, pp. 145-170.
View/Download from: Publisher's site
View description>>
This chapter reviews the rates and predictors of return to work (RTW) after severe traumatic brain injury (TBI) in Denmark, and compares RTW rates across numerous countries. While differences can be attributed to a multitude of methodological differences, including how RTW is defined and the type of data available, we argue that countries can be roughly categorized in terms of RTW performance. The comparative assessment discusses studies from Northern European countries representing social democratic (Denmark and Norway) and conservative-corporatist models (France and the Netherlands), as well as available data from a liberal welfare state overseas (USA). Complementing studies from these Global North countries, a study from Brazil is also included. The analysis reveals that RTW is lower in Denmark and Norway compared to other countries. One plausible explanation is that the welfare state institutional setting partly exempts employers from responsibilities towards job seekers with disabilities. We address the RTW challenges for severe TBI survivors in the context of inappropriate work opportunities and an increasing requirement for highly skilled workers in the labour market. Finally, we propose potential strategies for Nordic countries to improve RTW outcomes after severe TBI.
Onslow, M, Menzies, R, Packman, A, Lowe, R & O'Brian, S 2019, 'Back to the future: A virtual clinic for stuttering' in Tomaiuoli, D (ed), Proceedings of the 3rd International Conference on Stuttering, Erickson, Trento, Italy, pp. 163-171.
View description>>
Stuttering is a global health problem, and there are not enough speech-language pathologists to provide treatment services for all those in the world who are affected by the disorder. We went to the future and saw the ultimate solution; internet driven treatments for stuttering that do notneed a speech-language pathologist or a clinical psychologist. Clinical trials are now underway for four internet driven treatments, and the future of stuttering treatment is a wonderful place to be.
Rossing, C, Benrimoj, SI & Garcia-Cardenas, V 2019, 'Implementation of Pharmaceutical Care in Community Setting' in The Pharmacist Guide to Implementing Pharmaceutical Care, Springer International Publishing, Germany, pp. 213-223.
View/Download from: Publisher's site
View description>>
Pharmaceutical care services in primary care have been an area of research from the initial definitions in the early 1990s. The research has resulted in a range of evidence-based services delivered in primary care setting, from the community pharmacies and by the pharmacy workforce. Research has also been focusing on the implementation in community pharmacy practice, taking into account the change in perception of the pharmacy that is needed to deliver pharmaceutical care services. In many countries, pharmaceutical care services are remunerated and to a some extent are delivered to the public, although there is still an implementation gap between what is the potential of service delivery and what is actually delivered. The services are implemented in primary care, primarily delivered by the community pharmacy confirming the role of the community pharmacy in the primary healthcare system.
Ryan, B, Worrall, L, Sekhon, J, Baker, C, Carragher, M, Bohan, J, Power, E, Rose, M, Simmons-Mackie, N, Togher, L & Kneebone, I 2019, 'Time to step up' in Psychotherapy and Aphasia, Routledge, pp. 1-16.
View/Download from: Publisher's site
Wadhwa, R, Aggarwal, T, Thapliyal, N, Chellappan, DK, Gupta, G, Gulati, M, Collet, T, Oliver, B, Williams, K, Hansbro, PM, Dua, K & Maurya, PK 2019, 'Nanoparticle-Based Drug Delivery for Chronic Obstructive Pulmonary Disorder and Asthma' in Nanotechnology in Modern Animal Biotechnology, Elsevier, The Netherlands, pp. 59-73.
View/Download from: Publisher's site
View description>>
Pulmonary diseases including chronic obstructive pulmonary disease (COPD) and asthma affect millions of people all over the world. Conventional treatment methodologies are not sufficient to cure or prevent the disease. With the advent of nanotechnology, drug delivery to specific target site is still challenging, but targeted delivery can be achieved by physiochemical properties of the nanoparticles. Delivery of nanoparticles, liposomes, dendrimers, and others has been extensively studied for successful delivery by inhalation and aerosols. Several factors such as size, density, surface, and physical-chemical properties of nanoparticle are essential to cross airway barriers. In this chapter, different nanoparticle-mediated drug delivery systems have been highlighted along with their applications and toxicity in COPD and asthma.
Wadhwa, R, Shukla, SD, Chellappan, DK, Gupta, G, Collet, T, Hansbro, N, Oliver, B, Williams, K, Hansbro, PM, Dua, K & Maurya, PK 2019, 'Phytotherapy in Inflammatory Lung Diseases: An Emerging Therapeutic Interventional Approach' in Phytochemistry: An in-silico and in-vitro Update, Springer Singapore, Singapore, pp. 331-347.
View/Download from: Publisher's site
View description>>
Chronic obstructive pulmonary disease (COPD) and asthma are the most common inflammatory respiratory diseases related to an increase in mortality and morbidity. Generally, bronchodilators, ß- agonists, anticholinergics and theophylline used for treatment in these conditions and administered by inhalation for delivery, have localized and systematic effects. The adverse effects are due to pharmacodynamic and pharmacokinetic changes and especially drug-drug and drug-disease interactions. However, phytotherapy is classical and widespread throughout the world for the treatment of ailments. This chapter highlights cellular and molecular mediators involved in COPD and asthma, the shortcomings of current therapies and the emerging need of phytomedicines. Phytomedicine supports respiratory physiology, bronchial action and possesses antioxidants to maintain homeostasis.
Journal articles
Abdelraheem, M, McAloon, J & Shand, F 2019, 'Mediating and moderating variables in the prediction of self-harm in young people: A systematic review of prospective longitudinal studies', Journal of Affective Disorders, vol. 246, pp. 14-28.
View/Download from: Publisher's site
View description>>
© 2018 Elsevier B.V. Background: : Self-harm is widespread amongst young people. A growing body of research has explored factors that predict self-harm in young people, however, a systematic review of mediators and moderators of those factors has not yet been offered. This review aims to fill this gap by synthesising research about mediators and moderators of factors that prospectively predict self-harm in young people. Method: : A systematic review of research trials published up until 2018 was undertaken. Electronic databases Scopus (Elsevier), CINAHL, PsychINFO (EBSCO) and Medline were searched. Included studies utilised prospective longitudinal designs with participants aged 25 years or younger and self-harm outcome measures with published or reported psychometric properties. The aim of the review was to identify mediators and moderators of factors that predict self-harm in young people. Results: : Of the 25 studies that met inclusion criteria, 22 reported at least one positive finding of a mediator or moderator. Specifically, 15 significant mediators and 20 significant moderators were identified in relation to a broad range of predictors of self-harm. Predictors were classified as adverse childhood experiences and parenting factors, psychological and psychiatric factors, social factors and intrapersonal factors. A number of potentially modifiable mediators and moderators were identified including interpersonal difficulties, impulsivity, self-esteem and self-compassion. Gender was the most commonly reported moderator. Limitations: : Included studies were assessed as limited by the heterogeneity of the mediators and moderators assessed, and by methodological factors including study durations, population characteristics, and the definition and assessment of self-harm. In addition, replication research was limited. Therefore it was difficult to integrate results and draw firm conclusions. Conclusions: : This review allowed us to explore diverse relatio...
Ahumada-Canale, A, Quirland, C, Martinez-Mardones, FJ, Plaza-Plaza, JC, Benrimoj, S & Garcia-Cardenas, V 2019, 'Economic evaluations of pharmacist-led medication review in outpatients with hypertension, type 2 diabetes mellitus, and dyslipidaemia: a systematic review', The European Journal of Health Economics, vol. 20, no. 7, pp. 1103-1116.
View/Download from: Publisher's site
View description>>
OBJECTIVES:To evaluate the health economics evidence based on randomized controlled trials of pharmacist-led medication review in pharmacotherapy managed cardiovascular disease risk factors, specifically, hypertension, type-2 diabetes mellitus and dyslipidaemia in ambulatory settings and to provide recommendations for future evaluations. METHODS:A systematic review was carried out according to the Cochrane Handbook for Systematic Reviews. PubMed (Medline), Scopus, Web of Science, National Health System Economic Evaluation Database (NHS EED), Cochrane Library, and Econlit were searched and screened by two independent authors. Incremental cost-effectiveness ratio was the main outcome. Risk of bias was assessed with the Effective Practice and Organisation of Care tool by the Cochrane Collaboration. Economic evaluation quality was assessed with the he Consensus Health Economic Criteria list (CHEC list). RESULTS:5636 records were found, and 174 were retrieved for full-text review yielding 11 articles. Eight articles deemed the intervention as cost effective and two as dominant. Two cost-utility analyses were performed yielding ICERs of $612.7 and $59.8 per QALY. Four articles were considered to perform a high-quality economic evaluation and four had a low risk of bias. Future economic evaluations should consider cost-utility analysis, to describe usual care thoroughly, and use time horizons that capture the effect of cardiovascular disease prevention, a societal perspective and uncertainty analysis. CONCLUSION:Pharmacist-led medication review has proven to be cost effective in various studies in different settings. Policy decision makers are advised to undertake local economic evaluations reflecting the gaps observed in this systematic review and published literature. If this is not possible, a transferability assessment should be conducted.
Aldryhim, AY, Alomair, A, Alqhtani, M, Mahmoud, MA, Alshammari, TM, Pont, LG, Kamal, KM, Aljadhey, H, Mekonnen, AB, Alwhaibi, M, Balkhi, B & Alhawassi, TM 2019, 'Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia', Expert Opinion on Drug Safety, vol. 18, no. 8, pp. 745-752.
View/Download from: Publisher's site
View description>>
Objectives: Adverse drug reactions (ADRs) are a pervasive global problem, and its management is integral to patient safety and healthcare quality. Pharmacists play a pivotal role in monitoring and reporting ADRs, which has a direct impact on patient care. The aim of this study was to identify potential factors that facilitate pharmacists in community and hospital settings to report ADRs. Methods: A cross-sectional, online survey using a validated questionnaire was administered to pharmacists working in community and hospital pharmacies in Saudi Arabia. Results: 1,717 community and 153 hospital pharmacists participated in this study. Only 10.2% and 26.8% of community and hospital pharmacists, respectively, admitted ever reporting an ADR. The most reported factors that may facilitate ADRs reporting have included ongoing improvements in therapeutic knowledge about ADRs, attending educational programs with continuous medical education credits, the seriousness of the experienced ADRs and accessibility to patients' medical profile. The impact of peers by seeing colleagues reporting ADRs and ADRs due to herbal or traditional medicine were the least important factors reported by pharmacists. Conclusion: The study identified factors that can effectively address the under-reporting of ADRs by pharmacists. A multi-stakeholder, multi-pronged approach of ADR reporting is needed to develop greater awareness of this issue among pharmacists.
Allen, CG, Fohner, AE, Landry, L, Paul, J, Smith, SG, Turbitt, E & Roberts, MC 2019, 'Early career investigators and precision public health', The Lancet, vol. 394, no. 10196, pp. 382-383.
View/Download from: Publisher's site
Allen, CG, Fohner, AE, Landry, L, Paul, JL, Smith, SG, Turbitt, E & Roberts, MC 2019, 'Perspectives From Early Career Investigators Who Are “Staying in the Game” of Precision Public Health Research', American Journal of Public Health, vol. 109, no. 9, pp. 1186-1187.
View/Download from: Publisher's site
Aly, M, García-Cárdenas, V, Williams, KA & Benrimoj, SI 2019, 'A qualitative study of stakeholder views and experiences of minor ailment services in the United Kingdom', Research in Social and Administrative Pharmacy, vol. 15, no. 5, pp. 496-504.
View/Download from: Publisher's site
View description>>
© 2018 Elsevier Inc. Background: An international strategy designed to promote access to primary care is the utilisation of community pharmacy to deliver structured minor ailment services (MASs). An understanding of key implementation features of MASs will support effective service delivery and implementation, promote MAS viability, sustainability and overall improvement. Aim: The aim of this study is to explore the views and experiences of a range of stakeholders concerning the implementation of MASs in the United Kingdom. Methods: A qualitative approach was used to obtain data. Participants were recruited using purposeful and snowball sampling. Stakeholders from five different regions were included. Using the digital recordings of the interviews, thematic content analysis was undertaken. Results: Thirty-three participants agreed to be interviewed. Twenty-nine semi-structured interviews were conducted. Thematic content analysis yielded three major themes, including (1)benefits of MASs, (2)structural challenges associated with MAS design and (3)other implementation factors associated with MAS delivery. Stakeholders recognised the positive impact of the service to improve patient access and care, promote efficiencies, and promote the professional role of the pharmacist. Nevertheless barriers do exist to service delivery and implementation. Stakeholders identified the need to potentially increase the population groups served by MASs, increase the conditions treated and widen their formulary lists. Similarly, marketing strategies needed to be improved to enhance consumer awareness. Stakeholders presented mixed views about whether pharmacists needed to complete clinical training and the need to increase pharmacist's remuneration. In addition the level of healthcare collaboration needed to improve. Conclusion: Several concepts emerged from the investigation to facilitate service delivery. Barriers to service implementation had a variable impact on implementa...
Andrews, S & Veldre, A 2019, 'What is the most plausible account of the role of parafoveal processing in reading?', Language and Linguistics Compass, vol. 13, no. 7.
View/Download from: Publisher's site
View description>>
Bailey, PE & Leon, T 2019, 'A SYSTEMATIC REVIEW AND META-ANALYSIS OF AGE-RELATED DIFFERENCES IN TRUST', Innovation in Aging, vol. 3, no. Supplement_1, pp. S477-S477.
View/Download from: Publisher's site
View description>>
Bailey, PE, Petridis, K, McLennan, SN, Ruffman, T & Rendell, PG 2019, 'Age-Related Preservation of Trust Following Minor Transgressions', The Journals of Gerontology: Series B, vol. 74, no. 1, pp. 74-81.
View/Download from: Publisher's site
Bancroft, EK, Saya, S, Page, EC, Myhill, K, Thomas, S, Pope, J, Chamberlain, A, Hart, R, Glover, W, Cook, J, Rosario, DJ, Helfand, BT, Hutten Selkirk, C, Davidson, R, Longmuir, M, Eccles, DM, Gadea, N, Brewer, C, Barwell, J, Salinas, M, Greenhalgh, L, Tischkowitz, M, Henderson, A, Evans, DG, Buys, SS, Eeles, RA & Aaronson, NK 2019, 'Psychosocial impact of undergoing prostate cancer screening for men with
View/Download from: Publisher's site
View description>>
Benson, H, Lucas, C, Benrimoj, SI & Williams, KA 2019, 'The development of a role description and competency map for pharmacists in an interprofessional care setting', International Journal of Clinical Pharmacy, vol. 41, no. 2, pp. 391-407.
View/Download from: Publisher's site
View description>>
Background Pharmacists are increasingly being included as members of general practice primary care teams. To date, there have been few published studies describing the competencies of general practice (GP) pharmacists and establishing their subsequent educational needs. Aim of the review The aim of this literature review is to establish the activities of pharmacists in general practice to inform the development of a comprehensive role description and competency map. Method A systematic literature search of EMBASE, MEDLINE, international pharmaceutical abstracts and the Cochrane database of systematic reviews was conducted from the start of the databases to August 2018. The search focused on studies investigating the roles performed by GP pharmacists. Full text peer-reviewed English language articles were included. A qualitative content analysis of included studies was performed. Two researchers reviewed studies to identify pharmacist roles. Subcategories of roles were then agreed by the research team and used to present the data. GP pharmacist's activities were mapped by two researchers to associated competencies. Any discrepancies between role descriptions and competency maps were resolved in consultation with a third member of the research team. Results The search conducted resulted in 5370 potential articles. Two hundred and twenty-seven full text articles were selected for review resulting in 34 articles that were included for analysis. Seven GP pharmacist role sub-categories and 48 GP pharmacist individual roles were identified. The seven GP pharmacist role sub-categories included medication management, patient examination and screening, chronic disease management, drug information and education, collaboration and liaison, audit and quality assurance and research. All FIP competency domains were included in the GP pharmacist competency map. Competencies related to compounding, dispensing and packaging of medications were not found relevant to the GP Pharmaci...
Best, M, Butow, P, Juraskova, I, Savard, J, Meiser, B, Goldstein, D, Ballinger, M, Jacobs, C, Bartley, N, Davies, G, Thomas, D, Biesecker, B, Tucker, K, Schlub, TE & Newson, A 2019, 'Advanced cancer patient preferences for return of molecular profiling results', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 15, pp. 92-92.
Best, MC, Bartley, N, Jacobs, C, Juraskova, I, Goldstein, D, Newson, AJ, Savard, J, Meiser, B, Ballinger, M, Napier, C, Thomas, D, Biesecker, B & Butow, P 2019, 'Patient perspectives on molecular tumor profiling: “Why wouldn’t you?”', BMC Cancer, vol. 19, no. 1, pp. 753-753.
View/Download from: Publisher's site
View description>>
© 2019 The Author(s). Aim: This study explored the attitudes of patients with advanced cancer towards MTP and return of results, prior to undergoing genomic testing within a research program. Methods: Participants were recruited as part of the longitudinal PiGeOn (Psychosocial Issues in Genomics in Oncology) study involving patients with advanced/metastatic solid cancer who had exhausted therapeutic options and who were offered MTP in order to identify cognate therapies. Twenty patients, selected by purposive sampling, were interviewed around the time they gave consent to MTP. Interviews were audio recorded, transcribed and analysed using thematic analysis. Themes identified in the transcripts were cross-validated via qualitative responses to the PiGeOn study survey (n = 569; 63%). Results: All interviewed participants gave consent to MTP without reservation. Three themes were identified and further supported via the survey responses: (1) Obvious agreement to participate, primarily because of desire for new treatments and altruism. (2) The black box - while participant knowledge of genomics was generally poor, faith in their oncologists and the scientific process encouraged them to proceed with testing; and (3) Survival is the priority - receiving treatment to prolong life was the priority for all participants, and other issues such as identification of a germline variant were generally seen as ancillary. Conclusion: Having advanced cancer seemed to abrogate any potential concerns about MTP. Participants valued the research for varied reasons, but this was secondary to their priority to survive. While no negative attitudes toward MTP emerged, limitations in understanding of genomics were evident.
Bhattarai, P, Newton-John, TRO & Phillips, JL 2019, 'Feasibility evaluation of a pain self-management app-based intervention among older people living with arthritic pain: study protocol', Pilot and Feasibility Studies, vol. 5, no. 1, pp. 57-57.
View/Download from: Publisher's site
View description>>
Background: Optimal management of chronic arthritic pain experienced by older adults involves applying active self-management strategies every day. Cost-effective and innovative strategies to help build older people's pain self-management capability are required. This study protocol is designed to evaluate the feasibility, acceptability, and preliminary outcomes of a pain self-management app among older people living in the community with arthritic pain. Methods/design: This is a phase I feasibility study. A pre-post test study design will be used to trial a freely available pain self-management app named Rheumatoid Arthritis Information Support and Education ('RAISE') for 14 days. Thirty community-dwelling older people living with arthritic pain who use a smartphone will be recruited from (1) various community-based social clubs/organizations/groups or (2) via Facebook groups with potentially high number of older members. In addition, snowballing sampling approach will also be utilized.These participants will trial the RAISE app, which was selected following a systematic evaluation of all available chronic pain apps by the investigator team. A face-to-face or telephone-based meeting will be organized with all consenting participants in order to seek their informed consent, download and set up the intervention app on their mobile device, be provided with app training, and complete the pre-test data (Time 1 (T1)). Participants will be asked to use the RAISE app as desired for 14 days. Post-test data collection (Time 2 (T2)) will occur on day 15. Data collected includes participant's demographic and clinical information, pain scores, pain self-efficacy, and online technology self-efficacy. Participants will be invited to take part in a semi-structured telephone interview at T2 to explore their experiences of using the app.An evaluation of patterns of app use, recruitment, retention, attrition rates, and analysis of the missing data will inform the study a...
Bier, JD, Scholten-Peeters, WGM, Staal, JB, Pool, J, van Tulder, MW, Beekman, E, Knoop, J, Meerhoff, G & Verhagen, AP 2019, 'Author Response', Physical Therapy, vol. 99, no. 1, pp. 120-120.
View/Download from: Publisher's site
Blake, HL & McLeod, S 2019, 'Speech-language pathologists’ support for multilingual speakers’ English intelligibility and participation informed by the ICF', Journal of Communication Disorders, vol. 77, pp. 56-70.
View/Download from: Publisher's site
View description>>
PURPOSE:To use the ICF to classify characteristics and aspirations of multilingual university students and faculty who seek speech-language pathologists' support for intelligibility in English and to identify activities, facilitators, and barriers that impact participation in society. METHOD:A retrospective record review was conducted on files of 175 clients attending a university clinic for intelligibility enhancement (accent modification). Participants came from 35 countries and spoke 28 different home languages. RESULTS:Assessment and intervention for intelligibility enhancement involved consideration of ICF components of Body Functions and Structures (e.g., articulating phonemes, rate, prosody), Environmental Factors (e.g., support), and Personal Factors (e.g., motivation). Consonant substitutions and deletions were common, although participants were often unaware of these. For example, only 25.6% of participants reported English dental fricatives (/θ/ and /ð/) were difficult to pronounce; however, 94.9% substituted them with other phonemes such as [t] and [d]. The combination of substitutions/deletions, fast speech rate, low speaking volume, and differences in word stress exacerbated poor intelligibility. More time conversing in English was associated with greater confidence and less difficulty communicating in English, although more time knowing English was not. Difficult communication situations were reported to be conversing over the phone, talking to strangers, and communicating in English on professional fieldwork placements. Participants were motivated to seek intelligibility enhancement for academic, employment, and social reasons. CONCLUSIONS:To ensure multilingual speakers are able to participate fully in society, intelligibility enhancement requires a multi-pronged approach where speech and environmental characteristics interweave.
Blake, HL, Bennetts Kneebone, L & McLeod, S 2019, 'The impact of oral English proficiency on humanitarian migrants’ experiences of settling in Australia', International Journal of Bilingual Education and Bilingualism, vol. 22, no. 6, pp. 689-705.
View/Download from: Publisher's site
View description>>
© 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group. Key drivers for migrants’ social integration are education, employment, and skills in the dominant language of the settlement country. Data from Building a New Life in Australia: The Longitudinal Study of Humanitarian Migrants were used to examine migrants’ English proficiency and how oral English proficiency facilitated or hindered participation in activities that may help them become self-sufficient and settle. Participants were 2399 humanitarian migrants interviewed in the first wave of data collection (during 2013/14). Before arrival in Australia, 80.1% reported they spoke English not well or not at all. After arrival, oral English proficiency was a statistically significant predictor of self-sufficiency (knowing how to look for a job, get help in an emergency, etc.) explaining 21% of the variance while controlling for confounding variables such as age and education. After English proficiency, age (neither too young nor too old), gender (male), education (more than 12 years), and time since arrival (more than one year) were significant predictors of self-sufficiency. Identification of factors that predict self-sufficiency informs the understanding of people who provide support for humanitarian migrants. These findings indicate poor oral English skills may profoundly hinder humanitarian migrants’ ability to settle and highlight the importance of supporting migrants’ English learning.
Brady, B, Kneebone, II & Bailey, PE 2019, 'Validation of the Emotion Regulation Questionnaire in older community‐dwelling adults', British Journal of Clinical Psychology, vol. 58, no. 1, pp. 110-122.
View/Download from: Publisher's site
View description>>
Brady, B, Kneebone, II & Bailey, PE 2019, 'Validation of the Five Facet Mindfulness Questionnaire Among Community-Dwelling Older Adults', Mindfulness, vol. 10, no. 3, pp. 529-536. © 2018, Springer Science+Business Media, LLC, part of Springer Nature. The 24-item Five Facet Mindfulness Questionnaire – Short Form (FFMQ-SF) was developed to measure five facets of dispositional mindfulness: observing, describing, acting with awareness, non-judgment of inner experience, and non-reactivity to inner experience. The FFMQ-SF is increasingly used with older adult populations, despite not having been appropriately validated for such use. The present study examined the psychometric properties of the FFMQ-SF among community-dwelling older adults (N = 210). The five subscales of the FFMQ-SF were found to be internally consistent. Convergent validity analyses revealed that all facets of mindfulness except observing were negatively correlated with negative affect, and all facets except for non-judgment were positively correlated with positive affect. Similarly, all facets except for non-judgment were positively correlated with cognitive reappraisal emotion regulation tendencies. Only describing, acting with awareness, and non-judgment were negatively correlated with expressive suppression tendencies. The original five-factor structure of the FFMQ-SF was supported by confirmatory factor analyses. The two-factor higher order structure of the FFMQ-SF was also supported. Overall, the results support the psychometric properties of the FFMQ-SF for use with older adult samples. Breiholz, S, -Mammen, NG, Krueger, K, Schaefer, M & Schulz, M 2019, 'Acceptance of a medication refill reminder service in German community pharmacy practice.', Pharmazie, vol. 74, no. 3, pp. 186-190. Medication refill reminder services (MRRS), having the potential to support the detection of non-adherence and to promote periodic medication refilling by addressing forgetfulness, are not generally available in community pharmacy practice. Based on a new software module, a MRRS was developed. The acceptance of this service was tested in community pharmacies in Germany. Patients were recruited by trained pharmacy staff. Supported by the software, the pharmacies reminded patients to refill their prescription. After 7 months, the service was evaluated by patients and pharmacy staff. The pharmacy owners/managers were interviewed. Ten pharmacies applied the service to 148 patients, with 806 refill reminders for 391 drugs. Seventy-five patients (50.7%) chose to be reminded by a phone call, followed by text message (n=25), and email (n=18). Of all patients, 75 (50.7%) completed the paper-based questionnaire. Sixty-eight (90.7%) rated the service as good or very good and 54 (72.0%) felt more satisfied with their pharmacy. Sixty-four patients (85.3%) considered the service as supportive and wanted to continue. Thirty-nine pharmacy staff members (61.9%) answered the online questionnaire. Twenty-four (61.5%) stated that they found it difficult to use and apply the MRRS; twenty-six (66.6%) experienced technical problems. The service was rated good by 16 (41.0%) pharmacy staff members. They regarded the service helpful for some patients and wanted to continue after the end of the study. The majority of the ten interviewed pharmacy owners/managers expressed the opinion that the service was not very suitable for increasing customer loyalty and not cost-effective. Nevertheless, six (60.0%) of them wanted to continue using the service. The MRRS seems to be feasible, apart from technical difficulties. Patients rated the service as supportive, and the personal contact seems to be of high importance; most patients would like to continue the service. However, offering the ... Brunner, M, Palmer, S, Togher, L & Hemsley, B 2019, '‘I kind of figured it out’: the views and experiences of people with traumatic brain injury (TBI) in using social media—self‐determination for participation and inclusion online', International Journal of Language & Communication Disorders, vol. 54, no. 2, pp. 221-233. Bryant, L, Ferguson, A, Valentine, M & Spencer, E 2019, 'Implementation of discourse analysis in aphasia: investigating the feasibility of a Knowledge-to-Action intervention', Aphasiology, vol. 33, no. 1, pp. 31-57. Bulsara, SM, Begley, K, Smith, DE, Chan, DJ, Furner, V, Coote, KV, Hennessy, RM, Alperstein, DM, Price, A, Smith, M, Wyson, A & Wand, H 2019, 'The development of an HIV-specific complexity rating scale', International Journal of STD & AIDS, vol. 30, no. 13, pp. 1265-1274. Bulsara, SM, Wainberg, ML, Audet, CM & Newton-John, TRO 2019, 'Retention in HIV Care in Australia: The Perspectives of Clinicians and Clients, and the Impact of Medical and Psychosocial Comorbidity', AIDS Patient Care and STDs, vol. 33, no. 10, pp. 415-424. © Copyright 2019, Mary Ann Liebert, Inc., publishers 2019. Significant advances in our understanding and treatment of HIV have led to improvements in the medical management of the illness, as HIV infection has evolved from an acute to a chronic illness. Increasing our understanding of the medical and/or psychosocial comorbidities, which can interact to determine 'clinical complexity' and impact HIV management, will further strengthen this process. Retention in care is a critical step of the HIV Treatment Cascade, which facilitates effective management of these comorbidities and their impact on HIV medical management. This study sought to build on literature regarding medical and/or psychosocial comorbidity that impacts retention in care, and it often leads to clinically complex presentations, by gaining the perspectives of people living with HIV (PLHIV), and medical and allied health clinicians in the field in Sydney, Australia. A total of 16 clinicians (medical doctors, nurses, clinical psychologists, and social workers) and 14 clients participated in a series of focus groups; they were asked to comment on the perceived barriers to retention and the potential solutions to overcome these. The results indicated a significant degree of overlap between clinician and client perspectives, and they identified 'service-specific factors,' 'logistic/practical factors,' 'medical/physical factors,' and 'psychosocial factors' as potential barriers to retention. Results are reviewed in the context of similarities and differences in perspectives between clinicians and PLHIV, and limitations regarding the generalizability of findings are discussed. The broader context of comorbidity and clinical complexity is also examined. Burton, AL & Abbott, MJ 2019, 'Processes and pathways to binge eating: development of an integrated cognitive and behavioural model of binge eating', Journal of Eating Disorders, vol. 7, no. 1, p. 18. Background:There are a number of factors commonly believed to be important to the development and maintenance of binge eating that have been identified across multiple models and theories in the psychological literature. In the present study, we sought to develop and test a psychological model for binge eating that incorporated the main variables identified in the literature to drive binge eating behaviour; specifically, core low self-esteem, negative affect, difficulty with emotional regulation, restricted eating and beliefs about eating. Methods:Questionnaire data was collected from 760 unselected participants. The proposed model of binge eating was developed, bivariate relationships between the included variables were assessed, and the goodness-of-fit of this new model was evaluated using structural equations modelling. Result:The results identified significant bivariate relationships between all the included variables. While the originally proposed model did not provide a good fit to the data, the revised version of the model provided a good fit to the data. Conclusions:Supporting, integrating and building upon the current existing psychological models of binge eating, this study presents a new integrated cognitive and behavioural model of binge eating. The dual-pathway to binge eating identified in the new model provides a different way to understand transdiagnostic binge eating. Burton, O, Tenen, A & Hodge, C 2019, 'First presentation of keratoconus in a geriatric patient: Diagnosis and treatment of late progression', JCRS Online Case Reports, vol. 7, no. 4, pp. 65-70. © 2019 This case report presents an atypical, late presentation of keratoconus in a geriatric patient with successful management using a transepithelial corneal crosslinking (CXL) procedure. The treatment-naive 77-year old patient presented to the clinic after an assessment by an optometrist for recent onset of reduced vision that was initially thought to represent early cataract development. Corneal topography confirmed keratoconus, and subsequent review identified further progression. Crosslinking was performed using a transepithelial approach. The patient was followed for 3 years postoperatively. By the final visit, the uncorrected distance visual acuity had improved and the corrected distance visual acuity remained at 20/20 bilaterally. Corneal topographic parameters were considered stable. This case shows that keratoconus can present outside the previously established parameters and that CXL might be an effective option in older patients showing signs of progression. This might have additional benefits for future intraocular lens power calculations. Carcel, C, Neal, B, Oparil, S, Rogers, K, Narkiewicz, K, Wang, JG, Schiffrin, EL, Poulter, N, Azizi, M & Chalmers, J 2019, 'Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension', Journal of Hypertension, vol. 37, no. 11, pp. 2216-2224. OBJECTIVE:We evaluated the characteristics of patients with treatment-resistant hypertension (TRH) and the prevalence of TRH in a large multicountry sample of specialist tertiary centres. METHODS:The Survey of PatIents with treatment ResIstant hyperTension (SPIRIT) study was a retrospective review of medical records of patients seen at tertiary centres located in Western Europe, Eastern Europe, North America, South America, Australia and Asia. Data on demographics, medical history and medication use were extracted from medical records. Prevalence and incidence of TRH were based upon estimated catchment populations. RESULTS:On thousand, five hundred and fifty-five patients from 76 centres were included, mostly from centres that specialize in hypertension (55%), cardiology (11%) or nephrology (19%). Mean age was 64, 60% were men, 62% were Caucasian, 36% had chronic kidney disease, 41% had diabetes, 12% were smokers and 31% had a previous cardiovascular event. Daytime and night-time ambulatory blood pressure (BP) was the most frequently used measurement for diagnosis (82%). Ninety-five percent of patients were prescribed diuretics, 93% an inhibitor of the renin-angiotensin system, 86% a calcium channel blocker, 74% a beta-blocker and 36% an aldosterone antagonist. The overall estimated mean incidence of TRH was 5.8 per 100 000 per year (ranging between 2.3 and 14.0 across regions) and the corresponding estimated mean prevalence of TRH was 23.9 per 100 000 (ranging between 7.6 and 90.5 across regions). CONCLUSION:Observed variation likely reflects real differences in patient characteristics and physician management practices across regions and specialities but may also reflect differences in patient selection and errors in estimation of catchment population across participating centres. Carey, EA, del Pozo de Bolger, A & Wootton, BM 2019, 'Psychometric properties of the Hoarding Disorder-Dimensional Scale', Journal of Obsessive-Compulsive and Related Disorders, vol. 21, pp. 91-96. © 2019 Elsevier Inc. The Hoarding Disorder-Dimensional Scale (HD-D) is a new measure of hoarding symptom severity developed by the Diagnostic and Statistical Manual (5th Edition) Obsessive-Compulsive Spectrum Disorders Sub-workgroup. The aim of the current study was to assess the psychometric properties of this measure in a large, community sample. Five hundred and seventeen participants completed the study. The results indicated that the HD-D consists of a single factor accounting for 66% of the variance. The measure demonstrated high internal consistency (α = 0.87–0.88) and test-retest reliability (r = 0.84). The HD-D also demonstrated good convergent and divergent validity in this sample. There appeared to be good convergence between internet and paper and pencil formats of the HD-D (r = 0.88). Overall, the results indicate that the HD-D demonstrates sound psychometric properties in a community sample. Carragher, M, Ryan, B, Worrall, L, Thomas, S, Rose, M, Simmons-Mackie, N, Khan, A, Hoffmann, TC, Power, E, Togher, L & Kneebone, I 2019, 'Fidelity protocol for the Action Success Knowledge (ASK) trial: a psychosocial intervention administered by speech and language therapists to prevent depression in people with post-stroke aphasia', BMJ Open, vol. 9, no. 5, pp. e023560-e023560. Caruana, N, Inkley, C, Zein, ME & Seymour, K 2019, 'No influence of eye gaze on emotional face processing in the absence of conscious awareness', Scientific Reports, vol. 9, no. 1. Caruana, N, Seymour, K, Brock, J & Langdon, R 2019, 'Responding to joint attention bids in schizophrenia: An interactive eye-tracking study', Quarterly Journal of Experimental Psychology, vol. 72, no. 8, pp. 2068-2083. Caruana, N, Stein, T, Watson, T, Williams, N & Seymour, K 2019, 'Intact prioritisation of unconscious face processing in schizophrenia', Cognitive Neuropsychiatry, vol. 24, no. 2, pp. 135-151. Caynes, K, Rose, TA, Theodoros, D, Burmester, D, Ware, RS & Johnston, LM 2019, 'The Functional Communication Classification System: extended reliability and concurrent validity for children with cerebral palsy aged 5 to 18 years', Developmental Medicine & Child Neurology, vol. 61, no. 7, pp. 805-812. Cohen, R, Fardouly, J, Newton-John, T & Slater, A 2019, '#BoPo on Instagram: An experimental investigation of the effects of viewing body positive content on young women’s mood and body image', New Media & Society, vol. 21, no. 7, pp. 1546-1564. Cohen, R, Irwin, L, Newton-John, T & Slater, A 2019, '#bodypositivity: A content analysis of body positive accounts on Instagram', Body Image, vol. 29, pp. 47-57. © 2019 Elsevier Ltd In the last decade, the body image literature has begun to extend beyond a primary focus on body image disturbances and examine the construct of positive body image. Similarly, “Body positivity” is a growing social media trend that seeks to challenge dominant societal appearance ideals and promote acceptance and appreciation of all bodies and appearances. The present study provides a content analysis of body positive posts on Instagram. A set of 640 Instagram posts sampled from popular body positive accounts were coded for physical appearance-related attributes and central themes featured. Results showed that body positive imagery typically depicted a broad range of body sizes and appearances. Additionally, while a proportion of posts were appearance-focused, the majority of posts conveyed messages aligned with theoretical definitions of positive body image. This study clarifies body positive content on Instagram, as well as highlights points of overlap and distinction from academic principles of positive body image and other appearance-focused social media content. Accordingly, the results offer theoretical and practical implications for future research and prevention efforts. Crabtree, J & Newton-John, TRO 2019, 'Comparisons and associations between personality, creative potential and achievement in creative, non-creative and early psychosis participants', Psychosis, vol. 11, no. 2, pp. 138-150. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Epidemiological evidence supports common genetic determinants between psychosis spectrum populations and creative individuals. Aspects of personality may contribute to protecting the creative artist from psychosis vulnerability. This study examines the similarities and differences in personality within a sample of early psychosis (EP), creative control (CC) and non-creative control (NCC) participants. Findings indicated that the CC group shared closer personality commonalities with the EP group than with NCC participants, on traits such as Neuroticism, Openness and Impulsive Non-Conformity as well as on variables such as Unusual Experiences, Cognitive Disorganisation and Paranoia/Suspiciousness. However, the CC group may better manage their emotional sensitivity and interpersonal suspiciousness than the EP participants. In separate analyses, CC and EP participants recorded higher creative cognition than NCC participants. Unsurprisingly, the CC group reported significantly higher creative achievement than the EP and NCC samples. Of note, the findings indicate that EP participants recorded significantly higher creative achievement than NCC, suggesting that EP patients demonstrate some capacity for creative cognition and creative achievement. These preliminary findings may encourage further research and promote avenues of treatment for at-risk creative individuals and EP individuals. Crook, A, Hogden, A, Mumford, V, Blair, IP, Williams, KL & Rowe, DB 2019, 'Theme 13 Clinical management and support', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 20, no. sup1, pp. 327-347. Background: Pathogenic variants in ALS genes are known to be present in up to 70% of familial and 10% of apparently sporadic ALS cases, and can be associated with risks for ALS only, or risks for other neurodegenerative diseases (eg. frontotemporal dementia). While there are no changes to medical management for patients confirmed as pathogenic variant carriers, genetic testing may be important for future drug trials. Confirmation of a pathogenic variant also provides relatives with the opportunity to consider predictive and/or reproductive genetic testing. Genetic counselling is an important aspect of testing decision-making as it enables individuals to make informed decisions about genetic testing while minimising adverse psychological, ethical and legal outcomes. Few studies have explored how individuals decide whether to pursue testing, nor the needs and experiences of familial ALS families.Objective: To identify factors that influence patient and family member decision-making about genetic testing for ALS genes, assess the impact of familial disease on the patient and their family, and identify information and support needs.Methods: In-depth, semi-structured interviews with individuals from Australian ALS families with known pathogenic gene variants explored experiences of familial ALS, and factors that influenced genetic testing decision-making. Interviews were analysed using an inductive approach.Results: Thirty-four individuals from 24 families were interviewed and included patients (n = 4), spouses (n = 4), and asymptomatic at-risk relatives (n = 26). Life stage, experience of disease, costs, research opportunities, and attitudes to familial ALS and/or reproductive options influenced decision-making. Some patients and relatives experienced difficulty gaining accurate information from their health professionals about the costs and implications of genetic counselling or testing, resulting in a reluctance to proceed.Discussion and conclusion: This study prov... Crook, A, McEwen, A, Fifita, JA, Zhang, K, Kwok, JB, Halliday, G, Blair, IP & Rowe, DB 2019, 'The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 20, no. 5-6, pp. 310-316. © 2019, © 2019 World Federation of Neurology on behalf of the Research Group on Motor Neuron Diseases. C9orf72 hexanucleotide repeat expansions are the most common known cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Genetic testing for C9orf72 expansions in patients with ALS and/or FTD and their relatives has become increasingly available since hexanucleotide repeat expansions were first reported in 2011. The repeat number is highly variable and the threshold at which repeat size leads to neurodegeneration remains unknown. We present the case of an ALS patient who underwent genetic testing through our Motor Neurone Disease Clinic. We highlight current limitations to analysing and interpreting C9orf72 expansion test results and describe how this resulted in discordant reports of pathogenicity between testing laboratories that confounded the genetic counselling process. We conclude that patients with ALS or FTD and their at-risk family members, need to be adequately counselled about the limitations of current knowledge to ensure they are making informed decisions about genetic testing for C9orf72. Greater collaboration between clinicians, testing laboratories and researchers is required to ensure risks to patients and their families are minimised. Cutler, RL, der Linden, NV, (Charlie) Benrimoj, SI, Fernandez-Llimos, F & Garcia-Cardenas, V 2019, 'An evidence-based model to consolidate medication adherence cost estimation: the medication adherence cost estimation framework', Journal of Comparative Effectiveness Research, vol. 8, no. 8, pp. 555-567. Cutler, RL, Torres-Robles, A, Wiecek, E, Drake, B, Van der Linden, N, Benrimoj, SIC & Garcia-Cardenas, V 2019, '<p>Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system</p>', Patient Preference and Adherence, vol. Volume 13, pp. 853-862. © 2019 Cutler et al. Background: Scarcity of prospective medication non-adherence cost measurements for the Australian population with no directly measured estimates makes determining the burden medication non-adherence places on the Australian health care system difficult. This study aims to indirectly estimate the national cost of medication non-adherence in Australia comparing the cost prior to and following a community pharmacy-led intervention. Methods: Retrospective observational study. A de-identified database of dispensing data from 20,335 patients (n=11,257 on rosuvastatin, n=6,797 on irbesartan and n=2,281 on desvenlafaxine) was analyzed and average adherence rate determined through calculation of PDC. Included patients received a pharmacist-led medication adherence intervention and had twelve months dispensing records; six months before and six months after the intervention. The national cost estimate of medication non-adherence in hypertension, dyslipidemia and depression pre-and post-intervention was determined through utilization of disease prevalence and comorbidity, non-adherence rates and per patient disease-specific adherence-related costs. Results: The total national cost of medication non-adherence across three prevalent conditions, hypertension, dyslipidemia and depression was $10.4 billion equating to $517 per adult. Following enrollment in the pharmacist-led intervention medication non-adherence costs per adult decreased $95 saving the Australian health care system and patients $1.9 billion annually. Conclusion: In the absence of a directly measured national cost of medication non-adherence, this estimate demonstrates that pharmacists are ideally placed to improve patient adherence and reduce financial burden placed on the health care system due to non-adherence. Funding of medication adherence programs should be considered by policy and decision makers to ease the current burden and improve patient health outcomes moving forward. Dahm, MR, Georgiou, A, Balandin, S, Hill, S & Hemsley, B 2019, 'Health Information Infrastructure for People with Intellectual and Developmental Disabilities (I/DD) Living in Supported Accommodation: Communication, Co-Ordination and Integration of Health Information', Health Communication, vol. 34, no. 1, pp. 91-99. © 2019, © 2019 Taylor & Francis Group, LLC. People with intellectual and/or developmental disability (I/DD) commonly have complex health care needs, but little is known about how their health information is managed in supported accommodation, and across health services providers. This study aimed to describe the current health information infrastructure (i.e., how data and information are collected, stored, communicated, and used) for people with I/DD living in supported accommodation in Australia. It involved a scoping review and synthesis of research, policies, and health documents relevant in this setting. Iterative database and hand searches were conducted across peer-reviewed articles internationally in English and grey literature in Australia (New South Wales) up to September 2015. Data were extracted from the selected relevant literature and analyzed for content themes. Expert stakeholders were consulted to verify the authors’ interpretations of the information and content categories. The included 286 sources (peer-reviewed n = 27; grey literature n = 259) reflect that the health information for people with I/DD in supported accommodation is poorly communicated, coordinated and integrated across isolated systems. ‘Work-as-imagined’ as outlined in policies, does not align with ‘work-as-done’ in reality. This gap threatens the quality of care and safety of people with I/DD in these settings. The effectiveness of the health information infrastructure and services for people with I/DD can be improved by integrating the information sources and placing people with I/DD and their supporters at the centre of the information exchange process. Dahm, MR, Georgiou, A, Bryant, L & Hemsley, B 2019, 'Information infrastructure and quality person-centred support in supported accommodation: An integrative review', Patient Education and Counseling, vol. 102, no. 8, pp. 1413-1426. © 2019 Objectives: To integrate findings on the information infrastructure for people with intellectual or developmental disability (I/DD) living in supported accommodation, to understand how documentation use impacts person-centred support. Methods: We conducted an integrative literature review. Following screening by two independent reviewers, we included English language peer-reviewed empirical studies (n = 34) on documentation use for people with I/DD in domestic-scale supported accommodation. We appraised quality and extracted information for iterative comparative thematic and content analysis. Result: All studies reported written documentation regarding either the person with disability or the residence. Eighteen studies focused on health-specific information. We identified three key themes impacting on the person-centred support; 1) level of inclusion and independence of people with I/DD, 2) the culture of support within group homes, and 3) the quality use of information. Conclusions: Information infrastructure is closely aligned with the support culture in residences and can affect whether and to what extent key stakeholders (i.e., people with I/DD, family members) are involved in making decisions about healthcare and support needs. Practice implications: Surveying local service health information infrastructure can provide crucial insights which can be leveraged to improve the safety and quality of supports provided for people living in supported accommodation. D'Amanda, CS, Peay, HL, Wheeler, AC, Turbitt, E & Biesecker, BB 2019, 'Fragile X syndrome clinical trials: exploring parental decision‐making', Journal of Intellectual Disability Research, vol. 63, no. 8, pp. 926-935. dasNair, R, Griffiths, H, Clarke, S, Methley, A, Kneebone, I & Topcu, G 2019, 'Everyday memory measures in multiple sclerosis: a systematic review', Neuropsychological Rehabilitation, vol. 29, no. 10, pp. 1543-1568. Everyday memory is one of the most affected cognitive functions in multiple sclerosis (MS). Assessing everyday memory problems is crucial for monitoring the impact of memory deficits on individuals' day-to-day lives and evaluating the effectiveness of interventions that aim to improve cognitive functions. The aim of this systematic review was to identify the research literature on everyday memory measures used with people with MS, describe the types of measures used, and summarise their psychometric properties. Empirical studies of cognitive function in MS using standardised everyday memory measures were included. Online databases (MEDLINE, PsycINFO, PsycARTICLES, Embase) and Google Scholar were searched. Forty-four studies met the inclusion criteria. A total of 12 measures were identified, with varied uses and administration methods. The majority of papers did not report any psychometric properties for MS populations. The few papers that did, reported that the measures have good reliability and appear to have good face, concurrent, and ecological validity, but these need to be evaluated further. This review presents researchers and clinicians with an overview of the various everyday memory measures used in studies with people with MS, to help them choose the appropriate measure for their evaluations. de Almeida, MO, Saragiotto, BT, Maher, C & Costa, LOP 2019, 'Allocation Concealment and Intention-To-Treat Analysis Do Not Influence the Treatment Effects of Physical Therapy Interventions in Low Back Pain Trials: a Meta-epidemiologic Study', Archives of Physical Medicine and Rehabilitation, vol. 100, no. 7, pp. 1359-1366. de Oliveira, CQ, Middleton, JW, Refshauge, K & Davis, GM 2019, 'Activity-Based Therapy in a Community Setting for Independence, Mobility, and Sitting Balance for People With Spinal Cord Injuries', Journal of Central Nervous System Disease, vol. 11, pp. 117957351984162-117957351984162. de Oliveira, RF, Fandim, JV, Fioratti, I, Fernandes, LG, Saragiotto, BT & Pena Costa, LO 2019, 'The contemporary management of nonspecific lower back pain', Pain Management, vol. 9, no. 5, pp. 475-482. De Rubis, G, Rajeev Krishnan, S & Bebawy, M 2019, 'Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis', Trends in Pharmacological Sciences, vol. 40, no. 3, pp. 172-186. © 2019 Elsevier Ltd Liquid biopsies, comprising the noninvasive analysis of circulating tumor-derived material (the ‘tumor circulome’), represent an innovative tool in precision oncology to overcome current limitations associated with tissue biopsies. Within the tumor circulome, circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) are the only components the clinical application of which is approved by the US Food and Drug Administration (FDA). Extracellular vesicles (EVs), circulating tumor RNA (ctRNA), and tumor-educated platelets (TEPs) are relatively new tumor circulome constituents with promising potential at each stage of cancer management. Here, we discuss the clinical applications of each element of the tumor circulome and the prevailing factors that currently limit their implementation in clinical practice. We also detail the most recent technological developments in the field, which demonstrate potential in improving the clinical value of liquid biopsies. Dineen-Griffin, S, Garcia-Cardenas, V, Rogers, K, Williams, K & Benrimoj, SI 2019, 'Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial', JMIR Research Protocols, vol. 8, no. 8, pp. e13973-e13973. Dineen-Griffin, S, Garcia-Cardenas, V, Williams, K & Benrimoj, SI 2019, 'Helping patients help themselves: A systematic review of self-management support strategies in primary health care practice', PLOS ONE, vol. 14, no. 8, pp. e0220116-e0220116. © 2019 Dineen-Griffin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Background Primary health professionals are well positioned to support the delivery of patient self-management in an evidence-based, structured capacity. A need exists to better understand the active components required for effective self-management support, how these might be delivered within primary care, and the training and system changes that would subsequently be needed. Objectives (1) To examine self-management support interventions in primary care on health outcomes for a wide range of diseases compared to usual standard of care; and (2) To identify the effective strategies that facilitate positive clinical and humanistic outcomes in this setting. Method A systematic review of randomized controlled trials evaluating self-management support interventions was conducted following the Cochrane handbook & PRISMA guidelines. Published literature was systematically searched from inception to June 2019 in PubMed, Scopus and Web of Science. Eligible studies assessed the effectiveness of individualized interventions with follow-up, delivered face-to-face to adult patients with any condition in primary care, compared with usual standard of care. Matrices were developed that mapped the evidence and components for each intervention. The methodological quality of included studies were appraised. Results 6,510 records were retrieved. 58 studies were included in the final qualitative synthesis. Findings reveal a structured patient-provider exchange is required in primary care (including a one-on-one patient-provider consultation, ongoing follow up and provision of self-help materials). Interventions should be tailored to patient needs and may include combinations of strategies to improve a patient’s d... Donald, JN, Sahdra, BK, Van Zanden, B, Duineveld, JJ, Atkins, PWB, Marshall, SL & Ciarrochi, J 2019, 'Does your mindfulness benefit others? A systematic review and meta‐analysis of the link between mindfulness and prosocial behaviour', British Journal of Psychology, vol. 110, no. 1, pp. 101-125. Dorstyn, D, Roberts, R, Murphy, G, Craig, A, Kneebone, I, Stewart, P, Chur-Hansen, A, Marshall, R, Clark, J & Migliorini, C 2019, 'Work and SCI: a pilot randomized controlled study of an online resource for job-seekers with spinal cord dysfunction', Spinal Cord, vol. 57, no. 3, pp. 221-228. STUDY DESIGN:A prospective, parallel randomized controlled trial (RCT). OBJECTIVES:To test the preliminary effects of an online resource targeted to job-seekers with spinal cord injury or disorder (SCI/D), and to determine the feasibility of proceeding to a full-scale RCT. SETTING:A community cohort in Australia. METHODS:Forty-eight adults (M = 42 years, SD = 10.95, 27 males) were randomized to receive 4-weeks access to the Work and SCI resource (n = 25) or to a wait-list control group (n = 23). The Work and SCI intervention involved six stand-alone learning modules which provided job-searching and career-planning information through text, videos, and interactive activities. Self-report measures were administered at baseline and after 4 weeks: Job Procurement Self-Efficacy Scale (JSES), Life Orientation Test-Revised (LOT-R), and Patient Health Questionnaire-9 (PHQ-9). RESULTS:Online usage data identified high uptake of the Work and SCI resource, although study attrition was problematic. Intention-to-treat analyses failed to reach statistical significance, whereas complete data revealed a significant interaction effect for optimism (LOT-R). CONCLUSION:Further research to develop and enhance Work and SCI is indicated. Remediable strategies to optimize recruitment and statistical power in a future definitive RCT are discussed. SPONSORSHIP:This project was funded by the auDA Foundation (project 16019). Dorstyn, D, Roberts, R, Murphy, G, Kneebone, I, Craig, A, Chur-Hansen, A, Migliorini, C, Potter, E, Marshall, R, Clark, J, Neeson, S & Stewart, P 2019, 'Can targeted job-information for adults with spinal cord dysfunction be effectively delivered online? A pilot study', The Journal of Spinal Cord Medicine, vol. 42, no. 1, pp. 94-101. © 2019, © The Academy of Spinal Cord Injury Professionals, Inc. 2019. Objective: To pilot a novel email-based information package (Work and SCI) for job-seekers with an acquired spinal cord injury (SCI) or spinal cord dysfunction (SCI/D). Study design: Prospective, non-randomized, repeated measures trial. Setting: Community dwelling cohort in Australia. Participants: Five people with SCI (mean age 46.4 years, SD = 10.2; 4 female) initially reviewed Work and SCI. Twenty-four with SCI/D subsequently enrolled, of whom 16 (mean age 46.4 years, SD = 11.1; 7 female), completed the intervention. Intervention: Intervention participants accessed Work and SCI over a 4-week period. Outcome measures: Individual changes in pre-post scores for the My Vocational Situation Scale, Job Procurement Self-Efficacy Scale, Patient Health Questionnaire-9 and Life Orientation Test-Revised were examined. Results: Reliable change in pre-post scores across outcomes were reported by 38% (n = 6) of participants. Favorable comments on the Work and SCI resource were provided in addition to suggestions for improvement. Conclusions: Preliminary data suggest that Work and SCI may help to establish vocational interests among job-seekers with a SCI/D, however further work is needed to enhance participant compliance. This might include moderator support to promote and maintain participation. A controlled design will also help to identify factors that influence engagement with the Work and SCI resource. Drieghe, D, Veldre, A, Fitzsimmons, G, Ashby, J & Andrews, S 2019, 'The influence of number of syllables on word skipping during reading revisited', Psychonomic Bulletin & Review, vol. 26, no. 2, pp. 616-621. Dua, K, Gupta, G, Chellappan, DK, Shukla, S & Hansbro, PM 2019, 'Targeting bacterial biofilms in pulmonary diseases in pediatric population', Minerva Pediatrica, vol. 71, no. 3, pp. 309-310. Dua, K, Malyla, V, Singhvi, G, Wadhwa, R, Krishna, RV, Shukla, SD, Shastri, MD, Chellappan, DK, Maurya, PK, Satija, S, Mehta, M, Gulati, M, Hansbro, N, Collet, T, Awasthi, R, Gupta, G, Hsu, A & Hansbro, PM 2019, 'Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems', Chemico-Biological Interactions, vol. 299, pp. 168-178. © 2018 Elsevier B.V. Oxidative stress is intensely involved in enhancing the severity of various chronic respiratory diseases (CRDs) including asthma, chronic obstructive pulmonary disease (COPD), infections and lung cancer. Even though there are various existing anti-inflammatory therapies, which are not enough to control the inflammation caused due to various contributing factors such as anti-inflammatory genes and antioxidant enzymes. This leads to an urgent need of novel drug delivery systems to combat the oxidative stress. This review gives a brief insight into the biological factors involved in causing oxidative stress, one of the emerging hallmark feature in CRDs and particularly, highlighting recent trends in various novel drug delivery carriers including microparticles, microemulsions, microspheres, nanoparticles, liposomes, dendrimers, solid lipid nanocarriers etc which can help in combating the oxidative stress in CRDs and ultimately reducing the disease burden and improving the quality of life with CRDs patients. These carriers improve the pharmacokinetics and bioavailability to the target site. However, there is an urgent need for translational studies to validate the drug delivery carriers for clinical administration in the pulmonary clinic. Dua, K, Wadhwa, R, Singhvi, G, Rapalli, V, Shukla, SD, Shastri, MD, Gupta, G, Satija, S, Mehta, M, Khurana, N, Awasthi, R, Maurya, PK, Thangavelu, L, S, R, Tambuwala, MM, Collet, T, Hansbro, PM & Chellappan, DK 2019, 'The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress', Drug Development Research, vol. 80, no. 6, pp. 714-730. Ehgoetz Martens, KA, Matar, E, Hall, JM, Phillips, J, Szeto, JYY, Gouelle, A, Grunstein, RR, Halliday, GM & Lewis, SJG 2019, 'Subtle gait and balance impairments occur in idiopathic rapid eye movement sleep behavior disorder', Movement Disorders, vol. 34, no. 9, pp. 1374-1380. Eickhoff, C, Müller, U, Strunz, AK, Seidling, HM, Lampert, A, Felberg, M, Breiholz, S, Klintworth, D & Schulz, M 2019, 'Das Projekt PRIMA – Elektronische Erstellung und Aktualisierung von Medikationsplänen als gemeinsame Aufgabe von Ärzten und Apothekern', DMW - Deutsche Medizinische Wochenschrift, vol. 144, no. 18, pp. e114-e120. Eitivipart, AC, de Oliveira, CQ, Arora, M, Middleton, J & Davis, GM 2019, 'Overview of Systematic Reviews of Aerobic Fitness and Muscle Strength Training after Spinal Cord Injury', Journal of Neurotrauma, vol. 36, no. 21, pp. 2943-2963. The number of systematic reviews on the effects of exercise on aerobic fitness and muscle strength in people with spinal cord injury (SCI) has recently increased. However, the results of some of these reviews are inconclusive or inconsistent. To strengthen recommendations, this overview was undertaken to assimilate evidence about the effectiveness of different types of physical activities, exercises, and therapeutic interventions for improving aerobic fitness and muscle strength in people with SCI. Cochrane Overview of reviews methods were adopted to undertake this overview. An online search was conducted in August 2018 on eight databases based on predefined search criteria. Potential systematic reviews were screened, selected, and assessed on methodological quality by two independent authors, and discussed and resolved with a third author, when necessary. Only systematic reviews published in the English language were included. The protocol was registered on PROSPERO. Overall, 16 systematic reviews were included (aerobic fitness, n = 10; muscle strength, n = 15). For all 16 reviews, the quality of evidence was rated as "critically low." Despite low evidence, this overview strengthens the existing guidelines for people with SCI, providing specific advice on exercise domains (types, intensities, frequency, and duration) for improving aerobic fitness and muscle strength. The evidence from this overview suggests that ergometry training with/without additional therapeutic interventions (20 min, moderate to vigorous intensity, twice weekly for 6 weeks) may improve aerobic fitness; similarly, resistance training with/without additional therapeutic interventions (three sets of 8-10 repetitions, moderate to vigorous intensity, twice weekly for 6 weeks) may improve muscle strength. Elbourn, E, Kenny, B, Power, E, Honan, C, McDonald, S, Tate, R, Holland, A, MacWhinney, B & Togher, L 2019, 'Discourse recovery after severe traumatic brain injury: exploring the first year', Brain Injury, vol. 33, no. 2, pp. 143-159. Essack, S, Bell, J, Burgoyne, DS, Duerden, M & Shephard, A 2019, 'Topical (local) antibiotics for respiratory infections with sore throat: An antibiotic stewardship perspective', Journal of Clinical Pharmacy and Therapeutics, vol. 44, no. 6, pp. 829-837. WHAT IS KNOWN AND OBJECTIVE:The overuse and misuse of antibiotics, especially for viral, and self-limiting, respiratory tract infections such as sore throat, increases the risk of the development and spread of antimicrobial resistance within communities. Up to 80% of sore throat cases have a viral aetiology, and even when the infection is bacterial, most cases resolve without antibiotics. However, antibiotics are still frequently and often inappropriately prescribed for the treatment of sore throat. Furthermore, topical (local) antibiotics for treatment of sore throat are widely available over the counter. The objective of this systematic review was to establish the evidence for the benefits, risk of harm and antimicrobial resistance associated with topical (local) antibiotics used for patients with sore throat. METHODS:Eligible studies included those in patients with sore throat of any aetiology receiving the topical (local) antibiotics tyrothricin, bacitracin, gramicidin or neomycin where the antibiotic was topically/locally applied via the nasal cavity or throat. Nasal applications were included as these are occasionally used to treat upper respiratory tract infections that may involve sore throat. There was no restriction or requirement regarding comparator. The outcomes of interest included efficacy, safety, and in vitro culture and antimicrobial resistance data. RESULTS AND DISCUSSION:This systematic review found sparse and mainly poor-quality evidence relating to the use of topical (local) antibiotics for sore throat, and it was not possible to establish the benefits, risk of harm or impact of use on antimicrobial resistance. WHAT IS NEW AND CONCLUSIONS:Further research is necessary to ascertain the risks and benefits of topical (local) antibiotics, their contribution to antimicrobial resistance and the risk of harm. We do, however, question whether it is appropriate and rational to use topical (local) antibiotics for the treatment of sore throat caused by... Faras, TJ, Laporte, MD, Sandoval, R, Najjar, F, Ade, V & Stubbs, P 2019, 'The effect of unilateral blood flow restriction on temporal and spatial gait parameters', Heliyon, vol. 5, no. 1, pp. e01146-e01146. Blood flow restriction walking (BFR-W) is becoming more frequently used in aerobic and strength training and it has been proposed that BFR-W can be used in clinical populations. BFR-W may change gait stability yet few studies have assessed gait changes during or following BFR-W. The aim of this study was to assess if spatial-temporal gait parameters change during and following BFR-W. Twenty-four participants completed two walking sessions (>48-hours apart); 1) Unilateral BFR-W applied at the dominant thigh, 2) walking without BFR. In each session participants performed a 5-min warmup, 15-min walking intervention and 10-min active recovery. The warmup and active recovery were performed without BFR on both days. Measurements were attained at baseline, during the intervention and post-intervention using the GAITRite®. Linear mixed models were applied to each measured variable. Fixed factors were timepoint (warmup, intervention, and active recovery), condition (BFR-W and control walking) and condition × timepoint. Random factors were subject and subject × condition. Participants took shorter (3.2-cm (mean difference), CI95%: 0.8-5.6-cm) and wider strides (1.4-cm, CI95%: 0.9-1.9-cm) during BFR-W. For single leg measures, participants took shorter steps (2.8-cm, CI95%: 1.7-4.0-cm) with a faster single support time (7.5-ms, CI95%: 2.9-12.0-ms) on the non-dominant (unoccluded) leg during BFR-W compared to the non-dominant leg during control walking. There were no differences in step length and single support time between the dominant (occluded) leg during BFR-W compared to the dominant leg during control walking. There were no significant changes in velocity, cadence or double support time between BFR-W and control walking (P > 0.05). BFR-W caused small transient changes to several gait parameters. These changes should be considered when using BFR-W in clinical populations. Figlioli, G, Bogliolo, M, Catucci, I, Caleca, L, Lasheras, SV, Pujol, R, Kiiski, JI, Muranen, TA, Barnes, DR, Dennis, J, Michailidou, K, Bolla, MK, Leslie, G, Aalfs, CM, Balleine, R, Baxter, R, Braye, S, Carpenter, J, Dahlstrom, J, Forbes, J, Lee, CS, Marsh, D, Morey, A, Pathmanathan, N, Scott, R, Simpson, P, Spigelman, A, Wilcken, N, Yip, D, Zeps, N, Adank, MA, Adlard, J, Agata, S, Cadoo, K, Agnarsson, BA, Ahearn, T, Aittomäki, K, Ambrosone, CB, Andrews, L, Anton-Culver, H, Antonenkova, NN, Arndt, V, Arnold, N, Aronson, KJ, Arun, BK, Asseryanis, E, Auber, B, Auvinen, P, Azzollini, J, Balmaña, J, Barkardottir, RB, Barrowdale, D, Barwell, J, Beane Freeman, LE, Beauparlant, CJ, Beckmann, MW, Behrens, S, Benitez, J, Berger, R, Bermisheva, M, Blanco, AM, Blomqvist, C, Bogdanova, NV, Bojesen, A, Bojesen, SE, Bonanni, B, Borg, A, Brady, AF, Brauch, H, Brenner, H, Brüning, T, Burwinkel, B, Buys, SS, Caldés, T, Caliebe, A, Caligo, MA, Campa, D, Campbell, IG, Canzian, F, Castelao, JE, Chang-Claude, J, Chanock, SJ, Claes, KBM, Clarke, CL, Collavoli, A, Conner, TA, Cox, DG, Cybulski, C, Czene, K, Daly, MB, de la Hoya, M, Devilee, P, Diez, O, Ding, YC, Dite, GS, Ditsch, N, Domchek, SM, Dorfling, CM, dos-Santos-Silva, I, Durda, K, Dwek, M, Eccles, DM, Ekici, AB, Eliassen, AH, Ellberg, C, Eriksson, M, Evans, DG, Fasching, PA, Figueroa, J, Flyger, H, Foulkes, WD, Friebel, TM, Friedman, E, Gabrielson, M, Gaddam, P, Gago-Dominguez, M, Gao, C, Gapstur, SM, Garber, J, García-Closas, M, García-Sáenz, JA, Gaudet, MM, Gayther, SA, Belotti, M, Bertrand, O, Birot, A-M, Buecher, B, Caputo, S, Dupré, A, Fourme, E, Gauthier-Villars, M, Golmard, L, Le Mentec, M, Moncoutier, V, de Pauw, A, Saule, C, Boutry-Kryza, N, Calender, A, Giraud, S, Léone, M, Bressac-de-Paillerets, B, Caron, O, Guillaud-Bataille, M, Bignon, Y-J, Uhrhammer, N, Bonadona, V, Lasset, C, Berthet, P, Castera, L, Vaur, D, Bourdon, V, Noguès, C, Noguchi, T, Popovici, C, Remenieras, A, Sobol, H, Coupier, I, Pujol, P, Adenis, C, Dumont, A, Révillion, F, Muller, D, Barouk-Simonet, E, Bonnet, F, Bubien, V, Longy, M, Sevenet, N, Gladieff, L, Guimbaud, R, Feillel, V, Toulas, C, Dreyfus, H, Leroux, CD, Peysselon, M, Rebischung, C, Legrand, C, Baurand, A, Bertolone, G, Coron, F, Faivre, L, Jacquot, C, Lizard, S, Kientz, C, Lebrun, M, Prieur, F, Fert-Ferrer, S, Mari, V, Vénat-Bouvet, L, Bézieau, S & et al. 2019, 'The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer', npj Breast Cancer, vol. 5, no. 1. Fleming, C, Gunawan, C, Golzan, M, Torpy, F, Irga, P & Mcgrath, K 2019, 'Investigating the effects of air pollutant nanoparticles on the onset or progression of Alzheimer's disease', IBRO Reports, vol. 6, pp. S329-S330. Freeman-Sanderson, A, Morris, K & Elkins, M 2019, 'Characteristics of patient communication and prevalence of communication difficulty in the intensive care unit: An observational study', Australian Critical Care, vol. 32, no. 5, pp. 373-377. PURPOSE:To summarise the patient communication status in an intensive care unit (ICU), including methods of communication used and the frequency, degree and nature of communication breakdown. MATERIALS AND METHODS:A multidisciplinary daily ward audit was conducted on ten consecutive weekdays in a 30-bed general ICU of a tertiary Australian hospital. Data included patient demographics, patients' mode of communication and the level of difficulty in communicating. Descriptive statistics and means (standard deviation)/medians (interquartile range) were used to summarise the data. RESULTS:Over the audit period, data were collected from 87 patients (median age 58 years, interquartile range 43 to 67; 60% males), equivalent to 232 occupied bed days. Patients from non-English-speaking backgrounds accounted for 14% of the cohort, with Mandarin the most common non-English language. Altered cognition occurred on 11% of bed days. Staff reported difficulty in communicating with patients on 35% of bed days, with an inability to communicate with patients in 49% of these cases. Alternate modes of communication were reported, with gesture the most common, but they were not used with all suitable patients. CONCLUSIONS:About one-third of the caseload in the ICU experienced difficulty in communicating. While alternate communication methods were reported, they were not used with all patients. A multidisciplinary approach to enhance communication ability may be beneficial. Geerling, R, Browne, JL, Holmes-Truscott, E, Furler, J, Speight, J & Mosely, K 2019, 'Positive reinforcement by general practitioners is associated with greater physical activity in adults with type 2 diabetes', BMJ Open Diabetes Research & Care, vol. 7, no. 1, pp. e000701-e000701. Georgevsky, D, Gangoda, SVS & Golzan, SM 2019, 'Postural effects on spontaneous retinal venous pulsations in healthy individuals', Acta Ophthalmologica, vol. 97, no. 6, pp. e839-e843. Georgevsky, D, Retsas, S, Raoufi, N, Shimoni, O & Golzan, SM 2019, 'A longitudinal assessment of retinal function and structure in the APP/PS1 transgenic mouse model of Alzheimer’s disease', Translational Neurodegeneration, vol. 8, no. 1, p. 30. Gomes, BSQ, Coelho, VK, Terra, BS, Bunn, PS, Saragiotto, BT, Ferreira, AS & Nogueira, LAC 2019, 'Patients with Subacromial Pain Syndrome Present no Reduction of Shoulder Proprioception: A Matched Case‐Control Study', PM&R, vol. 11, no. 9, pp. 972-978. Gordon, N, Hohwy, J, Davidson, MJ, van Boxtel, JJA & Tsuchiya, N 2019, 'From intermodulation components to visual perception and cognition-a review', NeuroImage, vol. 199, pp. 480-494. Gunasekaran, P, Hodge, C, Rose, K & Fraser, C 2019, 'Persistent visual disturbances after concussion', Australian Journal of General Practice, vol. 48, no. 8, pp. 531-536. BACKGROUND: Ocular dysfunction, including eye movement defects, has been documented in up to 69% of patients with concussion. However, standard sports-related concussion assessment protocols do not typically include any clinical examination of the ocular system. OBJECTIVE: The aim of this article is to inform general practitioners (GPs) about ocular defects associated with concussion, identify test procedures and highlight the important role of GPs within the concussion paradigm. DISCUSSION: Ocular dysfunction that commonly occurs with concussion includes abnormalities of accommodation, convergence, saccades and smooth pursuits. This may cause blurred vision, double vision, ocular pain and difficulty with close work. Symptoms can severely affect daily work, school or play activities. Patients complaining of extended ocular symptoms following concussion should be referred to an ophthalmologist for a complete ocular assessment. Gunn, A, Menzies, RG, Onslow, M, O'Brian, S, Packman, A, Lowe, R, Helgadóttir, FD & Jones, M 2019, 'Phase I trial of a standalone internet social anxiety treatment for adolescents who stutter: iBroadway', International Journal of Language & Communication Disorders, vol. 54, no. 6, pp. 927-939. Guo, J, Marsh, HW, Parker, PD, Dicke, T & Van Zanden, B 2019, 'Countries, parental occupation, and girls' interest in science', The Lancet, vol. 393, no. 10171, pp. e6-e8. Haebich, KM, Pride, NA, Walsh, KS, Chisholm, A, Rouel, M, Maier, A, Anderson, V, Barton, B, Silk, T, Korgaonkar, M, Seal, M, Lami, F, Lorenzo, J, Williams, K, Dabscheck, G, Rae, CD, Kean, M, North, KN & Payne, JM 2019, 'Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study', BMJ Open, vol. 9, no. 9, pp. e030601-e030601. Haghi, M, Windhab, N, Hartwig, B, Young, PM & Traini, D 2019, 'Human Stimulus Factor Is a Promising Peptide for Delivery of Therapeutics', Journal of Pharmaceutical Sciences, vol. 108, no. 4, pp. 1401-1403. Fluticasone propionate uptake in the presence of a proprietary cell-penetrating peptide (human stimulus factor, [HSF]) based on the N-terminal domain of lactoferrin was studied, alone and in combination with salmeterol, using an air interface Calu-3 epithelial model. The HSF enhanced uptake and transport of fluticasone propionate across the epithelial barrier when alone and in presence of salmeterol. This was attributed to transcellular-mediated uptake. This HSF is a promising peptide for delivery of therapeutics where enhanced epithelial penetrating is required. Hall, JM, O’Callaghan, C, Muller, AJ, Ehgoetz Martens, KA, Phillips, JR, Moustafa, AA, Lewis, SJG & Shine, JM 2019, 'Changes in structural network topology correlate with severity of hallucinatory behavior in Parkinson’s disease', Network Neuroscience, vol. 3, no. 2, pp. 521-538. Harrison, LE, Pate, JW, Richardson, PA, Ickmans, K, Wicksell, RK & Simons, LE 2019, 'Best-Evidence for the Rehabilitation of Chronic Pain Part 1: Pediatric Pain', Journal of Clinical Medicine, vol. 8, no. 9, pp. 1267-1267. Hart, MR, Biesecker, BB, Blout, CL, Christensen, KD, Amendola, LM, Bergstrom, KL, Biswas, S, Bowling, KM, Brothers, KB, Conlin, LK, Cooper, GM, Dulik, MC, East, KM, Everett, JN, Finnila, CR, Ghazani, AA, Gilmore, MJ, Goddard, KAB, Jarvik, GP, Johnston, JJ, Kauffman, TL, Kelley, WV, Krier, JB, Lewis, KL, McGuire, AL, McMullen, C, Ou, J, Plon, SE, Rehm, HL, Richards, CS, Romasko, EJ, Miren Sagardia, A, Spinner, NB, Thompson, ML, Turbitt, E, Vassy, JL, Wilfond, BS, Veenstra, DL, Berg, JS, Green, RC, Biesecker, LG & Hindorff, LA 2019, 'Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study', Genetics in Medicine, vol. 21, no. 5, pp. 1100-1110. © 2018, American College of Medical Genetics and Genomics. Purpose: Clinical sequencing emerging in health care may result in secondary findings (SFs). Methods: Seventy-four of 6240 (1.2%) participants who underwent genome or exome sequencing through the Clinical Sequencing Exploratory Research (CSER) Consortium received one or more SFs from the original American College of Medical Genetics and Genomics (ACMG) recommended 56 gene–condition pair list; we assessed clinical and psychosocial actions. Results: The overall adjusted prevalence of SFs in the ACMG 56 genes across the CSER consortium was 1.7%. Initially 32% of the family histories were positive, and post disclosure, this increased to 48%. The average cost of follow-up medical actions per finding up to a 1-year period was $128 (observed, range: $0–$678) and $421 (recommended, range: $141–$1114). Case reports revealed variability in the frequency of and follow-up on medical recommendations patients received associated with each SF gene–condition pair. Participants did not report adverse psychosocial impact associated with receiving SFs; this was corroborated by 18 participant (or parent) interviews. All interviewed participants shared findings with relatives and reported that relatives did not pursue additional testing or care. Conclusion: Our results suggest that disclosure of SFs shows little to no adverse impact on participants and adds only modestly to near-term health-care costs; additional studies are needed to confirm these findings. Hart, MR, Biesecker, BB, Blout, CL, Christensen, KD, Amendola, LM, Bergstrom, KL, Biswas, S, Bowling, KM, Brothers, KB, Conlin, LK, Cooper, GM, Dulik, MC, East, KM, Everett, JN, Finnila, CR, Ghazani, AA, Gilmore, MJ, Goddard, KAB, Jarvik, GP, Johnston, JJ, Kauffman, TL, Kelley, WV, Krier, JB, Lewis, KL, McGuire, AL, McMullen, C, Ou, J, Plon, SE, Rehm, HL, Richards, CS, Romasko, EJ, Sagardia, AM, Spinner, NB, Thompson, ML, Turbitt, E, Vassy, JL, Wilfond, BS, Veenstra, DL, Berg, JS, Green, RC, Biesecker, LG & Hindorff, LA 2019, 'Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study', Genetics in Medicine, vol. 21, no. 5, pp. 1261-1262. Heathcote, LC, Pate, JW, Park, AL, Leake, HB, Moseley, GL, Kronman, CA, Fischer, M, Timmers, I & Simons, LE 2019, 'Pain neuroscience education on YouTube', PeerJ, vol. 7, no. 3, pp. e6603-e6603. Hemsley, B, Meredith, J, Bryant, L, Wilson, NJ, Higgins, I, Georgiou, A, Hill, S, Balandin, S & McCarthy, S 2019, 'An integrative review of stakeholder views on Advance Care Directives (ACD): Barriers and facilitators to initiation, documentation, storage, and implementation', Patient Education and Counseling, vol. 102, no. 6, pp. 1067-1079. © 2019 Elsevier B.V. Objective: To examine the views and experiences of patients and their health care providers on developing advance care planning (ACP) and advance care directives (ACD); and determine barriers and facilitators to ACD development, storage, and use, including implications for people with communication disability. Method: An integrative review of 93 studies, analysed according to their content themes. Results: Content themes encapsulated the initiation, documentation, and implementation stages of ACP/ACD. Lack of guidance for initiating and supporting ACP/ACD impedes discussions, and both patients and healthcare providers avoid discussions owing to fear of dying and reluctance to think about end-of-life. Conclusions: There are several barriers and facilitators to the initiation of ACP discussions, documentation and implementation of ACD, and little research exploring the views of legal professionals on the development, storage, or use of ACP documents. Further research is needed to explore the timing and responsibility of both legal and health professionals in initiating and supporting ACP discussions. Practice Implications: It is important for healthcare providers to raise ACP discussions regularly so that patients have time to make informed advance care decisions. Storage of the document in an electronic health record might facilitate better access to and implementation of patients’ end-of-life care decisions. Hemsley, B, Steel, J, Sheppard, JJ, Malandraki, GA, Bryant, L & Balandin, S 2019, 'Dying for a Meal: An Integrative Review of Characteristics of Choking Incidents and Recommendations to Prevent Fatal and Nonfatal Choking Across Populations', American Journal of Speech-Language Pathology, vol. 28, no. 3, pp. 1283-1297. Hemsley, B, Steel, J, Worrall, L, Hill, S, Bryant, L, Johnston, L, Georgiou, A & Balandin, S 2019, 'A systematic review of falls in hospital for patients with communication disability: Highlighting an invisible population', Journal of Safety Research, vol. 68, pp. 89-105. © 2018 The Authors Background: Patients with communication disability, associated with impairments of speech, language, or voice, have a three-fold increased risk of adverse events in hospital. However, little research yet examines the causal relationship between communication disability and risk for specific adverse events in hospital. Objective: To examine the impact of a patient's communication disability on their falls risk in hospital. Methods: This systematic review examined 61 studies on falls of adult hospital patients with communication disability, and patients at high risk of communication disability, to determine whether or not communication disability increased risk for falls, and the nature of and reasons for any increased risk. Results: In total, 46 of the included studies (75%) reported on participants with communication disability, and the remainder included patients with health conditions placing them at high risk for communication disability. Two thirds of the studies examining falls risk identified communication disability as contributing to falls. Commonly, patients with communication disability were actively excluded from participation; measures of communication or cognition were not reported; and reasons for any increased risk of falls were not discussed. Conclusions: There is some evidence that communication disability is associated with increased risk of falls. However, the role of communication disability in falls is under-researched, and reasons for the increased risk remain unclear. Practical applications: Including patients with communication disability in falls research is necessary to determine reasons for their increased risk of adverse events in hospital. Their inclusion might be helped by the involvement of speech-language pathologists in falls research teams. Hespanhol, L, Vallio, CS, Costa, LM & Saragiotto, BT 2019, 'Understanding and interpreting confidence and credible intervals around effect estimates', Brazilian Journal of Physical Therapy, vol. 23, no. 4, pp. 290-301. Hronis, A, Roberts, R, Roberts, L & Kneebone, I 2019, 'Fearless Me!©: A feasibility case series of cognitive behavioral therapy for adolescents with intellectual disability', Journal of Clinical Psychology, vol. 75, no. 6, pp. 919-932. Ihle, P, Krueger, K, Schubert, I, Griese‐Mammen, N, Parrau, N, Laufs, U & Schulz, M 2019, 'Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure', Clinical Pharmacology & Therapeutics, vol. 106, no. 1, pp. 211-218. Iverach, L, Jones, M, Lowe, R, O’Brian, S, Menzies, RG, Packman, A & Onslow, M 2019, 'Characteristics of adults who stutter by treatments sought', Logopedics Phoniatrics Vocology, vol. 44, no. 3, pp. 134-142. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Several treatment approaches are available for adults who stutter, including speech treatment, cognitive behaviour therapy (CBT) treatment for anxiety, and a combination of both. It is useful to determine whether any differences exist between adults who stutter enrolled in different types of treatment. Therefore, the purpose of this study was to compare demographic, speech, and psychological characteristics of adults who stutter enrolled in speech, psychological, and combined treatment programs. Participants were 288 adults who stuttered (18–80 years) enrolled in one of three different treatment programs: Speech Treatment for stuttering (n = 134), Anxiety Treatment for anxiety about stuttering (n = 70), or Speech Treatment for Stuttering With or Without Anxiety Treatment (n = 84). Participants completed a range of demographic, speech, and psychological measures prior to the start of treatment. A significantly higher proportion of participants in the Anxiety Treatment group were in a personal relationship than the other treatment groups. The Anxiety Treatment group had higher average age than the other treatment groups. The Speech Treatment group also demonstrated significantly higher self-rated stuttering severity than the Anxiety Treatment group, even though there were no significant difference between groups for clinician-rated percentage of syllables stuttered. Although most characteristics of adults who stuttered did not vary by treatment type, the present findings suggest that adults who stutter enrolled in speech treatment perceived their stuttering as more severe, which may have prompted treatment seeking. Further research is needed regarding the supportive influence of personal relationship for those with the disorder. Jacobs, C, Patch, C & Michie, S 2019, 'Communication about genetic testing with breast and ovarian cancer patients: a scoping review', European Journal of Human Genetics, vol. 27, no. 4, pp. 511-524. © 2018, The Author(s). Genetic testing of patients with cancer is increasingly offered to guide management, resulting in a growing need for oncology health professionals to communicate genetics information and facilitate informed decision-making in a short time frame. This scoping review aimed to map and synthesise what is known about health professionals’ communication about genetic testing for hereditary breast and ovarian cancer with cancer patients. Four databases were systematically searched using a recognised scoping review method. Areas and types of research were mapped and a narrative synthesis of the findings was undertaken. Twenty-nine papers from 25 studies were included. Studies were identified about (i) information needs, (ii) process and content of genetic counselling, (iii) cognitive and emotional impact, including risk perception and recall, understanding and interpretation of genetic test results, and anxiety and distress, (iv) patients’ experiences, (v) communication shortly after diagnosis and (vi) alternatives to face-to-face genetic counselling. Patients’ need for cancer-focused, personalised information is not always met by genetic counselling. Genetic counselling tends to focus on biomedical information at the expense of psychological support. For most patients, knowledge is increased and anxiety is not raised by pre-test communication. However, some patients experience anxiety and distress when results are disclosed, particularly those tested shortly after diagnosis who are unprepared or unsupported. For many patients, pre-test communication by methods other than face-to-face genetic counselling is acceptable. Research is needed to identify patients who may benefit from genetic counselling and support and to investigate communication about hereditary breast and ovarian cancer by oncology health professionals. Jacobs, C, White, S & Phillips, J 2019, 'Genetics in palliative care: too much to ask?', International Journal of Palliative Nursing, vol. 25, no. 5, pp. 212-214. Jenkins, L, Chang, W-J, Buscemi, V, Cunningham, C, Cashin, A, McAuley, JH, Liston, M & Schabrun, SM 2019, 'Is there a causal relationship between acute stage sensorimotor cortex activity and the development of chronic low back pain? a protocol and statistical analysis plan', BMJ Open, vol. 9, no. 12, pp. e035792-e035792. Jenkins, LC, Chang, W-J, Buscemi, V, Liston, M, Toson, B, Nicholas, M, Graven-Nielsen, T, Ridding, M, Hodges, PW, McAuley, JH & Schabrun, SM 2019, 'Do sensorimotor cortex activity, an individual’s capacity for neuroplasticity, and psychological features during an episode of acute low back pain predict outcome at 6 months: a protocol for an Australian, multisite prospective, longitudinal cohort study', BMJ Open, vol. 9, no. 5, pp. e029027-e029027. Jeon, Y-H, Casey, A-N, Vo, K, Rogers, K, Poole, B & Fethney, J 2019, 'Associations between clinical indicators of quality and aged-care residents’ needs and consumer and staff satisfaction: the first Australian study', Australian Health Review, vol. 43, no. 2, pp. 133-133. Johnson, C, Santos, JA, Sparks, E, Raj, TS, Mohan, S, Garg, V, Rogers, K, Maulik, PK, Prabhakaran, D, Neal, B & Webster, J 2019, 'Sources of Dietary Salt in North and South India Estimated from 24 Hour Dietary Recall', Nutrients, vol. 11, no. 2, pp. 318-318. Johnson, R, Peters, S, Ingles, J, Correnti, G, Ingrey, A, Mountain, H, Zentner, D, Thompson, T, Oates, E, Ronan, A, Pachter, N, Haan, E, Van Spaendonck-Zwarts, K, Semsarian, C, McGaughran, J, Atherton, J, James, P & Fatkin, D 2019, 'Penetrance of Dilated Cardiomyopathy in Families with Truncating TTN Variants: a National Perspective', Heart, Lung and Circulation, vol. 28, pp. S140-S140. Jun, M, Jardine, MJ, Perkovic, V, Pilard, Q, Billot, L, Rodgers, A, Rogers, K & Gallagher, M 2019, 'Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study', PLOS ONE, vol. 14, no. 3, pp. e0213192-e0213192. © 2019 Jun et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data on hyperkalemia frequency among chronic kidney disease (CKD) patients receiving renin-angiotensin aldosterone system inhibitors (RAASis) and its impact on subsequent RAASi treatment are limited. This population-based cohort study sought to assess the incidence of clinically significant hyperkalemia among adult CKD patients who were prescribed a RAASi and the proportion of patients with RAASi medication change after experiencing incident hyperkalemia. We conducted a retrospective, population-based cohort study (1 January 2013–30 June 2017) using Australian national general practice data from the NPS MedicineWise’s MedicineInsight program. The study included adults aged 18 years who received 1 RAASi prescription during the study period and had CKD (estimated glomerular filtration rate [eGFR] <60 ml/min/1.73m 2 ). Study outcomes included incident clinically significant hyperkalemia (serum potassium >6 mmol/L or a record of hyperkalemia diagnosis) and among patients who experienced incident hyperkalemia, the proportion who had RAASi medication changes (cessation or dose reduction during the 210-day period after the incident hyperkalemia event). Among 20,184 CKD patients with a median follow-up of 3.9 years, 1,992 (9.9%) patients experienced an episode of hyperkalemia. The overall incidence rate was 3.1 (95% CI: 2.9–3.2) per 100 person-years. Rates progressively increased with worsening eGFR (e.g. 3.5-fold increase in patients with eGFR <15 vs. 45–59 ml/min/ 1.73m 2 ). Among patients who experienced incident hyperkalemia, 46.6% had changes made to their RAASi treatment regimen following the first occurrence of hyperkalemia (discontinuation: 36.6% and dose reduction: 10.0%). In this analysis of adult RAAS... Kaliuzhna, M, Stein, T, Rusch, T, Sekutowicz, M, Sterzer, P & Seymour, KJ 2019, 'No evidence for abnormal priors in early vision in schizophrenia', Schizophrenia Research, vol. 210, pp. 245-254. Karel, YHJM, Miranda, A, Thoomes-de Graaf, M, Scholten-Peeters, GGM, Ottenheijm, RPG, Koes, BW & Verhagen, AP 2019, 'Does the outcome of diagnostic ultrasound influence the treatment modalities and recovery in patients with shoulder pain in physiotherapy practice? Results from a prospective cohort study', Musculoskeletal Science and Practice, vol. 41, pp. 28-35. © 2019 Elsevier Ltd Study design: Prospective cohort study including patients with shoulder pain in primary care physiotherapy. Background: There is an increased tendency to use diagnostic ultrasound to aid the diagnostic strategy and target treatment. It is a relatively cheap and accessible imaging technique but the implications for practice and patients are unknown. Objectives: To study the influence of diagnostic ultrasound (DUS) on diagnostic work-up, treatment modalities and recovery. Methods: Participants (n = 389) with a new episode of shoulder pain were assessed at baseline and followed for 6, 12 and 26 weeks. Diagnostic work-up, including the use of DUS, and treatment strategies were reported by the therapists at 3, 6 and 12 weeks. Results: Most patients (41%) were diagnosed with subacromial impingement/pain syndrome after physical examination or DUS. DUS was used in 31% of the participants. Tendinopathy was the most found abnormality in this sub-population. Patients who underwent DUS were more frequently treated using exercise therapy. Patients that not had DUS were more likely to receive massage therapy, trigger point therapy or mobilisation techniques. Logistic regression analyses did not show a significant association between DUS and recovery after 26 weeks (0.88, 95%CI:0.50–1.57). Correcting for the therapist as a confounder using a multilevel binary logistic regression did not show a significant cluster effect. Conclusion: Diagnostic US as a work-up component does not seem to influence diagnosis or recovery but does influence the choice of treatment modality. Conclusions are limited to observational data. High quality randomized trials should study the effect of DUS on recovery. Katzmann, J, Mahfoud, F, Böhm, M, Schulz, M & Laufs, U 2019, 'Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk', Patient Preference and Adherence, vol. Volume 13, pp. 9-19. Background:Many patients at high cardiovascular risk do not reach targets for low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP). Depression is a frequent comorbidity in these patients and contributes to poor medication adherence. Objective:The aim of this study was to elucidate the associations between adherence to lipid-and BP-lowering drugs, the diagnosis of depression, and the control of LDL-C and BP. Patients and methods:This study was conducted as multicenter, single-visit cross-sectional study in Germany. Adherence was assessed by the Morisky Medication Adherence Scale-8 (MMAS-8), and depression was assessed as documented in the patient chart. Results:A total of 3,188 ambulatory patients with hypercholesterolemia (39.8%), stable coronary artery disease (CAD; 7.4%), or both (52.9%) were included. Patients had a history of myocardial infarction (30.8%), diabetes (42.0%), were smokers (19.7%), and 16.1% had the investigator-reported diagnosis of depression. High or moderate adherence to lipid-lowering medication compared to low adherence was associated with lower LDL-C levels (105.5±38.3 vs 120.8±42.4 mg/dL) and lower BP (systolic BP 133.4±14.5 vs 137.9±13.9 mmHg, diastolic BP 78.3±9.6 vs 81.8±9.6 mmHg) and with a higher proportion of patients achieving the guideline-recommended LDL-C (16.9% vs 10.1%) and BP target (52.2% vs 40.8%, all comparisons P<0.0001). Adherence was worse in patients with depression. Correspondingly, patients with depression showed higher LDL-C levels, higher BP, and a lower probability of achieving the LDL-C and BP goal. Medication adherence correlated between BP- and lipid-lowering medications. Conclusion:Self-reported medication adherence can be easily obtained in daily practice. A low adherence and the diagnosis of depression identify patients at risk for uncontrolled LDL-C and BP who likely benefit from intensified care. Kefalianos, E, Onslow, M, Packman, A, Vogel, A, Pezic, A, Mensah, F, Conway, L, Bavin, E, Block, S & Reilly, S 2019, 'Response to the Letter to the Editor From Marcotte (2019) Regarding “The History of Stuttering by 7 Years: Follow-Up of a Prospective Community Cohort” by Kefalianos et al. (2017)', Journal of Speech, Language, and Hearing Research, vol. 62, no. 5, pp. 1369-1370. Kjeldsen, SS, Næss-Schmidt, ET, Hansen, GM, Nielsen, JF & Stubbs, PW 2019, 'Neuromuscular effects of dorsiflexor training with and without blood flow restriction', Heliyon, vol. 5, no. 8, pp. e02341-e02341. © 2019 Blood flow restriction training (BFRT) has been proposed for elderly and clinical populations with weakness. Before being used in these populations it is important to understand the neurological effects of, and subject perceptions to, BFRT. Seventeen healthy subjects were recruited and performed 2 experimental sessions, BFRT and training without blood flow restriction (TR-only), on separate days. Four sets of concentric/eccentric dorsiflexion contractions against theraband resistance were performed. Surface electromyography of the tibialis anterior was recorded during exercise and for the electrophysiological measures. At baseline, immediately-post, 10-min-post and 20-min-post exercise, motor evoked potentials (MEPs) from single pulse transcranial magnetic stimulation (TMS), paired-pulse TMS with interstimulus intervals of 2-ms (SICI) and 15-ms (ICF), and the M-max amplitude were recorded in the resting TA. Following training, subjects provided a numerical rating of the levels of pain, discomfort, fatigue, focus and difficulty during training. Muscle activation was higher in the last 20 contractions during BFRT compared to TR. There was no difference (time × condition interaction) between BFRT and TR for single-pulse MEP, SICI, ICF or M-max amplitude. There was a significant main effect of timepoint for single-pulse MEP and M-max amplitudes with both significantly reduced for 20-min-post exercise. No reductions were observed for SICI and ICF amplitudes. Taken together, BFRT and TR-only were only different during exercise and both regimes induced similar significant reductions in M-Max and MEP-amplitude post-training. Due to the lack of changes in SICI and ICF, it is unlikely that changes occurred in cortical sites related to these pathways. The increased surface electromyography activity in the last 20 contractions, indicate that the training regimes are different and that BFRT possibly induces more fatigue than TR. As such, BFRT could be used as... Koushik, S, Hewat, S, Onslow, M, Shenker, R, Jones, M, O’Brian, S, Packman, A, Menzies, R, Harrison, E & Wilson, L 2019, 'Three Lidcombe program clinic visit options: a phase II trial', Journal of Communication Disorders, vol. 82, pp. 105919-105919. © 2019 Elsevier Inc. Purpose: Weekly clinic visits are recommended in the Lidcombe Program Treatment Guide (Packman et al., 2015). That specification is based on traditional speech-language pathology practices rather than empirical research, and two studies have suggested that such a format does not always occur in clinical communities. This research was conducted to determine the relative efficacy of different Lidcombe Program models of clinic visits. Method: Thirty-one children were randomized to three different service delivery models: twice-weekly, weekly and fortnightly (once every two weeks) clinic visits. All children were treated with the Lidcombe Program following manualised procedures. Measures of percentage syllables stuttered were obtained from beyond clinic audio recordings pre- and post-randomization. Results: Results showed that the twice-weekly and fortnightly treatment formats were not suitable for all families. However, the fortnightly outcomes at 9 months post-randomization were comparable with those attained during weekly clinic visits. Conclusions: These results justify further, large-scale clinical trialling to compare weekly Lidcombe Program clinic visits with schedules involving less frequent clinic visits. Kumar, N, Turbitt, E, Biesecker, BB, Miller, IM, Cham, B, Smith, KC & Rimal, RN 2019, 'Managing the need to tell: Triggers and strategic disclosure of thalassemia major in Singapore', American Journal of Medical Genetics Part A, vol. 179, no. 5, pp. 762-769. Kwok, EL, Leys, G, Koenig-Robert, R & Pearson, J 2019, 'Measuring Thought-Control Failure: Sensory Mechanisms and Individual Differences', Psychological Science, vol. 30, no. 6, pp. 811-821. Lagad, A, Hodgkinson, K & Newton‐John, TRO 2019, 'Is ignorance bliss, or is knowledge power? When cancer healthcare professionals become cancer patients', European Journal of Cancer Care, vol. 28, no. 4. © 2019 John Wiley & Sons Ltd Cancer healthcare professionals who are diagnosed with cancer enter the patient journey with considerable illness-specific and healthcare expertise, which may influence the nature of their experience. Insights gained from having personal cancer experience may also lead to changes in professionals' subsequent clinical practice. This study explored cancer professional-patients' experiences of their own cancer diagnosis, changes in practice, and recommendations for cancer care improvements. Participants were current or former cancer healthcare professionals who had ever received a cancer diagnosis. Semi-structured interviews were conducted with 26 participants. Thematic analysis with an inductive approach was used for data analysis. Cancer professional-patients faced unique needs, benefits and disadvantages due to their professional background, which both aided and marred their personal cancer experience. Individuals reported subjective practical and emotional-related improvements in their clinical practice, although adverse emotional consequences upon returning to work were also prevalent. Care recommendations highlighted the importance of communication skills training for professionals, integrating psychological support, and providing patient-centred care. In order to provide optimal care for cancer professional-patients, providers must acknowledge their distinct challenges. Findings may help to foster improvements in cancer care practices through developing guidelines for treating cancer professional-patients, and as part of narrative-based medicine. Langevin, M, Schneider, P, Packman, A & Onslow, M 2019, 'Exploring how preschoolers who stutter use spoken language during free play: A feasibility study', International Journal of Speech-Language Pathology, vol. 21, no. 6, pp. 646-654. © 2018, © 2018 The Speech Pathology Association of Australia Limited Published by Informa UK Limited, trading as Taylor & Francis Group. Purpose: Play is critically important for the healthy development of children. This study explored the viability of a methodology to investigate how preschoolers who stutter use language in play with peers. Method: Transcripts of peer-directed utterances of four preschoolers who stutter and four matched non-stuttering children during free play were analysed for measures of verbal output (numbers of utterances and words), length and complexity of utterances (mean length of communication unit and syntactic complexity), and lexical diversity (number of different words, type token ratio and vocd). Result: Viable speech samples were obtained. Verbal output scores of two children who stutter were the same or higher than their matched controls whereas mean length of communication unit and syntactic complexity scores for three children who stutter were lower than their matched controls. In 22 of the 24 comparisons across number of different words, type token ratio, and vocd, scores of children who stutter were the same or higher than their matched controls. Conclusion: Interpretation of data is limited by the small sample size and lack of standardised testing. However, results indicate that the methodology has promise for future research into the way preschoolers who stutter use spoken language during play and the quality of their play. Leake, HB, Heathcote, LC, Simons, LE, Stinson, J, Kamper, SJ, Williams, CM, Burgoyne, LL, Craigie, M, Kammers, M, Moen, D, Pate, JW, Szeto, K & Moseley, GL 2019, 'Talking to Teens about Pain: A Modified Delphi Study of Adolescent Pain Science Education', Canadian Journal of Pain, vol. 3, no. 1, pp. 200-208. Background: Persistent pain is a prevalent condition that negatively influences physical, emotional, social and family functioning in adolescents. Pain science education is a promising therapy for adults, yet to be thoroughly investigated for persistent pain in adolescents. There is a need to develop suitable curricula for adolescent pain science education. Methods: An interdisciplinary meeting of 12 clinicians and researchers was held during March 2018 in Adelaide, South Australia. An a priori objective of the meeting was to identify and gain consensus on key learning objectives for adolescent pain science education using a modified-Delphi process. Results and Conclusion: Consensus was reached via a modified Delphi process for seven learning objectives to form the foundation of a curriculum: 1) Pain is a protector; 2) The pain system can become overprotective; 3) Pain is a brain output; 4) Pain is not an accurate marker of tissue state; 5) There are many potential contributors to anyone’s pain; 6) We are all bioplastic and; 7) Pain education is treatment. Recommendations are made for promising areas for future research in adolescent pain science education. Leung, JKH 2019, 'A Need to Specify the Nonspecificity of Mental Disorders and Interventions: Response to Hofmann and Hayes', Clinical Psychological Science, vol. 7, no. 2, pp. 187-188. Lewis, ET, Dent, E, Alkhouri, H, Kellett, J, Williamson, M, Asha, S, Holdgate, A, Mackenzie, J, Winoto, L, Fajardo-Pulido, D, Ticehurst, M, Hillman, K, McCarthy, S, Elcombe, E, Rogers, K & Cardona, M 2019, 'Which frailty scale for patients admitted via Emergency Department? A cohort study', Archives of Gerontology and Geriatrics, vol. 80, pp. 104-114. OBJECTIVES:To determine the prevalence of frailty in Emergency Departments (EDs); examine the ability of frailty to predict poor outcomes post-discharge; and identify the most appropriate instrument for routine ED use. METHODS:In this prospective study we simultaneously assessed adults 65+yrs admitted and/or spent one night in the ED using Fried, the Clinical Frailty Scale (CFS), and SUHB (Stable, Unstable, Help to walk, Bedbound) scales in four Australian EDs for rapid recognition of frailty between June 2015 and March 2016. RESULTS:899 adults with complete follow-up data (mean (SD) age 80.0 (8.3) years; female 51.4%) were screened for frailty. Although different scales yielded vastly different frailty prevalence (SUHB 9.7%, Fried 30.4%, CFS 43.7%), predictive discrimination of poor discharge outcomes (death, poor self-reported health/quality of life, need for community services post-discharge, or reattendance to ED after the index hospitalization) for all identical final models was equivalent across all scales (AUROC 0.735 for Fried, 0.730 for CFS and 0.720 for SUHB). CONCLUSION:This study confirms that screening for frailty in older ED patients can inform prognosis and target discharge planning including community services required. The CFS was as accurate as the Fried and SUHB in predicting poor outcomes, but more practical for use in busy clinical environments with lower level of disruption. Given the limitations of objectively measuring frailty parameters, self-report and clinical judgment can reliably substitute the assessment in EDs. We propose that in a busy ED environment, frailty scores could be used as a red flag for poor follow-up outcome. Li, A, Geyer, FC, Blecua, P, Lee, JY, Selenica, P, Brown, DN, Pareja, F, Lee, SSK, Kumar, R, Rivera, B, Bi, R, Piscuoglio, S, Wen, HY, Lozada, JR, Gularte-Mérida, R, Cavallone, L, Aghmesheh, M, Amor, D, Andrews, L, Antill, Y, Balleine, R, Beesley, J, Blackburn, A, Bogwitz, M, Brown, M, Burgess, M, Burke, J, Butow, P, Caldon, L, Campbell, I, Christian, A, Clarke, C, Cohen, P, Crook, A, Cui, J, Cummings, M, Dawson, S-J, De Fazio, A, Delatycki, M, Dobrovic, A, Dudding, T, Duijf, P, Edkins, E, Edwards, S, Farshid, G, Fellows, A, Field, M, Flanagan, J, Fong, P, Forbes, J, Forrest, L, Fox, S, French, J, Friedlander, M, Ortega, DG, Gattas, M, Giles, G, Gill, G, Gleeson, M, Greening, S, Haan, E, Harris, M, Hayward, N, Hickie, I, Hopper, J, Hunt, C, James, P, Jenkins, M, Kefford, R, Kentwell, M, Kirk, J, Kollias, J, Lakhani, S, Lindeman, G, Lipton, L, Lobb, L, Lok, S, Macrea, F, Mann, G, Marsh, D, McLachlan, S-A, Meiser, B, Milne, R, Nightingale, S, O’Connell, S, Pachter, N, Patterson, B, Phillips, K, Saleh, M, Salisbury, E, Saunders, C, Saunus, J, Scott, C, Scott, R, Sexton, A, Shelling, A, Simpson, P, Spigelman, A, Spurdle, M, Stone, J, Taylor, J, Thorne, H, Trainer, A, Trench, G, Tucker, K, Visvader, J, Walker, L, Wallis, M, Williams, R, Winship, I, Wu, K, Young, MA, Rezoug, Z, Nguyen-Dumont, T, Peterlongo, P, Tondini, C, Terkelsen, T, Rønlund, K, Boonen, SE, Mannerma, A, Winqvist, R, Janatova, M, Rajadurai, P, Xia, B, Norton, L, Robson, ME, Ng, P-S, Looi, L-M, Southey, MC, Weigelt, B, Soo-Hwang, T, Tischkowitz, M, Foulkes, WD & Reis-Filho, JS 2019, 'Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers', npj Breast Cancer, vol. 5, no. 1. Li, A, Geyer, FC, Blecua, P, Lee, JY, Selenica, P, Brown, DN, Pareja, F, Lee, SSK, Kumar, R, Rivera, B, Bi, R, Piscuoglio, S, Wen, HY, Lozada, JR, Gularte-Mérida, R, Cavallone, L, Rezoug, Z, Nguyen-Dumont, T, Peterlongo, P, Tondini, C, Terkelsen, T, Rønlund, K, Boonen, SE, Mannerma, A, Winqvist, R, Janatova, M, Rajadurai, P, Xia, B, Norton, L, Robson, ME, Ng, P-S, Looi, L-M, Southey, MC, Weigelt, B, Soo-Hwang, T, Tischkowitz, M, Foulkes, WD, Reis-Filho, JS, Aghmesheh, M, Amor, D, Andrews, L, Antill, Y, Balleine, R, Beesley, J, Blackburn, A, Bogwitz, M, Brown, M, Burgess, M, Burke, J, Butow, P, Caldon, L, Campbell, I, Christian, A, Clarke, C, Cohen, P, Crook, A, Cui, J, Cummings, M, Dawson, S-J, De Fazio, A, Delatycki, M, Dobrovic, A, Dudding, T, Duijf, P, Edkins, E, Edwards, S, Farshid, G, Fellows, A, Field, M, Flanagan, J, Fong, P, Forbes, J, Forrest, L, Fox, S, French, J, Friedlander, M, Ortega, DG, Gattas, M, Giles, G, Gill, G, Gleeson, M, Greening, S, Haan, E, Harris, M, Hayward, N, Hickie, I, Hopper, J, Hunt, C, James, P, Jenkins, M, Kefford, R, Kentwell, M, Kirk, J, Kollias, J, Lakhani, S, Lindeman, G, Lipton, L, Lobb, L, Lok, S, Macrea, F, Mann, G, Marsh, D, McLachlan, S-A, Meiser, B, Milne, R, Nightingale, S, O’Connell, S, Pachter, N, Patterson, B, Phillips, K, Saleh, M, Salisbury, E, Saunders, C, Saunus, J, Scott, C, Scott, R, Sexton, A, Shelling, A, Simpson, P, Spigelman, A, Spurdle, M, Stone, J, Taylor, J, Thorne, H, Trainer, A, Trench, G, Tucker, K, Visvader, J, Walker, L, Wallis, M, Williams, R, Winship, I, Wu, K & Young, MA 2019, 'Homologous recombination DNA repair defects in PALB2-associated breast cancers', npj Breast Cancer, vol. 5, no. 1. Light, E, Wiersma, M, Dive, L, Kerridge, I, Critchley, C & Lipworth, W 2019, 'Disruption, Diversity, and Global Biobanking', The American Journal of Bioethics, vol. 19, no. 5, pp. 45-47. Ling, MLH, Wells, M, Petsoglou, C, Luo, K, Georges, P, Devasahayam, R, Hodge, C, Treloggen, J, Sutton, G & Zhu, M 2019, 'Factors Affecting Corneal Organ Culture Contamination: A 6-year Study at the New South Wales Tissue Bank', Cornea, vol. 38, no. 7, pp. 829-835. Lucas, C, Smith, L, Lonie, JM, Hough, M, Rogers, K & Mantzourani, E 2019, 'Can a reflective rubric be applied consistently with raters globally? A study across three countries', Currents in Pharmacy Teaching and Learning, vol. 11, no. 10, pp. 987-994. INTRODUCTION:Reflection is a powerful tool for assisting students to develop the skills to make better informed decisions. As a pharmacy competency standard, reliable and fair assessment strategies are required to measure reflective skills and support students in developing their reflective capacity. The aim of this research was to explore whether we can extend the applicability of a previously tested rubric to a range of educational settings, to account for diversity of pharmacy educators and curricula internationally. METHODS:Four raters from three countries applied a reflective rubric to assess a sample (n = 43) of reflective accounts, representing 41% of a cohort of 105 second-year undergraduate pharmacy students. The interrater reliability (IRR) was measured utilizing the intra-class correlation coefficient (ICC), using a two-way random effects model with absolute agreement, to determine the level of agreement between the raters' absolute scores. Generalizability Theory analysis was used to estimate generalizability of raters and stages. RESULTS:Results indicated agreement of raters for (i) each of the seven stages of reflection and (ii) overall score for the reflective account, with moderate to substantial agreement (ICC = 0.55-0.69, p < 0.001); and high agreement for all raters for the overall score (ICC = 0.96, p < 0.001), respectively. The G-Study estimated a relative error coefficient of 0.78. CONCLUSION:This additional analysis further confirms the reliability and applicability of the rubric to a range of rater academic backgrounds. Lucas, C, Williams, K & Bajorek, B 2019, 'Virtual Pharmacy Programs to Prepare Pharmacy Students for Community and Hospital Placements', American Journal of Pharmaceutical Education, vol. 83, no. 10, pp. 7011-7011. Objective. To explore and evaluate pharmacy students' perceptions of the value and relevance of virtual community and virtual hospital on-campus placement programs. Methods. Students enrolled in a Master of Pharmacy program completed the required Virtual Community Placement (VCP) program and/or the Virtual Hospital Placement (VHP) program. A six-item questionnaire was administered to students after completion of each of the virtual programs to elicit students' perceptions of the value and relevance of the virtual programs. Additional data related to the relevance of specific workshops were collected, including students' self-reported confidence levels to undertake placement in a real-world setting following completion of the virtual programs. Results. Surveys were completed by 61 students in the VCP program and 50 students in the VHP program. Students perceived the virtual programs to be beneficial, with the majority (84% of the VCP students and 98% of the VHP students) reporting that the programs should be an essential component of any pharmacy degree. The majority of students (72%) self-reported an increase in their confidence levels in undertaking a real-world experiential placement after they completed their virtual hospital placement. Conclusion. Completing virtual placement programs prior to pharmacy students beginning their first "real world" pharmacy placements had a positive effect on student learning and confidence levels. Pharmacy students' feedback from this study regarding the relevance of specific learning modules and laboratory sessions will inform future curriculum development of the virtual placement programs. Lucas, C, Woulfe, J, Lonie, JM, Williams, KA & Smith, L 2019, 'Pharmacy students’ perceptions of ePortfolios in pharmacy education', Pharmacy Education, vol. 19, no. 1, pp. 162-170. Aims: To investigate perceptions of an ePortfolio structure, its utility to support pharmacy student learning, development of reflective capacity, and attainment of professional competencies. Methods: Mixed-methods two-phase study: Phase 1 (Quantitative): pre- and post-use, 6-item student survey; Phase 2 (Qualitative): 45-minute student focus group. Survey (n=49, RR 82%) and focus group respondents (n=12) provided their perceptions of ePortfolios. Statistically significant findings between Week 1 and Week 14 indicated that in addition to a time consuming exercise, students perceived that the current structure of the ePortfolio did not fully support their learning; development of their reflective capacity; self-directed learning skills; and professional practice. Conclusions: Pharmacy students perceived the ePortfolio needed improvements to reach its full potential. Students indicated that maintaining an ePortfolio is a useful tool to track professional competencies, linking digital evidence and reflections. Proposed suggestions were identified for improvement that would enable them to meet curricular competencies. Maas, ET, van Dongen, JM, Juch, JNS, Groeneweg, JG, Kallewaard, J-W, de Boer, MR, Koes, B, Verhagen, AP, Huygen, FJPM, van Tulder, MW & Ostelo, RWJG 2019, 'Randomized controlled trials reflected clinical practice when comparing the course of low back pain symptoms in similar populations', Journal of Clinical Epidemiology, vol. 116, pp. 122-132. MacMillan, V, Sheedy, S & Onslow, M 2019, 'Further Predictors of Lidcombe Program Treatment Time', Journal of Clinical Practice in Speech-Language Pathology, vol. 21, no. 3, pp. 159-164. Mallet, K, Shamloul, R, Pugliese, M, Power, E, Corbett, D, Hatcher, S, Shamy, M, Stotts, G, Zakutney, L, Dukelow, S & Dowlatshahi, D 2019, 'RecoverNow: A patient perspective on the delivery of mobile tablet-based stroke rehabilitation in the acute care setting', International Journal of Stroke, vol. 14, no. 2, pp. 174-179. Manchanda, R, Burnell, M, Gaba, F, Sanderson, S, Loggenberg, K, Gessler, S, Wardle, J, Side, L, Desai, R, Brady, AF, Dorkins, H, Wallis, Y, Chapman, C, Jacobs, C, Tomlinson, I, Beller, U, Menon, U & Jacobs, I 2019, 'Attitude towards and factors affecting uptake of population‐based Martínez‐Mardones, F, Fernandez‐Llimos, F, Benrimoj, SI, Ahumada‐Canale, A, Plaza‐Plaza, JC, S. Tonin, F & Garcia‐Cardenas, V 2019, 'Systematic Review and Meta‐Analysis of Medication Reviews Conducted by Pharmacists on Cardiovascular Diseases Risk Factors in Ambulatory Care', Journal of the American Heart Association, vol. 8, no. 22. Matar, E, Phillips, JR, Martens, KAE, Halliday, GM & Lewis, SJG 2019, 'Impaired Color Discrimination—A Specific Marker of Hallucinations in Lewy Body Disorders', Journal of Geriatric Psychiatry and Neurology, vol. 32, no. 5, pp. 257-264. Mavaddat, N, Michailidou, K, Dennis, J, Lush, M, Fachal, L, Lee, A, Tyrer, JP, Chen, T-H, Wang, Q, Bolla, MK, Yang, X, Adank, MA, Ahearn, T, Aittomäki, K, Allen, J, Andrulis, IL, Anton-Culver, H, Antonenkova, NN, Arndt, V, Aronson, KJ, Auer, PL, Auvinen, P, Barrdahl, M, Beane Freeman, LE, Beckmann, MW, Behrens, S, Benitez, J, Bermisheva, M, Bernstein, L, Blomqvist, C, Bogdanova, NV, Bojesen, SE, Bonanni, B, Børresen-Dale, A-L, Brauch, H, Bremer, M, Brenner, H, Brentnall, A, Brock, IW, Brooks-Wilson, A, Brucker, SY, Brüning, T, Burwinkel, B, Campa, D, Carter, BD, Castelao, JE, Chanock, SJ, Chlebowski, R, Christiansen, H, Clarke, CL, Collée, JM, Cordina-Duverger, E, Cornelissen, S, Couch, FJ, Cox, A, Cross, SS, Czene, K, Daly, MB, Devilee, P, Dörk, T, dos-Santos-Silva, I, Dumont, M, Durcan, L, Dwek, M, Eccles, DM, Ekici, AB, Eliassen, AH, Ellberg, C, Engel, C, Eriksson, M, Evans, DG, Fasching, PA, Figueroa, J, Fletcher, O, Flyger, H, Försti, A, Fritschi, L, Gabrielson, M, Gago-Dominguez, M, Gapstur, SM, García-Sáenz, JA, Gaudet, MM, Georgoulias, V, Giles, GG, Gilyazova, IR, Glendon, G, Goldberg, MS, Goldgar, DE, González-Neira, A, Grenaker Alnæs, GI, Grip, M, Gronwald, J, Grundy, A, Guénel, P, Haeberle, L, Hahnen, E, Haiman, CA, Håkansson, N, Hamann, U, Hankinson, SE, Harkness, EF, Hart, SN, He, W, Hein, A, Heyworth, J, Hillemanns, P, Hollestelle, A, Hooning, MJ, Hoover, RN, Hopper, JL, Howell, A, Huang, G, Humphreys, K, Hunter, DJ, Jakimovska, M, Jakubowska, A, Janni, W, John, EM, Johnson, N, Jones, ME, Jukkola-Vuorinen, A, Jung, A, Kaaks, R, Kaczmarek, K, Kataja, V, Keeman, R, Kerin, MJ, Khusnutdinova, E, Kiiski, JI, Knight, JA, Ko, Y-D, Kosma, V-M, Koutros, S, Kristensen, VN, Krüger, U, Kühl, T, Lambrechts, D, Le Marchand, L, Lee, E, Lejbkowicz, F, Lilyquist, J, Lindblom, A, Lindström, S, Lissowska, J, Lo, W-Y, Loibl, S, Long, J, Lubiński, J, Lux, MP, MacInnis, RJ, Maishman, T, Makalic, E, Maleva Kostovska, I, Mannermaa, A, Manoukian, S, Margolin, S, Martens, JWM, Martinez, ME, Mavroudis, D, McLean, C, Meindl, A, Menon, U, Middha, P, Miller, N, Moreno, F, Mulligan, AM, Mulot, C, Muñoz-Garzon, VM, Neuhausen, SL, Nevanlinna, H, Neven, P, Newman, WG, Nielsen, SF, Nordestgaard, BG, Norman, A, Offit, K, Olson, JE, Olsson, H, Orr, N, Pankratz, VS, Park-Simon, T-W, Perez, JIA, Pérez-Barrios, C, Peterlongo, P, Peto, J, Pinchev, M & et al. 2019, 'Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes', The American Journal of Human Genetics, vol. 104, no. 1, pp. 21-34. McAlinden, KD, Deshpande, DA, Ghavami, S, Xenaki, D, Sohal, SS, Oliver, BG, Haghi, M & Sharma, P 2019, 'Autophagy Activation in Asthma Airways Remodeling', American Journal of Respiratory Cell and Molecular Biology, vol. 60, no. 5, pp. 541-553. Copyright © 2019 by the American Thoracic Society Current asthma therapies fail to target airway remodeling that correlates with asthma severity driving disease progression that ultimately leads to loss of lung function. Macroautophagy (hereinafter “autophagy”) is a fundamental cell-recycling mechanism in all eukaryotic cells; emerging evidence suggests that it is dysregulated in asthma. We investigated the interrelationship between autophagy and airway remodeling and assessed preclinical efficacy of a known autophagy inhibitor in murine models of asthma. Human asthmatic and nonasthmatic lung tissues were histologically evaluated and were immunostained for key autophagy markers. The percentage area of positive staining was quantified in the epithelium and airway smooth muscle bundles using ImageJ software. Furthermore, the autophagy inhibitor chloroquine was tested intranasally in prophylactic (3 wk) and treatment (5 wk) models of allergic asthma in mice. Human asthmatic tissues showed greater tissue inflammation and demonstrated hallmark features of airway remodeling, displaying thickened epithelium (P, 0.001) and reticular basement membrane (P, 0.0001), greater lamina propria depth (P, 0.005), and increased airway smooth muscle bundles (P, 0.001) with higher expression of Beclin-1 (P, 0.01) and ATG5 (autophagy-related gene 5) (P, 0.05) together with reduced p62 (P, 0.05) compared with nonasthmatic control tissues. Beclin-1 expression was significantly higher in asthmatic epithelium and ciliated cells (P, 0.05), suggesting a potential role of ciliophagy in asthma. Murine asthma models demonstrated effective preclinical efficacy (reduced key features of allergic asthma: airway inflammation, airway hyperresponsiveness, and airway remodeling) of the autophagy inhibitor chloroquine. Our data demonstrate cell context–dependent and selective activation of autophagy in structural cells in asthma. Furthermore, this pathway can be effectively targeted to amelio... McAloon, J & Lazarou, K 2019, 'Preventative Intervention for Social, Emotional and Behavioural Difficulties in Toddlers and Their Families: A Pilot Study', International Journal of Environmental Research and Public Health, vol. 16, no. 4, pp. 569-569. McCabe, MJ, Gauthier, M-EA, Chan, C-L, Thompson, TJ, De Sousa, SMC, Puttick, C, Grady, JP, Gayevskiy, V, Tao, J, Ying, K, Cipponi, A, Deng, N, Swarbrick, A, Thomas, ML, Lord, RV, Johns, AL, Kohonen-Corish, M, O’Toole, SA, Clark, J, Mueller, SA, Gupta, R, McCormack, AI, Dinger, ME, Cowley, MJ, Aghmesheh, M, Amor, D, Andrews, L, Antill, Y, Armitage, S, Arnold, L, Balleine, R, Bastick, P, Beesley, J, Beilby, J, Bennett, I, Blackburn, A, Bogwitz, M, Botes, L, Brennan, M, Brown, M, Buckley, M, Burgess, M, Burke, J, Butow, P, Caldon, L, Callen, D, Campbell, I, Chauhan, D, Chauhan, M, Chenevix-Trench, G, Christian, A, Clarke, C, Cohen, P, Colley, A, Crook, A, Cui, J, Culling, B, Cummings, M, Dawson, S-J, deFazio, A, Delatycki, M, Dickson, R, Dixon, J, Dobrovic, A, Dudding, T, Edkins, T, Edwards, S, Eisenbruch, M, Farshid, G, Fellows, A, Fenton, G, Field, M, Flanagan, J, Fong, P, Forrest, L, Fox, S, French, J, Friedlander, M, Gaff, C, Ortega, DG, Gattas, M, George, P, Giles, G, Gill, G, Greening, S, Haan, E, Harris, M, Hart, S, Hayward, N, Heiniger, L, Hopper, J, Hunt, C, James, P, Jenkins, M, Kefford, R, Kidd, A, Kirk, J, Koehler, J, Kollias, J, Lakhani, S, Lindeman, G, Lipton, L, Lobb, L, Mann, G, Marsh, D, McLachaln, SA, Meiser, B, Milne, R, Nightingale, S, O’Connell, S, O’Sullivan, S, Pachter, N, Patterson, B, Phillips, K, Pieper, E, Rickard, E, Robinson, B, Saleh, M, Salisbury, E, Sambrook, J, Saunders, C, Saunus, J, Scott, E, Scott, C, Scott, R, Sexton, A, Shelling, A, Simpson, P, Southey, M, Spurdle, A, Taylor, J, Thorne, H, Trainer, A, Tucker, K, Visvader, J, Walker, L, Williams, R, Winship, I & Young, M-A 2019, 'Development and validation of a targeted gene sequencing panel for application to disparate cancers', Scientific Reports, vol. 9, no. 1. McCall, HC, Helgadottir, FD, Menzies, RG, Hadjistavropoulos, HD & Chen, FS 2019, 'Evaluating a Web-Based Social Anxiety Intervention Among Community Users: Analysis of Real-World Data', Journal of Medical Internet Research, vol. 21, no. 1, pp. e11566-e11566. © Hugh Cameron McCall, Fjola Dogg Helgadottir, Ross G Menzies, Heather D Hadjistavropoulos, Frances S Chen. Background: Social anxiety is both harmful and prevalent. It also currently remains among the most undertreated major mental disorders, due, in part, to socially anxious individuals’ concerns about the stigma and expense of seeking help. The privacy and affordability of computer-aided psychotherapy interventions may render them particularly helpful in addressing these concerns, and they are also highly scalable, but most tend to be only somewhat effective without therapist support. However, a recent evaluation of a new self-guided, 7-module internet-delivered cognitive behavioral therapy intervention called Overcome Social Anxiety found that it was highly effective. Objective: The initial evaluation of Overcome Social Anxiety revealed that it led to significant reductions in symptom severity among university undergraduates. The aim of this study was to extend the results of the initial study and investigate their generalizability by directly evaluating the intervention’s effectiveness among a general community sample. Methods: While signing up for Overcome Social Anxiety, users consented to the usage of their anonymized outcome data for research purposes. Before and after completing the intervention, users completed the Fear of Negative Evaluation Scale (FNE), which we employed as the primary outcome measure. Secondary outcome measures included the Depression Anxiety Stress Scales (DASS) and 2 bespoke questionnaires measuring socially anxious thoughts (Thoughts Questionnaire) and avoidance behaviors (Avoidance Questionnaire). Results: Participants who completed the intervention (102/369, 27.7%) experienced significant reductions in the severity of their symptoms on all measures employed, including FNE (P<.001; Cohen d=1.76), the depression subscale of DASS (P<.001; Cohen d=0.70), the anxiety subscale of DASS (P<.001; Cohen d=0.74), the stress subs... McEwen, A, McLean, J & Jacobs, C 2019, 'Reflections on the use of co-design to develop a genetic counselling curriculum fit for purpose for the genomic era: a case study', Journal of Educational Innovation, Partnership and Change, vol. 5, pp. 18-26. The era of genomic medicine heralds a pivotal moment for the genetic counselling profession, forcing a re-evaluation of the traditional roles of genetic counsellors and the emergence of new roles. Education providers have an exciting opportunity to incorporate the complexity of a rapidly-changing profession into curriculum design and the education of future generations of genetic counsellors. Co-design invites stakeholders to become participants, contributors and partners in the design process, to create a collective perspective on a complex issue. At University of Technology Sydney, development of a new ‘Master of Genetic Counselling’ program began by asking how best to design curriculum in times of rapid change in the field. Using co-design principles, we engaged members of the profession and other key stakeholders in activities exploring this matter. Engagement in program design fostered a sense of ownership and commitment to educating the genetic counsellors of the future among the current workforce. Early work has prepared us to engage with students as partners and build the foundation for a flexible and emergent curriculum that is responsive to the changing needs of the profession. McGrath, M, Lever, S, McCluskey, A & Power, E 2019, 'Developing interventions to address sexuality after stroke: Findings from a four-panel modified Delphi study', Journal of Rehabilitation Medicine, vol. 51, no. 5, pp. 352-360. © 2019 Foundation of Rehabilitation Information. Background: Although stroke has a profound impact on sexuality there are limited evidence-based interventions to support rehabilitation professionals in this area. The aim of the current research was to prioritize content areas and approaches to sexual rehabilitation from the perspective of stroke survivors, their partners, stroke rehabilitation clinicians and researchers. Methods: A 2-step online Delphi method was used to prioritize the content of, and approaches to, sexual rehabilitation with stroke survivors, their partners, stroke rehabilitation clinicians and researchers. Results: Stroke survivors (n=30), their partners (n=18), clinicians and researchers in stroke rehabilitation (n=45) completed at least 1 of 2 investigator-developed surveys. Participants prioritized 18 core content areas for inclusion in sexual rehabilitation following stroke with a high degree of consensus. Another 27 content areas were considered moderately important. There was strong consensus that sexual rehabilitation should be offered in the subacute and chronic phases of stroke recovery. Participants would prefer health professionals to deliver the intervention face-to-face. Conclusion: This study presents opinions from stroke survivors, partners of stroke survivors, clinicians and researchers. The information about content, timing and mode of delivery will be used to develop and evaluate a comprehensive sexuality rehabilitation programme. McMullan, RD, Berle, D, Arnáez, S & Starcevic, V 2019, 'The relationships between health anxiety, online health information seeking, and cyberchondria: Systematic review and meta-analysis', Journal of Affective Disorders, vol. 245, pp. 270-278. © 2018 Background: Cyberchondria refers to an abnormal behavioral pattern in which excessive or repeated online searches for health-related information are distressing or anxiety-provoking. Health anxiety has been found to be associated with both online health information seeking and cyberchondria. The aims of the present systematic review and meta-analysis were to examine the magnitude of these associations and identify any moderator variables. Methods: A systematic literature search was performed across several databases (PsycINFO, PubMed, Embase) and reference lists of included studies. Results: Twenty studies were included across two independent meta-analyses, with 7373 participants. Random effects meta-analyses showed that there was a positive correlation between health anxiety and online health information seeking [r = 0.34, 95% CI (0.20, 0.48), p <.0001], and between health anxiety and cyberchondria [r = 0.62, 95% CI (0.52, 0.71), p <.0001]. A meta-regression indicated that the age of study participants [Q(1) = 4.58, p =.03] was partly responsible for the heterogeneity found for the relationship between health anxiety and cyberchondria. Limitations: The generalizability and validity of our findings are restricted by the methodological limitations of the primary studies, namely, an over-reliance on a single measure of cyberchondria, the Cyberchondria Severity Scale. Conclusions: Our review found a positive correlation between health anxiety and online health information seeking, and between health anxiety and cyberchondria. Further research should aim to explore the contexts for these associations as well as address the identified limitations of the extant literature. Melvin, K, Meyer, C & Ryan, B 2019, '“We don't know what we don't know”: Providing information about communication to families of children with Down syndrome', Child: Care, Health and Development, vol. 45, no. 3, pp. 423-432. Menzies, R, O’Brian, S, Packman, A, Jones, M, Helgadóttir, FD & Onslow, M 2019, 'Supplementing stuttering treatment with online cognitive behavior therapy: An experimental trial', Journal of Communication Disorders, vol. 80, pp. 81-91. © 2019 Elsevier Inc. Purpose: It is now well established that adults who present to speech clinics for help with stuttering will have an increased risk of having an anxiety disorder, particularly social anxiety disorder. Concomitant psychological problems are known to interfere with the maintenance of the benefits of behavioral speech treatments for stuttering. The current team has developed and trialed a cognitive behavior therapy (CBT) program designed specifically to reduce anxiety in adults who stutter, and trials have shown promise for both an in-clinic version and a standalone internet-based version. The aim of the present study is to determine whether iGlebe, the internet-based version of the team's internet CBT treatment (previously known as CBTPsych), enhances the benefits of behavioral stuttering treatment. Method: Participants were 32 adults seeking treatment for stuttering. The design was a two-arm randomized experimental trial with blinded outcome assessments at 6 and 12 months post-randomization. Both arms received basic speech-restructuring training to reduce stuttering, without any anxiolytic (anxiety reducing) components. The experimental arm also received 5 months access to iGlebe. Results: There was evidence that, at 12 months post-randomization, iGlebe added clinically significant improvements to self-reported stuttering severity and quality of life. The present experimental trial provides the first evidence that the addition of CBT to speech restructuring improves speech outcomes. Conclusions: The present results will be the basis for the development of a comprehensive, internet-based treatment program for anxiety associated with stuttering. Ultimately, it may be possible for such an economical, scalable, and translatable comprehensive treatment model to supplement standard speech-language pathology treatment practices for those who stutter. Menzies, RG, Packman, A, Onslow, M, O'Brian, S, Jones, M & Helgadóttir, FD 2019, 'In-Clinic and Standalone Internet Cognitive Behavior Therapy Treatment for Social Anxiety in Stuttering: A Randomized Trial of iGlebe', Journal of Speech, Language, and Hearing Research, vol. 62, no. 6, pp. 1614-1624. Metcalfe, SA, Hickerton, C, Savard, J, Stackpoole, E, Tytherleigh, R, Tutty, E, Terrill, B, Turbitt, E, Gray, K, Middleton, A, Wilson, B, Newson, AJ & Gaff, C 2019, 'Australians’ perspectives on support around use of personal genomic testing: Findings from the Genioz study', European Journal of Medical Genetics, vol. 62, no. 5, pp. 290-299. Personal genomic testing using direct-to-consumer and consumer-directed models, with or without involvement of healthcare providers, is increasing internationally, including in Australia. This study forms a sub-set of the Genioz study - Genomics: National Insights of Australians. We aimed to explore Australians' experiences with these types of tests, especially online DNA tests, and their views regarding whom they would seek support from around understanding test results. The study used a mixed methods approach, employing an exploratory quantitative online survey and follow-up qualitative semi-structured interviews. Between May 2016 and May 2017, 2841 Australians responded to the survey. Interviews were conducted with 63 purposively sampled respondents, including 45 who had a genetic test and 18 who had not. Of 571 respondents who had any type of genetic test, 322 had a personal genomic test using criteria defined by the researchers. Testing for ancestry/genealogy was the most common, reported by 267 participants, reflecting the increased advertising of these tests in Australia. Some respondents described downloading their raw data for further interpretation through third party websites for genealogical as well as health related information. Carrier testing, testing for serious and preventable conditions and nutrition and/or wellness were the most common health related tests reported by respondents. Participants generally preferred to seek support from general practitioners (GPs), medical specialists with relevant expertise and independent genetics specialists, although another important preference for non-health information was online forums and networks. There was less preference for seeking support from employees associated with the testing companies. Generally, of those who had a health related PGT, the most common actions were seeking medical advice or doing nothing with the information, while more of those who had a personal genomic test for nutrition and/o... Morandini, JS, Veldre, A, Holcombe, AO, Hsu, K, Lykins, A, Bailey, JM & Dar-Nimrod, I 2019, 'Visual Attention to Sexual Stimuli in Mostly Heterosexuals', Archives of Sexual Behavior, vol. 48, no. 5, pp. 1371-1385. Morgan, IG, French, AN & Rose, K 2019, 'Myopia in low-resource settings.', Community Eye Health, vol. 32, no. 105, pp. 11-11. Increasing levels of myopia will pose particular challenges in low- or middleincome countries. Preventing or delaying myopia onset is crucial. Moussa, L, Garcia-Cardenas, V & Benrimoj, SI 2019, 'Change Facilitation Strategies Used in the Implementation of Innovations in Healthcare Practice: A Systematic Review', Journal of Change Management, vol. 19, no. 4, pp. 283-301. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. To improve patient outcomes, healthcare practices undergo constant implementation of innovations. An implementation intervention that considers organizational and behavioural aspects is facilitation. Change Facilitators help individuals and groups realize what they need to change and how to make change happen. However, behavioural change trials require more sufficient details to improve delivery, fidelity and evaluation. The aim of this paper was to identify facilitation strategies used during the implementation of innovations in health care, determine those most frequently used and their relation to study outcomes. For this systematic review, randomized controlled trials reporting an onsite facilitator to aid in innovation implementation in a healthcare setting were identified. The database search yielded 2,350 articles, from which 35 studies were included. From these, 51 facilitation strategies were identified. Nine of the strategies appeared in more than 50% of studies and those reporting positive results included: goal-setting, assessing progress and outcomes, and providing tools and resources. These findings provide facilitators with evidence-based strategies to deliver in practice and to ensure consistency in facilitation training. Future research should aim to provide further tools that recommend the most effective facilitation strategies and a model to improve the effectiveness, efficiency and evaluation of the change facilitation process. MAD statement This article sets out to make a difference for those implementing innovations in the healthcare industry, by arming change facilitators with practical, evidence-based strategies to facilitate change more effectively. Furthermore, this article highlights the need for specific tools and models that improve the efficiency and effectiveness of the change facilitation process and its evaluation. Naylor, B, Hesam-Shariati, N, McAuley, JH, Boag, S, Newton-John, T, Rae, CD & Gustin, SM 2019, 'Reduced Glutamate in the Medial Prefrontal Cortex Is Associated With Emotional and Cognitive Dysregulation in People With Chronic Pain', Frontiers in Neurology, vol. 10. Neukirch, N, Reid, S & Shires, A 2019, 'Yoga for PTSD and the role of interoceptive awareness: A preliminary mixed-methods case series study', European Journal of Trauma & Dissociation, vol. 3, no. 1, pp. 7-15. Nickerson, A, Byrow, Y, O’Donnell, M, Mau, V, McMahon, T, Pajak, R, Li, S, Hamilton, A, Minihan, S, Liu, C, Bryant, RA, Berle, D & Liddell, BJ 2019, 'The association between visa insecurity and mental health, disability and social engagement in refugees living in Australia', European Journal of Psychotraumatology, vol. 10, no. 1, pp. 1688129-1688129. Background: The vast majority of the world’s refugees and people seeking asylum live in a state of sustained displacement. Little is known, however, about the mental health impact of prolonged insecurity.
Objective: This study aimed to investigate the association between insecure visa status and mental health, suicidality, disability and social engagement in a sample of refugees and asylum-seekers living in Australia
Method: Participants were 1,085 refugees with secure (i.e. permanent residency or Australian citizenship, n = 826, 76.1%) and insecure (i.e. asylum-seeker claim, bridging visa, temporary visa, n = 259, 23.9%) visa status who had arrived in Australia since January 2011, and were from Arabic, Farsi, Tamil or English-speaking backgrounds. Participants completed an online survey assessing pre- and post-migration experiences, mental health, disability and social engagement.
Results: Results indicated that, after controlling for background factors, refugees with insecure visas had significantly greater PTSD symptoms, depression symptoms, thoughts of being better off dead and suicidal intent compared to those with secure visas. There were no group differences in disability. Refugees with insecure visas received support from significantly more groups in the Australian community than those with secure visas. Further, refugees with insecure visa status who had low group membership showed greater depression symptoms and suicidal intent than those with secure visa status who had low group membership.
Conclusion: Findings highlight the negative mental health consequences of living in a state of protracted uncertainty for refugees and people seeking asylum, and the key role of social engagement in influencing mental health amongst insecure visa holders. Results also underscore the importance of designing and implementing policies and services that facilitate improved mental health for those with visa insecurity. Nisselle, A, Martyn, M, Jordan, H, Kaunein, N, McEwen, A, Patel, C, Terrill, B, Bishop, M, Metcalfe, S & Gaff, C 2019, 'Ensuring Best Practice in Genomic Education and Evaluation: A Program Logic Approach', Frontiers in Genetics, vol. 10, p. 1057. © Copyright © 2019 Nisselle, Martyn, Jordan, Kaunein, McEwen, Patel, Terrill, Bishop, Metcalfe and Gaff. Targeted genomic education and training of professionals have been identified as core components of strategies and implementation plans for the use of genomics in health care systems. Education needs to be effective and support the sustained and appropriate use of genomics in health care. Evaluation of education programs to identify effectiveness is challenging. Furthermore, those responsible for development and delivery are not necessarily trained in education and/or evaluation. Program logic models have been used to support the development and evaluation of education programs by articulating a logical explanation as to how a program intends to produce the desired outcomes. These are highly relevant to genomic education programs, but do not appear to have been widely used to date. To assist those developing and evaluating genomic education programs, and as a first step towards enabling identification of effective genomic education approaches, we developed a consensus program logic model for genomic education. We drew on existing literature and a co-design process with 24 international genomic education and evaluation experts to develop the model. The general applicability of the model to the development of programs was tested by program convenors across four diverse settings. Conveners reported on the utility and relevance of the logic model across development, delivery and evaluation. As a whole, their feedback suggests that the model is flexible and adaptive across university award programs, competency development and continuing professional development activities. We discuss this program logic model as a potential best practice mechanism for developing genomic education, and to support development of an evaluation framework and consistent standards to evaluate and report genomic education program outcomes and impacts. Noetel, M, Ciarrochi, J, Van Zanden, B & Lonsdale, C 2019, 'Mindfulness and acceptance approaches to sporting performance enhancement: a systematic review', International Review of Sport and Exercise Psychology, vol. 12, no. 1, pp. 139-175. © 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group. Background: Mindfulness and experiential acceptance approaches have been suggested as a method of promoting athletic performance by optimally managing the interplay among attention, cognition, and emotion. Our aim was to systematically review the evidence for these approaches in the sporting domain. Method: Studies of any design exploring mindfulness and acceptance in athletic populations were eligible for inclusion. We completed searches of PsycINFO, Scopus, MEDLINE, and SPORTDiscus in May 2016. Two authors independently assessed risk of bias using the Cochrane Risk of Bias tool, and we synthesised the evidence using the GRADE criteria. Results: Sixty-six studies (n = 3908) met inclusion criteria. None of the included studies were rated as having a low risk of bias. Compared to no treatment in randomised trials, large effect sizes were found for improving mindfulness, flow, and performance, and lower competitive anxiety. Evidence was graded to be low quality, meaning further research is very likely to have an important impact on confidence in these effects. Conclusions: A number of studies found positive effects for mindfulness and acceptance interventions; however, with limited internal validity across studies, it is difficult to make strong causal claims about the benefits these strategies offer for athletes. O'Loughlin, I & Newton-John, TRO 2019, '‘Dis-comfort eating’: An investigation into the use of food as a coping strategy for the management of chronic pain', Appetite, vol. 140, pp. 288-297. © 2019 Objectives: Chronic pain and obesity are major public health concerns. Animal and human models have demonstrated that eating high-sugar nutrient-dense foods confers analgesic effects. Moreover, recent research suggests that people with chronic pain may “comfort eat” to cope with their pain. Given the harmful impact of obesity on chronic pain, it is critical to determine whether pain elicits comfort eating amongst individuals with chronic pain to ensure that this potentially maladaptive pain coping strategy is not overlooked in chronic pain treatment. Therefore, this study aimed to: determine whether chronic pain intensity predicts pain-induced comfort eating and identify mediators of this relationship; to determine whether pain-induced comfort eating predicts elevated BMI; and to establish whether BMI predicts chronic pain interference. Methods: This study utilised a cross-sectional online survey design and a sample of 151 adults with chronic pain. Results: Over three-quarters of this chronic pain sample reported engaging in pain-induced comfort eating. Chronic pain intensity did not significantly predict pain-induced comfort eating. However, there was a significant indirect effect of chronic pain intensity on pain-induced comfort eating through stress—but not experiential avoidance or pain catastrophising. As predicted, pain-induced comfort eating significantly predicted increased BMI, and BMI in turn significantly predicted greater chronic pain interference. Discussion: This study indicates that pain-induced comfort eating is both common and harmful amongst individuals with chronic pain, across the entire BMI spectrum. Pain-induced comfort eating and stress have emerged as promising chronic pain treatment targets. The findings are discussed and interpreted in light of extant research and theory, as well as limitations of the current study. Future research directions and clinical implications are also considered. Onslow, M & Lowe, R 2019, 'After the RESTART trial: six guidelines for clinical trials of early stuttering intervention', International Journal of Language & Communication Disorders, vol. 54, no. 4, pp. 517-528. Page, MJ, O’Connor, DA, Malek, M, Haas, R, Beaton, D, Huang, H, Ramiro, S, Richards, P, Voshaar, MJH, Shea, B, Verhagen, AP, Whittle, SL, van der Windt, DA, Gagnier, JJ & Buchbinder, R 2019, 'Patients’ experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set', Rheumatology, vol. 58, no. 8, pp. 1410-1421. Pate, J, Hancock, M, Tofts, L, Epps, A, Baldwin, J, McKay, M, Burns, J, Morris, E & Pacey, V 2019, 'Longitudinal Fibular Deficiency: A Cross-Sectional Study Comparing Lower Limb Function of Children and Young People with That of Unaffected Peers', Children, vol. 6, no. 3, pp. 45-45. Pate, JW, Noblet, T, Hush, JM, Hancock, MJ, Sandells, R, Pounder, M & Pacey, V 2019, 'Exploring the concept of pain of Australian children with and without pain: qualitative study', BMJ Open, vol. 9, no. 10, pp. e033199-e033199. Pate, JW, Veage, S, Lee, S, Hancock, MJ, Hush, JM & Pacey, V 2019, 'Which Patients With Chronic Pain Are More Likely to Improve Pain Biology Knowledge Following Education?', Pain Practice, vol. 19, no. 4, pp. 363-369. Peiris, D, Wright, L, News, M, Rogers, K, Redfern, J, Chow, C & Thomas, D 2019, 'A Smartphone App to Assist Smoking Cessation Among Aboriginal Australians: Findings From a Pilot Randomized Controlled Trial', JMIR mHealth and uHealth, vol. 7, no. 4, pp. e12745-e12745. © David Peiris, Lachlan Wright, Madeline News, Kris Rogers, Julie Redfern, Clara Chow, David Thomas. Background: Mobile health (mHealth) apps have the potential to increase smoking cessation, but little research has been conducted with Aboriginal communities in Australia. Objective: We conducted a pilot study to assess the feasibility and acceptability and explore the effectiveness of a novel mHealth app to assist Aboriginal people to quit smoking. Methods: A pilot randomized controlled trial (RCT) and process evaluation comprising usage analytics data and in-depth interviews was conducted. Current Aboriginal smokers (>16 years old), who were willing to make a quit attempt in the next month, were recruited from Aboriginal Community Controlled Health Services and a government telephone coaching service. The intervention was a multifaceted Android or iOS app comprising a personalized profile and quit plan, text and in-app motivational messages, and a challenge feature allowing users to compete with others. The comparator was usual cessation support services. Outcome data collection and analysis were conducted blinded to treatment allocation. The primary outcome was self-reported continuous smoking abstinence verified by carbon monoxide breath testing at 6 months. Secondary outcomes included point prevalence of abstinence and use of smoking cessation therapies and services. Results: A total of 49 participants were recruited. Competing service delivery priorities, the lack of resources for research, and lack of support for randomization to a control group were the major recruitment barriers. At baseline, 23/49 (47%) of participants had tried to quit in recent weeks. At 6-month follow-up, only 1 participant (intervention arm) was abstinent. The process evaluation highlighted low to moderate app usage (3-10 new users per month and 4-8 returning users per month), an average of 2.9 sessions per user per month and 6.3 min per session. Key themes from interviews with inter... Peters, R, Mutsaers, B, Verhagen, AP, Koes, BW & Pool-Goudzwaard, AL 2019, 'Prospective Cohort Study of Patients With Neck Pain in a Manual Therapy Setting: Design and Baseline Measures', Journal of Manipulative and Physiological Therapeutics, vol. 42, no. 7, pp. 471-479. Phillips, K, Brockman, R, Bailey, PE & Kneebone, II 2019, 'Young Schema Questionnaire – Short Form Version 3 (YSQ-S3): Preliminary validation in older adults', Aging & Mental Health, vol. 23, no. 1, pp. 140-147. © 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group. Objectives: The aim of the current study was to establish the reliability and validity of one of the most used schema questionnaires, Young Schema Questionnaire Short Form Version 3 (YSQ-S3) in older adults. Method: 104 participants aged 60–84 years were recruited. They were administered a battery of questionnaires, including the YSQ-S3, Young-Atkinson Mode Inventory (YAMI), Germans (Personality) Screener, the Geriatric Depression Scale (GDS), The Geriatric Anxiety Inventory (GAI) and the Basic Psychological Needs Scale (BPNS). The YSQ-S3 was completed a second time by 83 participants a median of 12 days later. Results: Satisfactory internal consistency reliability was found for 13 of the 18 early maladaptive schemas (EMS) of the YSQ-S3. Test-retest reliability was satisfactory for 17 of 18 EMS. Convergent validity was evident from significant correlations between the EMS of the YSQ-S3 and the vulnerable child and angry child schema modes from the YAMI. Congruent validity was evident from correlations of the majority of the EMS with the GDS, the GAI, German's (Personality) Screener and the BPNS measure. Conclusions: By and large the YSQ-S3 demonstrates internal and test re-test reliability in as well as congruent and convergent validity, in older adults. This suggests the YSQ-S3 may be of use in work establishing the utility of schema therapy in this population, and that schema therapy with older people warrants further exploration. Notwithstanding this some re-development of some EMS items appears to be required for the YSQ-S3 to be more relevant to older people. Piper, A & Berle, D 2019, 'The association between trauma experienced during incarceration and PTSD outcomes: a systematic review and meta-analysis', The Journal of Forensic Psychiatry & Psychology, vol. 30, no. 5, pp. 854-875. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Incarcerated people often experience victimisation and trauma. Whilst the occurrence of Potentially Traumatic Events (PTEs) withinduring incarceration is acknowledged, little empirical research has examined PTEs that occur during incarceration and their association with PTSD. The current systematic review and meta-analysis sought to explore the association between PTEs during incarceration and PTSD, summarise key characteristics of the existing literature and understand the extent to which specific PTEs and participant characteristics are associated with PTSD. Six studies met the review inclusion criteria. Overall, studies reported high rates of PTEs during incarceration and found significant positive associations between PTEs, including victimisation and abuse, solitary confinement and coercion experienced within incarceration and PTSD outcomes (r = 0.32). Surprisingly, time spent incarcerated and pre-incarceration mental health concerns were not significantly associated with PTSD. The results of this review highlight the detrimental psychological effects of PTEs experienced during incarceration. The associations highlighted underline the need for trauma-informed care and eradication of PTEs within the prison environment. However, there remains a need for methodologically robust studies, in order to increase understanding of the PTSD-related consequences that may arise from incarceration and to optimise the post-release adjustment of prisoners. Pont, LG, Fisher, M & Williams, K 2019, 'Appropriate Use of Laxatives in the Older Person', Drugs & Aging, vol. 36, no. 11, pp. 999-1005. Constipation is a common condition, affecting up to half of all older adults during their lifetime. Untreated constipation has significant impacts, decreasing quality of life and potentially leading to urinary and/or faecal incontinence, faecal impaction and, in severe cases, hospitalisation. The increased constipation prevalence among older populations is multifactorial, with a number of age-related factors contributing to the rise in prevalence with aging. Laxatives are the mainstay of constipation management and are commonly used among older populations for both treatment and prevention of constipation. A range of laxative types including bulk forming agents, softeners and emollients, osmotic agents, stimulants, and the newer prokinetic and secretory agents are available. Despite laxatives being freely available without prescription in many countries and commonly used by older individuals, evidence regarding the effectiveness or safety of most laxatives in older populations is lacking. Additionally, age-related changes increase the risk of adverse effects associated with laxatives, such as electrolyte disturbances, among older persons. Caution must be taken when extrapolating recommendations for general adult populations to older populations. Laxative choice for older individuals should be tailored after careful assessment and consideration of comorbid conditions, concomitant medications and the potential for adverse effects. Pottegård, A, Klungel, O, Winterstein, A, Huybrechts, K, Hallas, J, Schneeweiss, S, Evans, S, Bate, A, Pont, L, Trifirò, G, Smith, M & Bourke, A 2019, 'The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) ‐ EMA Joint Big Data Task Force', Pharmacoepidemiology and Drug Safety, vol. 28, no. 12, pp. 1640-1641. Prnjak, K & Jukic, I 2019, 'Searching for Eating Disorder-related Topics on the Internet: What Distinguishes Symptomatic from Asymptomatic Women?', Journal of Consumer Health on the Internet, vol. 23, no. 3, pp. 213-226. Raban, MZ, Walter, SR, Pont, LG, Cheung, L, Strumpman, D & Westbrook, JI 2019, 'The potential impact of an electronic medication management system on safety‐critical prescribing errors in an emergency department', Journal of Pharmacy Practice and Research, vol. 49, no. 2, pp. 108-115. Rahman, A, Jagnoor, J, Baset, KU, Ryan, D, Ahmed, T, Rogers, K, Hossain, MJ, Ivers, R & Rahman, AKMF 2019, 'Vulnerability to fatal drowning among the population in Southern Bangladesh: findings from a cross-sectional household survey', BMJ Open, vol. 9, no. 9, pp. e027896-e027896. Ramiro, S, Page, MJ, Whittle, SL, Huang, H, Verhagen, AP, Beaton, DE, Richards, P, Voshaar, M, Shea, B, van der Windt, DA, Kopkow, C, Lenza, M, Jain, NB, Richards, B, Hill, C, Gill, TK, Koes, B, Foster, NE, Conaghan, PG, Smith, T, Malliaras, P, Roe, Y, Gagnier, JJ & Buchbinder, R 2019, 'The OMERACT Core Domain Set for Clinical Trials of Shoulder Disorders', The Journal of Rheumatology, vol. 46, no. 8, pp. 969-975. Reid, K & Berle, D 2019, 'Parental trajectories of PTSD and child adjustment: Findings from the Building a New Life in Australia study.', American Journal of Orthopsychiatry, vol. 90, no. 2, pp. 288-295. © 2019 Global Alliance for Behavioral Health and Social Justice. Evidence suggests that the psychosocial adjustment of children of refugees may be compromised when a parent has symptoms of posttraumatic stress disorder (PTSD). We sought to determine whether trajectories of parental PTSD symptoms might relate to child adjustment and whether there is an additive effect when both parents, as opposed to just one, has prominent PTSD symptoms. We report data from the first three years of a prospective study of recent Australian humanitarian migrants: the Building a New Life in Australia study. Parental PTSD symptoms were assessed on three occasions, and latent class growth analysis was used to identify homogenous groups of parents based on their PTSD symptoms. The Strength and Difficulties Questionnaire was administered to assess child psychosocial adjustment. Regression analyses were then conducted to determine whether trajectories of parental PTSD symptoms predicted child adjustment. After controlling for child age and gender, the presence of either one or both parents with persistently high PTSD symptoms was associated with children's having greater emotional difficulties and poorer overall psychosocial adjustment. Children with both parents with persistently high PTSD had higher levels of emotional difficulties than did children with a single parent with high PTSD symptoms. For emotional difficulties, though not other domains of child psychosocial adjustment, there indeed appears to be an additive impact of having two parents, rather than just one, with persistently high PTSD symptoms, although the magnitude of these effects was small. The clinical and service provision implications of these findings are discussed. Roberts, MC, Turbitt, E & Klein, WMP 2019, 'Psychosocial, attitudinal, and demographic correlates of cancer-related germline genetic testing in the 2017 Health Information National Trends Survey', Journal of Community Genetics, vol. 10, no. 4, pp. 453-459. © 2019, Springer-Verlag GmbH Germany, part of Springer Nature. The study objective was to examine bivariate and multivariate associations among worry, perceptions, attitudes, sociodemographics, and uptake of cancer-related germline genetic testing. We used data from the Health Information National Trends Survey (cycle 5.1), administered (January–May 2017) to a nationally representative sample of non-institutionalized adults (n = 3285). Those who had “heard about genetic tests that determine how a disease can be treated” had a higher likelihood of Lynch syndrome and BRCA1/2 testing (aRR = 2.57, p < 0.01; aRR = 3.23, p < 0.04). Attitudinal and psychosocial variables were not associated with uptake. Future research should explore ways to educate the public about the potential use of genetics in treatment decision-making. Rose, TA, Wallace, SJ & Leow, S 2019, 'Family members’ experiences and preferences for receiving aphasia information during early phases in the continuum of care', International Journal of Speech-Language Pathology, vol. 21, no. 5, pp. 470-482. Ryan, B, Bohan, J & Kneebone, I 2019, 'Help‐seeking and people with aphasia who have mood problems after stroke: perspectives of speech–language pathologists', International Journal of Language & Communication Disorders, vol. 54, no. 5, pp. 779-793. Said, A, Ganso, M, Freudewald, L & Schulz, M 2019, 'Trends in dispensing oral emergency contraceptives and safety issues: a survey of German community pharmacists', International Journal of Clinical Pharmacy, vol. 41, no. 6, pp. 1499-1506. Sakiris, N & Berle, D 2019, 'A systematic review and meta-analysis of the Unified Protocol as a transdiagnostic emotion regulation based intervention', Clinical Psychology Review, vol. 72, pp. 101751-101751. © 2019 Elsevier Ltd Recent advances in clinical practice emphasise transdiagnostic interventions as an effective alternative to single disorder approaches. This current systematic review and meta-analysis evaluated the treatment efficacy of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) across internalising disorders, as an emotion regulation (ER) based intervention program. Across 15 studies and 1244 participants, large effect size reductions were found across symptoms of anxiety, depression, generalised anxiety disorder, obsessive-compulsive disorder, panic disorder with/without agoraphobia, social anxiety disorder, and borderline personality disorder. In addition, there were moderate effect sizes indicating increased use of adaptive and decreased use of maladaptive ER strategies, highlighting the UP as an effective ER based intervention. Secondary treatment benefits in functional impairment and quality of life were also evident. Implications on future transdiagnostic ER based research are discussed. Santo, K, Singleton, A, Rogers, K, Thiagalingam, A, Chalmers, J, Chow, CK & Redfern, J 2019, 'Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial', Heart, vol. 105, no. 4, pp. 323-329. Savard, J, Hickerton, C, Tytherleigh, R, Terrill, B, Turbitt, E, Newson, AJ, Wilson, B, Gray, K, Gaff, C, Middleton, A, Stackpoole, E & Metcalfe, SA 2019, 'Australians’ views and experience of personal genomic testing: survey findings from the Genioz study', European Journal of Human Genetics, vol. 27, no. 5, pp. 711-720. Schlosser, RW, Hemsley, B, Shane, H, Todd, J, Lang, R, Lilienfeld, SO, Trembath, D, Mostert, M, Fong, S & Odom, S 2019, 'Rapid Prompting Method and Autism Spectrum Disorder: Systematic Review Exposes Lack of Evidence', Review Journal of Autism and Developmental Disorders, vol. 6, no. 4, pp. 403-412. © 2019, Springer Science+Business Media, LLC, part of Springer Nature. This systematic review is aimed at examining the effectiveness of the rapid prompting method (RPM) for enhancing motor, speech, language, and communication and for decreasing problem behaviors in individuals with autism spectrum disorder (ASD). A multi-faceted search strategy was carried out. A range of participant and study variables and risk and bias indicators were identified for data extraction. RPM had to be evaluated as an intervention using a research design capable of empirical demonstration of RPM’s effects. No studies met the inclusion criteria, resulting in an empty review that documents a meaningful knowledge gap. Controlled trials of RPM are warranted. Given the striking similarities between RPM and Facilitated Communication, research that examines the authorship of RPM-produced messages needs to be conducted. Schönfeld, T, Heinemann, A, Schulz, M, Gradl, G, Andresen-Streichert, H, Müller, A & Iwersen-Bergmann, S 2019, 'Post-mortem analysis of prescription opioids—A follow-up examination by LC–MS/MS with focus on fentanyl', Forensic Science International, vol. 305, pp. 109970-109970. Schulz, M, Griese‐Mammen, N, Anker, SD, Koehler, F, Ihle, P, Ruckes, C, Schumacher, PM, Trenk, D, Böhm, M & Laufs, U 2019, 'Pharmacy‐based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM‐CHF randomized controlled trial', European Journal of Heart Failure, vol. 21, no. 8, pp. 1012-1021. Shires, A, Sharpe, L & Newton John, TRO 2019, 'The relative efficacy of mindfulness versus distraction: The moderating role of attentional bias', European Journal of Pain, vol. 23, no. 4, pp. 727-738. Shrubsole, K, Worrall, L, Power, E & O’Connor, DA 2019, 'Barriers and facilitators to meeting aphasia guideline recommendations: what factors influence speech pathologists’ practice?', Disability and Rehabilitation, vol. 41, no. 13, pp. 1596-1607. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Purpose: To explore factors influencing Australian speech pathologists’ guideline recommended aphasia management practices. Methods: Semi-structured interviews were conducted with hospital-based speech pathologists (n = 20). Interviews focused on barriers and facilitators to implementing recommendations related to five practice areas: Aphasia-friendly Information; Collaborative Goal Setting; Timing of Therapy; Amount and Intensity of Therapy; and Conversation Partner Training. Results: Speech pathologists working only in inpatient rehabilitation settings reported performing the recommended behaviours consistently, and identified few implementation barriers. However, clinicians working in the acute setting reported performing the majority of behaviours inconsistently or rarely. Seven (of 14) Theoretical Domains Framework domains were identified as key influencing factors. Three of these–“Environmental Context and Resources,” “Beliefs about Consequences,” and “Social Influences”–were consistently reported as influencing practice across all five behaviours. Other important domains included “Knowledge”, “Beliefs about Capabilities,” “Goals,” and “Social/Professional Role and Identity”, which each influenced at least two practice behaviours. Conclusions: Speech pathologists report a number of key factors influencing their practice, which differ in how they influence behaviours (i.e., a factor may be a barrier or a facilitator) depending on the behaviour and clinical setting. Future implementation interventions need to account for the strong influence of beliefs and social influences on speech pathology practice, which may facilitate successful implementation.Implications for rehabilitation Speech pathologists’ aphasia management practices are often inconsistent with guideline recommendations. Environmental and contextual barriers were identified for all guideline-recommended practices that... Silva, HJDA, Saragiotto, BT, Silva, RS, Lins, CADA & de Souza, MC 2019, 'Dry cupping in the treatment of individuals with non-specific chronic low back pain: a protocol for a placebo-controlled, randomised, double-blind study', BMJ Open, vol. 9, no. 12, pp. e032416-e032416. Starcevic, V, Baggio, S, Berle, D, Khazaal, Y & Viswasam, K 2019, 'Cyberchondria and its Relationships with Related Constructs: a Network Analysis', Psychiatric Quarterly, vol. 90, no. 3, pp. 491-505. © 2019, Springer Science+Business Media, LLC, part of Springer Nature. Cyberchondria denotes repeated online searches for health information that are associated with increasing levels of health anxiety. The aims of this study were to apply network analysis to investigate the extent to which cyberchondria is a distinct construct, ascertain which of the related constructs have the strongest relationships with cyberchondria and investigate whether some of the symptoms of cyberchondria are more central to the construct of cyberchondria. Questionnaires assessing the severity of cyberchondria, health anxiety, obsessive-compulsive disorder symptoms, intolerance of uncertainty, problematic Internet use, anxiety, depression and somatic symptoms were administered to 751 participants who searched for health information online during a previous 3-month period and were recruited from an online crowdsourcing platform. Network analyses were used to compute the networks, perform community detection tests and calculate centrality indices. Results suggest that cyberchondria is a relatively specific syndrome-like construct, distinct from all related constructs and consisting of interrelated symptoms. It has the strongest relationships with problematic Internet use and health anxiety. No symptom of cyberchondria emerged clearly as more central to the construct of cyberchondria. Future research should aim to deepen our understanding of cyberchondria and its links with psychopathology, especially its close relationship with problematic Internet use. Steel, J, Georgiou, A, Balandin, S, Hill, S, Worrall, L & Hemsley, B 2019, 'A content analysis of documentation on communication disability in hospital progress notes: diagnosis, function, and patient safety', Clinical Rehabilitation, vol. 33, no. 5, pp. 943-956. Sutton, G & Hodge, C 2019, 'Keratoconus treatment: The journey has just begun', Clinical & Experimental Ophthalmology, vol. 47, no. 8, pp. 978-979. Tan, WT, Kopecky, C, Manandhar, B, Rye, KA & Cochran, B 2019, 'Skeletal Muscle Specific Deletion Of Abca1 And Abcg1 Impacts Body Composition And Metabolism And Is Age Dependent', Atherosclerosis, vol. 287, pp. e43-e43. Taylor, S, Rodrigues, M, Poke, G, Wake, S & McEwen, A 2019, 'Family communication following a diagnosis of myotonic dystrophy: To tell or not to tell?', Journal of Genetic Counseling, vol. 28, no. 5, pp. 1029-1041. Thoomes-de Graaf, M, Ottenheijm, RPG, Verhagen, AP, Duijn, E, Karel, YHJM, van den Borne, MPJ, Beumer, A, van Broekhoven, J, Dinant, GJ, Tetteroo, E, Lucas, C, Koes, BW & Scholten-Peeters, GGM 2019, 'Agreement between physical therapists and radiologists of stratifying patients with shoulder pain into new treatment related categories using ultrasound; an exploratory study', Musculoskeletal Science and Practice, vol. 40, pp. 1-9. Tolin, DF, Das, A, Hallion, LS, Levy, HC, Wootton, BM & Stevens, MC 2019, 'Quality of life in patients with hoarding disorder', Journal of Obsessive-Compulsive and Related Disorders, vol. 21, pp. 55-59. © 2018 Elsevier Inc. The aim of this study was to investigate health-related quality of life (QoL) in patients with hoarding disorder (HD). Fifty-four patients with a primary diagnosis of HD, and 24 age- and sex-matched healthy control (HC) participants, completed a battery of questionnaires including the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36), Saving Inventory-Revised, and Depression, Anxiety, Stress Scales. Compared to HC participants, those with HD reported poorer health-related QoL across all domains of the SF-36. When controlling for comorbid affective symptoms, HD participants scored lower than did HC participants in the QoL domains of social functioning, emotional well-being, role limitations due to emotional problems, vitality, and general health. HD symptom severity predicted, beyond the effects of affective symptoms, lower QoL in social functioning, emotional well-being, role limitations due to emotional problems, vitality, and general health. Tolin, DF, Wootton, BM, Levy, HC, Hallion, LS, Worden, BL, Diefenbach, GJ, Jaccard, J & Stevens, MC 2019, 'Efficacy and mediators of a group cognitive–behavioral therapy for hoarding disorder: A randomized trial.', Journal of Consulting and Clinical Psychology, vol. 87, no. 7, pp. 590-602. OBJECTIVE:Hoarding disorder (HD) is a common and potentially debilitating psychiatric disorder. Thus far, psychological treatments have yielded modest effects and/or were time-consuming and costly to deliver. The aim of the present study was to test the efficacy of a brief group cognitive-behavioral therapy (CBT) for adults with HD and to test hypothesized mediators of treatment outcome. METHOD:Eighty-seven adults with a primary diagnosis of HD were randomized to either immediate CBT or wait list. CBT consisted of 16 weekly, 90-min group sessions that emphasized in-session practice of discarding and refraining from acquiring, decision-making and problem-solving training, emotional distress tolerance, motivational interviewing strategies, and contingency management. Participants were assessed at pretreatment, midtreatment, and posttreatment by an independent evaluator unaware of treatment condition. RESULTS:CBT was efficacious for the symptoms of HD compared with wait list. Saving-related cognitions, but not subjective cognitive impairment, partially mediated treatment outcomes. CONCLUSION:Brief Group CBT is an efficacious and feasible treatment for adults with HD, and is partially mediated by reductions in maladaptive beliefs about possessions. Superiority trials comparing CBT to active treatments, and additional research into mechanisms of treatment outcome, are warranted. (PsycINFO Database Record (c) 2019 APA, all rights reserved). Tonin, FS, Wiecek, E, Torres-Robles, A, Pontarolo, R, Benrimoj, SCI, Fernandez-Llimos, F & Garcia-Cardenas, V 2019, 'An innovative and comprehensive technique to evaluate different measures of medication adherence: The network meta-analysis', Research in Social and Administrative Pharmacy, vol. 15, no. 4, pp. 358-365. Background
Poor medication adherence is associated with adverse health outcomes and higher costs of care. However, inconsistencies in the assessment of adherence are found in the literature.
Objective
To evaluate the effect of different measures of adherence in the comparative effectiveness of complex interventions to enhance patients' adherence to prescribed medications.
Methods
A systematic review with network meta-analysis was performed. Electronic searches for relevant pairwise meta-analysis including trials of interventions that aimed to improve medication adherence were performed in PubMed. Data extraction was conducted with eligible trials evaluating short-period adherence follow-up (until 3 months) using any measure of adherence: self-report, pill count, or MEMS (medication event monitoring system). To standardize the results obtained with these different measures, an overall composite measure and an objective composite measure were also calculated. Network meta-analyses for each measure of adherence were built. Rank order and surface under the cumulative ranking curve analyses (SUCRA) were performed.
Results
Ninety-one trials were included in the network meta-analyses. The five network meta-analyses demonstrated robustness and reliability. Results obtained for all measures of adherence were similar across them and to both composite measures. For both composite measures, interventions comprising economic + technical components were the best option (90% of probability in SUCRA analysis) with statistical superiority against almost all other interventions and against standard care (odds ratio with 95% credibility interval ranging from 0.09 to 0.25 [0.02, 0.98]). Torres-Robles, A, Wiecek, E, Cutler, R, Drake, B, Benrimoj, SI, Fernandez-Llimos, F & Garcia-Cardenas, V 2019, 'Using Dispensing Data to Evaluate Adherence Implementation Rates in Community Pharmacy', Frontiers in Pharmacology, vol. 10, no. FEB, p. 130. Copyright © 2019 Torres-Robles, Wiecek, Cutler, Drake, Benrimoj, Fernandez-Llimos and Garcia-Cardenas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Background: Medication non-adherence remains a significant problem for the health care system with clinical, humanistic and economic impact. Dispensing data is a valuable and commonly utilized measure due accessibility in electronic health data. The purpose of this study was to analyze the changes on adherence implementation rates before and after a community pharmacist intervention integrated in usual real life practice, incorporating big data analysis techniques to evaluate Proportion of Days Covered (PDC) from pharmacy dispensing data. Methods: Retrospective observational study. A de-identified database of dispensing data from 20,335 patients (n = 11,257 on rosuvastatin, n = 6,797 on irbesartan, and n = 2,281 on desvenlafaxine) was analyzed. Included patients received a pharmacist-led medication adherence intervention and had dispensing records before and after the intervention. As a measure of adherence implementation, PDC was utilized. Analysis of the database was performed using SQL and Python. Results: Three months after the pharmacist intervention there was an increase on average PDC from 50.2% (SD: 30.1) to 66.9% (SD: 29.9) for rosuvastatin, from 50.8% (SD: 30.3) to 68% (SD: 29.3) for irbesartan and from 47.3% (SD: 28.4) to 66.3% (SD: 27.3) for desvenlafaxine. These rates declined over 12 months to 62.1% (SD: 32.0) for rosuvastatin, to 62.4% (SD: 32.5) for irbesartan and to 58.1% (SD: 31.1) for desvenla... Trajkovski, N, O'Brian, S, Onslow, M, Packman, A, Lowe, R, Menzies, R, Jones, M & Reilly, S 2019, 'A three-arm randomized controlled trial of Lidcombe Program and Westmead Program early stuttering interventions', Journal of Fluency Disorders, vol. 61, pp. 105708-105708. © 2019 Elsevier Inc. Purpose: To compare two experimental Westmead Program treatments with a control Lidcombe Program treatment for early stuttering. Method: The design was a three-arm randomized controlled trial with blinded outcome assessments 9 months post-randomization. Participants were 91 pre-school children. Results: There was no evidence of difference in percentage syllables stuttered at 9 months among groups. Dropout rates were substantive and may have been connected with novel aspects of the trial design: the use of community clinicians, no exclusion criteria, and randomization of children younger than 3 years of age. Conclusion: The substantive dropout rate for all three arms in this trial means that any conclusions about the 9-month stuttering outcomes must be regarded as tentative. However, continued development of the Westmead Program is warranted, and we are currently constructing an internet version. Trebilcock, M, Worrall, L, Ryan, B, Shrubsole, K, Jagoe, C, Simmons-Mackie, N, Bright, F, Cruice, M, Pritchard, M & Le Dorze, G 2019, 'Increasing the intensity and comprehensiveness of aphasia services: identification of key factors influencing implementation across six countries', Aphasiology, vol. 33, no. 7, pp. 865-887. Background: Aphasia services are currently faced by increasing evidence for therapy of greater intensity and comprehensiveness. Intensive Comprehensive Aphasia Programs (ICAPs) combine these elements in an evidence-based, time-limited group program. The incorporation of new service delivery models in routine clinical practice is, however, likely to pose challenges for both the service provider and administering clinicians. This program of research aims to identify these challenges from the perspective of aphasia clinicians from six countries and will seek to trial potential solutions. Continual advancements in global communication technologies suggest that solutions will be easily shared and accessed across multiple countries. Aims: To identify the perceived and experienced barriers and facilitators to the implementation of 1) intensive aphasia services, 2) comprehensive aphasia services, and 3) ICAPs, from aphasia clinicians across six countries. Methods and procedures: A qualitative enquiry approach included data from six focus groups (n = 34 participants) in Australia, New Zealand, Canada, United States of America (USA), United Kingdom (UK), and Ireland. A thematic analysis of focus group data was informed by the Theoretical Domains Framework (TDF). Outcomes and results: Five prominent theoretical domains from the TDF influenced the implementation of all three aphasia service types across participating countries: environmental context and resources, beliefs about consequences, social/professional role and identity, skills, and knowledge. Four overarching themes assisted the identification and explanation of the key barriers and facilitators: 1. Collaboration, joint initiatives and partnerships, 2. Advocacy, the promotion of aphasia services and evidence-based practice, 3. Innovation, the ability to problem solve challenges, and 4. Culture, the influence of underlying values. Conclusions: The results of this study will inform the development of a theo... Turbitt, E, Roberts, MC, Hollister, BM, Lewis, KL, Biesecker, LG & Klein, WMP 2019, 'Ethnic identity and engagement with genome sequencing research', Genetics in Medicine, vol. 21, no. 8, pp. 1735-1743. PURPOSE:We examined the role of ethnic identity (which measures the degree to which individuals identify with their ethnic group) in beliefs about, and intentions to learn, genomic results. METHODS:A longitudinal cohort was recruited to implement genome sequencing among healthy participants self-identifying as African, African American, or Afro-Caribbean, 40-65 years old (n = 408). Before receiving genomic results, participants completed a survey assessing social and behavioral constructs related to health, genomics, and ethnic identity. RESULTS:Ethnic identity was positively correlated with perceived value of genomic results and expected benefits from genomic research participation. Among participants with stronger ethnic identity, cognitive beliefs (perceived value of results [b = 0.63, 95% confidence interval: 0.29, 0.98, p < 0.001] and expected benefits from genomic research participation [b = 0.32, 95% confidence interval: 0.12, 0.53, p = 0.002]) were associated with intentions to receive results. Among those with weaker ethnic identity, there was no such association. CONCLUSION:Individuals with stronger ethnic identity seem to attend more to cognitive beliefs such as the value of genomic results when deliberating receipt of results compared with those with weaker ethnic identity. Understanding ethnic identity variation and its influence on genome sequencing perceptions and intentions can inform future research opportunities using ethnic identity to explore specific practical, clinical questions. Turbitt, E, Roberts, MC, Taber, JM, Waters, EA, McNeel, TS, Biesecker, BB & Klein, WMP 2019, 'Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: Results from the 2015 National Health Interview Survey', Preventive Medicine, vol. 123, pp. 12-19. © 2019 We examined what proportion of the U.S. population with no personal cancer history reported receiving either genetic counseling or genetic testing for cancer risk, and also the association of these behaviors with cancer risk perceptions. We used data from the 2015 National Health Interview Survey. Objective relative risk scores for breast (women) and colorectal (men and women) cancer risk were generated for individuals without a personal history of cancer. Participants' risk perceptions were compared with their objective relative risk. Of 12,631 women, 1.2% reported receiving genetic counseling and 0.8% genetic testing for hereditary breast cancer risk. Of 15,085 men and women, 0.8% reported receiving genetic counseling and 0.3% genetic testing for hereditary colorectal cancer risk. Higher breast cancer risk perception was associated with genetic counseling (OR: 4.31, 95%CI: 2.56, 7.26) and testing (OR: 3.56, 95%CI: 1.80, 7.03). Similarly, higher perception of colorectal cancer risk was associated with genetic counseling (OR: 5.04, 95%CI: 2.57, 9.89) and testing (OR: 5.92, 95%CI: 2.40, 14.63). A higher proportion of individuals with colorectal cancer risk perceptions concordant with their objective risk (vs. discordant) had undergone genetic counseling or testing for colorectal cancer risk. Concordant risk perceptions for breast cancer were not associated with breast cancer genetic counseling or testing. Given frequent dialogue about implementing population level programs involving genetic services for cancer risk, policy makers and investigators should consider the role of risk perceptions in the effectiveness and design of such programs and potential strategies for addressing inaccuracies in risk perceptions. Usman, B, Sharma, N, Satija, S, Mehta, M, Vyas, M, Khatik, GL, Khurana, N, Hansbro, PM, Williams, K & Dua, K 2019, 'Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update', Current Pharmaceutical Design, vol. 25, no. 23, pp. 2510-2525. van der Meer, HG, Taxis, K, Teichert, M, Griens, F, Pont, LG & Wouters, H 2019, 'Anticholinergic and sedative medication use in older community‐dwelling people: A national population study in the Netherlands', Pharmacoepidemiology and Drug Safety, vol. 28, no. 3, pp. 315-321. van der Meer, HG, Wouters, H, Teichert, M, Griens, F, Pavlovic, J, Pont, LG & Taxis, K 2019, 'Feasibility, acceptability and potential effectiveness of an information technology-based, pharmacist-led intervention to prevent an increase in anticholinergic and sedative load among older community-dwelling individuals', Therapeutic Advances in Drug Safety, vol. 10, pp. 204209861880588-204209861880588. © The Author(s), 2018. Background: Anticholinergic/sedative medications are frequently used by older people, despite their negative impacts on cognitive and physical function. We explore the feasibility, acceptability and potential effectiveness of an innovative information technology (IT)-based intervention to prevent an increase in anticholinergic/sedative load in older people. Methods: This was a prospective study in 51 Dutch community pharmacies. Pharmacists used an IT-based tool to identify patients aged ⩾65 years, with existing high anticholinergic/sedative loads (drug burden index ⩾2) and a newly initiated anticholinergic/sedative medication. We determined the following. Feasibility: number of eligible patients identified. Acceptability: pharmacists’ satisfaction with the intervention, pharmacists’ time investment and patients’ willingness to reduce medication use. Potential effectiveness: number of recommendations, rate of agreement of general practitioners (GPs) with proposed recommendations and factors associated with agreement. To evaluate the latter, pharmacists conducted medication reviews and proposed recommendations to GPs for 5–10 patients selected by the IT-based tool. Results: We included 305 patients from 47 pharmacies. Feasibility: a mean of 17.0 (standard deviation, 8.8) patients were identified per pharmacy. Acceptability: 43 pharmacists (91.5%) were satisfied with the intervention. The median time investment per patient was 33 min (range 6.5–210). Of 35 patients, 30 (85.7%) were willing to reduce medication use. Potential effectiveness: pharmacists proposed 351 recommendations for 212 patients (69.5%). GPs agreed with recommendations for 108 patients (35.4%). Agreement to stop a medication was reached in 19.8% of recommendations for newly initiated medications (37 of 187) and for 15.2% of recommendations for existing medications (25 of 164). Agreement was more likely for recommendations on codeine [odds ratio (OR) 3.30; 95% confidence inter... Van Der Pol-Harney, E & McAloon, J 2019, 'Psychosocial Interventions for Mental Illness among LGBTQIA Youth: A PRISMA-Based Systematic Review', Adolescent Research Review, vol. 4, no. 2, pp. 149-168. © 2018, Springer Nature Switzerland AG. Lesbian, Gay, Bisexual, Transgender, Queer, Intersex and Asexual (LGBTQIA) youth experience a unique range of psychosocial stressors often culminating in poor mental health outcomes. A systematic review of trials that evaluated psychosocial interventions for LGBTQIA youth aged 12–25 was undertaken to evaluate the effect of treatment components and participant-related variables on treatment outcome. The results suggest that creating safe, accepting places, discussion of shared experiences, and using a cognitive behavioural or attachment-based family therapy framework significantly decreased depression, sexual minority stress, anxiety and drug and alcohol use, and enhanced participant approval. LGBTQIA youth had poorer baseline mental health than non-LGBTQIA youth and experienced greater improvements. Further experimental research is needed to define effective treatment components and relevant individual factors to maximise treatment efficacy. Varcin, KJ, Grainger, SA, Bailey, PE, Richmond, JL & Henry, JD 2019, 'Empathy for others’ pain is disrupted at the neurophysiological level in schizophrenia', British Journal of Clinical Psychology, vol. 58, no. 4, pp. 406-426. Varcin, KJ, Grainger, SA, Richmond, JL, Bailey, PE & Henry, JD 2019, 'A role for affectivity in rapid facial mimicry: An electromyographic study', Social Neuroscience, vol. 14, no. 5, pp. 608-617. Varcin, KJ, Nangle, MR, Henry, JD, Bailey, PE & Richmond, JL 2019, 'Intact spontaneous emotional expressivity to non-facial but not facial stimuli in schizophrenia: An electromyographic study', Schizophrenia Research, vol. 206, pp. 37-42. Verhagen, AP, Ferreira, M, Reijneveld-van de Vendel, EAE, Teirlinck, CH, Runhaar, J, van Middelkoop, M, Hermsen, L, de Groot, IB & Bierma-Zeinstra, SMA 2019, 'Do we need another trial on exercise in patients with knee osteoarthritis?', Osteoarthritis and Cartilage, vol. 27, no. 9, pp. 1266-1269. Vyse, S, Hemsley, B, Lang, R, Lilienfeld, SO, Mostert, MP, Schlinger, HD, Shane, HC, Sherry, M & Todd, JT 2019, 'Whose words are these? Statements derived from Facilitated Communication and Rapid Prompting Method undermine the credibility of Jaswal & Akhtar's social motivation hypotheses', Behavioral and Brain Sciences, vol. 42. Waghule, T, Singhvi, G, Dubey, SK, Pandey, MM, Gupta, G, Singh, M & Dua, K 2019, 'Microneedles: A smart approach and increasing potential for transdermal drug delivery system', Biomedicine & Pharmacotherapy, vol. 109, pp. 1249-1258. © 2018 Elsevier Masson SAS The most widely used methods for transdermal administration of the drugs are hypodermic needles, topical creams, and transdermal patches. The effect of most of the therapeutic agents is limited due to the stratum corneum layer of the skin, which serves as a barrier for the molecules and thus only a few molecules are able to reach the site of action. A new form of delivery system called the microneedles helps to enhance the delivery of the drug through this route and overcoming the various problems associated with the conventional formulations. The primary principle involves disruption of the skin layer, thus creating micron size pathways that lead the drug directly to the epidermis or upper dermis region from where the drug can directly go into the systemic circulation without facing the barrier. This review describes the various potential and applications of the microneedles. The various types of microneedles can be fabricated like solid, dissolving, hydrogel, coated and hollow microneedles. Fabrication method selected depends on the type and material of the microneedle. This system has increased its application to many fields like oligonucleotide delivery, vaccine delivery, insulin delivery, and even in cosmetics. In recent years, many microneedle products are coming into the market. Although a lot of research needs to be done to overcome the various challenges before the microneedles can successfully launch into the market. Wallace, SJ, Baker, C, Brandenburg, C, Bryant, L, Le Dorze, G, Power, E, Pritchard, M, Rose, ML, Rose, T, Ryan, B, Shrubsole, K, Simmons-Mackie, N, Togher, L & Trebilcock, M 2019, 'A how-to guide to aphasia services: celebrating Professor Linda Worrall’s contribution to the field', Aphasiology, vol. 33, no. 7, pp. 888-902. © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Background: This article recognises Professor Linda Worrall’s contribution to aphasiology and discusses research themes which have grown from her work. Aims: To review, summarise, and discuss literature relating to four themes which have emerged from the work of Professor Worrall: (1) Research capacity building; (2) Implementation of research evidence in clinical practice; (3) Meaningful outcome measurement; and (4) Improvement of psychological and emotional outcomes. Main contribution: A review of the literature, with examples of practical applications. Conclusions: The work of Professor Worrall has greatly influenced the field of aphasia; her legacy is the research capacity she has built in Australia and around the world. Wallace, SJ, Worrall, L, Rose, T & Le Dorze, G 2019, 'Using the International Classification of Functioning, Disability, and Health to identify outcome domains for a core outcome set for aphasia: a comparison of stakeholder perspectives', Disability and Rehabilitation, vol. 41, no. 5, pp. 564-573. Wallace, SJ, Worrall, L, Rose, T, Le Dorze, G, Breitenstein, C, Hilari, K, Babbitt, E, Bose, A, Brady, M, Cherney, LR, Copland, D, Cruice, M, Enderby, P, Hersh, D, Howe, T, Kelly, H, Kiran, S, Laska, A-C, Marshall, J, Nicholas, M, Patterson, J, Pearl, G, Rochon, E, Rose, M, Sage, K, Small, S & Webster, J 2019, 'A core outcome set for aphasia treatment research: The ROMA consensus statement', International Journal of Stroke, vol. 14, no. 2, pp. 180-185. Watson, P, Pearson, D, Chow, M, Theeuwes, J, Wiers, RW, Most, SB & Le Pelley, ME 2019, 'Capture and Control: Working Memory Modulates Attentional Capture by Reward-Related Stimuli', Psychological Science, vol. 30, no. 8, pp. 1174-1185. Watson, P, Pearson, D, Wiers, RW & Le Pelley, ME 2019, 'Prioritizing pleasure and pain: attentional capture by reward-related and punishment-related stimuli', Current Opinion in Behavioral Sciences, vol. 26, pp. 107-113. Weißenborn, M, Schulz, M, Kraft, M, Haefeli, WE & Seidling, HM 2019, 'Potentielle Erfolgsindikatoren für die Durchführung von Projekten zur Arzt-Apotheker-Zusammenarbeit – eine systematische Übersicht', Das Gesundheitswesen, vol. 81, no. 12, pp. 1057-1068. Werth, BL, Williams, KA, Fisher, MJ & Pont, LG 2019, 'Defining constipation to estimate its prevalence in the community: results from a national survey', BMC Gastroenterology, vol. 19, no. 1. BACKGROUND:Different definitions of constipation have been used to estimate its prevalence in the community but this creates difficulties when comparing results from various studies. This study explores the impact of different definitions on prevalence estimates in the same population and compares the performance of simple definitions with the Rome III criteria. METHODS:The prevalence of constipation in a large nationally representative sample of community-dwelling adults was estimated using five simple definitions of constipation and compared with definitions based on the Rome III criteria. The sensitivity, specificity, and positive and negative predictive values, were calculated for each definition using the Rome III criteria as the gold standards for chronic and sub-chronic constipation. RESULTS:Prevalence estimates for the five simple definitions ranged from 9.4 to 58.9%, while the prevalence estimates using the Rome III criteria were 24.0% (95%CI: 22.1, 25.9) for chronic constipation and 39.6% (95%CI: 37.5, 41.7) for sub-chronic constipation. None of the simple definitions were adequate compared to the Rome III criteria. Self-reported constipation over the past 12 months had the highest sensitivity (91.1%, 95%CI: 88.8, 93.4) and negative predictive value (94.5%, 95%CI: 93.1, 96.1) compared to the Rome III criteria for chronic constipation but an unacceptably low specificity (51.3%, 95%CI: 48.8, 53.8) and positive predictive value (37.1%, 95%CI: 34.4, 39.9). CONCLUSIONS:The definition used to identify constipation within a population has a considerable impact on the prevalence estimate obtained. Simple definitions, commonly used in research, performed poorly compared with the Rome III criteria. Studies estimating population prevalence of constipation should use definitions based on the Rome criteria where possible. Wiecek, E, Tonin, FS, Torres-Robles, A, Benrimoj, SI, Fernandez-Llimos, F & Garcia-Cardenas, V 2019, 'Temporal effectiveness of interventions to improve medication adherence: A network meta-analysis', PLOS ONE, vol. 14, no. 3, pp. e0213432-e0213432. INTRODUCTION:Adherence-enhancing interventions have been assessed in the literature, however heterogeneity and conflicting findings have prohibited a consensus on the most effective approach to maintain adherence over time. With the ageing population and growth of chronic conditions, evaluation of sustainable strategies to improve and maintain medication adherence long term is paramount. We aimed to determine the comparative effectiveness of interventions for improving medication adherence over time among adults with any clinical condition. MATERIALS AND METHODS:Meta-analyses evaluating interventions to improve medication adherence were searched in PubMed in January 2019 and reviewed for primary studies. Experimental studies with a comparison group assessing an intervention to enhance medication adherence in adult patients with reported adherence outcomes were included. Two authors extracted data for study characteristics, interventions and adherence outcomes. Interventions were categorized into four groups or combinations: educational, attitudinal, technical and rewards. Four network meta-analyses were performed to compare interventions based on patient follow-up time. Medication adherence effect sizes were reported as odds ratios (OR) with a 95% credibility interval (CrI) and surface under the cumulative ranking curve (SUCRA) to allow ranking probabilities. Risk of bias was assessed as per Cochrane guidelines. RESULTS:Data was obtained from 69 meta-analyses with 468 primary studies being included in qualitative synthesis. The four networks compromised of 249 studies in total (0-3 month follow-up: 99 studies, 4-6 months: 104, 7-9 months: 18, ≥10 months: 94). Interventions showing success in follow-ups of less than 10 months varied across time. Significant effects compared to standard of care (SOC) were found in technical (4-6 months: OR 0.34, 95% CrI 0.25-0.45) and attitudinal interventions (7-9 months: 0.37, 0.17-0.84). Multicomponent interventions demonstrated... Wootton, BM, Karin, E, Titov, N & Dear, BF 2019, 'Self-guided internet–delivered cognitive behavior therapy (ICBT) for obsessive-compulsive symptoms: A randomized controlled trial', Journal of Anxiety Disorders, vol. 66, pp. 102111-102111. Internet-delivered cognitive behavior therapy (ICBT) for obsessive-compulsive disorder (OCD) has been demonstrated to be efficacious across multiple clinical trials. However, most of these interventions include clinician support, and many individuals with OCD prefer to manage their own symptoms. Self-guided ICBT overcomes this problem, but to date the efficacy of self-guided interventions has only been studied in uncontrolled trials. The present study aims to examine the efficacy and acceptability of ICBT for OCD symptoms when delivered in a self-guided format using a randomized controlled trial design. In the present study, 190 participants were randomized to either a self-guided ICBT condition or a waitlist control group. 140 participants completed the baseline assessment, initiated treatment, and were included in the analyses. The between-group effect size at post-treatment was large on the self-report version of the Yale-Brown Obsessive-Compulsive Scale (d = 1.05; 95% CI 0.89-1.21). Twenty-seven percent of the ICBT condition met conservative criteria for clinically significant change at post-treatment, which increased to thirty-eight percent at three-month follow-up. Participants rated the program as highly acceptable. The results indicate that self-guided ICBT may be a viable treatment option for some individuals with OCD symptoms. Wootton, BM, Worden, BL, Norberg, MM, Grisham, JR & Steketee, G 2019, 'A clinician's quick guide to evidence‐based approaches: Hoarding disorder', Clinical Psychologist, vol. 23, no. 1, pp. 85-87. Yeung, S, Traini, D, Tweedie, A, Lewis, D, Church, T & Young, PM 2019, 'Assessing Aerosol Performance of a Dry Powder Carrier Formulation with Increasing Doses Using a Novel Inhaler', AAPS PharmSciTech, vol. 20, no. 3. Yeung, S, Traini, D, Tweedie, A, Lewis, D, Church, T & Young, PM 2019, 'Effect of Dosing Cup Size on the Aerosol Performance of High-Dose Carrier-Based Formulations in a Novel Dry Powder Inhaler', Journal of Pharmaceutical Sciences, vol. 108, no. 2, pp. 949-959. Zeater, S, Benrimoj, SI, Fernandez-Llimos, F & Garcia-Cardenas, V 2019, 'A model for the financial assessment of professional services in community pharmacy: A systematic review', Journal of the American Pharmacists Association, vol. 59, no. 1, pp. 108-116.e1. © 2019 American Pharmacists Association® Objectives: Limited studies have assessed the financial benefit of professional pharmacy services (PPSs) to the community pharmacy as a business. These studies are crucial in developing an insight into the long-term sustainability and broader implementation of services. We reviewed the literature to identify measures and indicators used to assess the financial performance of professional services in community pharmacy. Data sources: The literature search was undertaken in Pubmed and Scopus, and a gray literature search was performed in Google.com. References of the included papers were reviewed for other relevant studies. Study selection: Articles were reviewed against the following exclusion criteria: 1) literature reviews, 2) studies not reporting quantitative financial data from community pharmacy, 3) studies not assessing a PPS, 4) studies lacking a methodology for the measurement and assessment of financial outcomes, and 5) cost-effectiveness analysis, cost-utility analysis, or cost-benefit analysis studies. Data extraction: A piloted data extraction form was used. A selection of key data collected is as follows: 1) method of data collection and calculation, 2) currency, limitations for cost and revenue and method of data collection and method of calculation, 3) standardized currency value for the results reported, 4) professional services: number assessed, type of service, name of services, nature of services, implementation stage reported, financial result, the frequency of service, costs, sources of revenue, net total cost, net total revenue, break-even point, break-even price, net profit and loss. Results: The 21 studies included used different methodologies and indicators to financially assess PPSs. This has led to the development of a model for assessing PPSs composed of the key financial elements identified in this systematic review. Conclusion: From this review, we propose a model that provides a str...
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View description>>
View/Download from: Publisher's site
View/Download from: Publisher's site
View/Download from: Publisher's site
View/Download from: Publisher's site
View description>>
Conferences
Berle, D, Steel, Z & Hilbrink, D 1970, 'Perceived injustice and betrayal: Association with anger during the course of residential treatment for PTSD.', 20th Australasian Conference on Traumatic Stress, Sydney.
Brunner, M, Palmer, S, Togher, L, Dann, S & Hemsley, B 1970, 'Content Analysis of Tweets by People with Traumatic Brain Injury (TBI): Implications for Rehabilitation and Social Media Goals', Proceedings of the Annual Hawaii International Conference on System Sciences, Hawaii International Conference on System Sciences, Hawaii International Conference on System Sciences, pp. 4329-4338.
View/Download from: Publisher's site
View description>>
In this Twitter research, 6874 tweets of six adults with traumatic brain injury (TBI) were analyzed qualitatively and quantitatively using content classification [1], inductive coding of content themes, socio-linguistic analysis, and computational analysis in KH Coder. The results reflected that participants used Twitter for: (i) supporting others, including people with TBI; (ii) discussing society and culture, popular issues, news, and personal interests; (iii) connecting with others; (iv) sharing their experiences of life after TBI; (v) knowledge via exchanging information; and (vii) advocacy. ‘Emotional expression’, and ‘connection’ were common threads running across themes. Attending to the expressions of people with TBI on Twitter provides important insights into their lived experiences and could inform the development of user-centered cognitive-communication and social participation goals for people with TBI.
Courtney-Harris, M, Rowe, F & Rose, K 1970, 'Enhanced investigation of vision problems for all patients diagnosed with stroke using the Stroke-Vision Screening Tool (S-ViST)', INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, pp. 18-19.
Eickhoff, C, Mueller, U, Strunz, AK, Felberg, M & Schulz, M 1970, 'Internal and external evaluation of an interdisciplinary medication management service in Germany', INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, SPRINGER, pp. 600-600.
Gunasekaran, P, Hodge, C, Browne, G, Fraser, C & Rose, KA 1970, 'Concussion-Related Visual Dysfunction in Children: A Retrospective Study', INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), ASSOC RESEARCH VISION OPHTHALMOLOGY INC, CANADA, Vancouver.
Hemsley, B, Palmer, S, Kouzani, A, Adams, S & Balandin, S 1970, 'Review Informing the Design of 3D Food Printing for People with Swallowing Disorders: Constructive, Conceptual, and Empirical Problems', Proceedings of the Annual Hawaii International Conference on System Sciences, Hawaii International Conference on System Sciences, Hawaii International Conference on System Sciences, pp. 5735-5744.
View/Download from: Publisher's site
View description>>
The aim of this review was to examine 3D food printing literature, its focus on problems and solutions, and its capacity for problem-solving in relation to the provision of texture-modified food for people with swallowing disorders (dysphagia). In June 2016 and 2018 the first and fourth authors searched 4 scientific databases with the key terms in 3D food printing and dysphagia to locate relevant peer reviewed journal articles for review. In total, 16 papers were included, and examined for: (a) problems, solutions, and potential for problem-solving capacity expressed in 3D food printing literature to date, and (b) applications of 3D printed foods in specific populations with swallowing disorders. Future research and development of 3D food printing technologies could consider empirical and conceptual problems, along with the multidimensional nature of special nutritional or swallowing needs. Taking these issues into account would facilitate the translation of findings into real-world outcomes and benefits.
Manchanda, R, Burnell, M, Gaba, F, Desai, R, Wardle, J, Gessler, S, Side, L, Sanderson, S, Loggenberg, K, Brady, A, Dorkins, H, Wallis, Y, Chapman, C, Jacobs, C, Legood, R, Beller, U, Tomlinson, I, Menon, U & Jacobs, I 1970, 'Randomised trial of unselected BRCA testing in ashkenazi jews: long term outcomes and factors affecting uptake of testing', Best Oral/Late-Breaking Abstracts 4 – Miscellaneous, ESGO Annual Meeting Abstracts, BMJ Publishing Group Ltd, pp. A13-A13.
View/Download from: Publisher's site
McAlinden, K, Cohen-Hyam, T, Killingsworth, M, Haghi, M & Sharma, P 1970, 'ELECTRONIC-CIGARETTE VAPING IN COMBINATION WITH A HIGH FAT DIET AUGMENTS LUNG FUNCTION AND INFLAMMATION', RESPIROLOGY, WILEY, pp. 47-47.
McAlinden, K, Cohen-Hyams, T, Killingsworth, M, Haghi, M & Sharma, P 1970, 'High Fat Diet in Conjunction with Electronic Cigarette Vaping Worsens Lung Function and Inflammation', AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, International Conference of the American-Thoracic-Society, AMER THORACIC SOC, Dallas, TX.
McEwen, A, Kligyte, G & McLean, J 1970, 'Imagining and designing the future of genetic counselling with the new generation of genetic counsellors', Human Genetics Society of Australasia, Wellington, NZ.
McEwen, A, Kligyte, G, McLean, J & Jacobs, C 1970, 'Imagining and designing the future of genetic counselling with the new generation of genetic counsellors', HGSA 43rd Annual Scientific Meeting, HGSA 43rd Annual Scientific Meeting, Wellington, NZ.
Rezaeian, M, Butlin, M, Golzan, SM, Graham, SL & Avolio, AP 1970, 'A novel method for retinal vessel segmentation and diameter measurement using high speed video', 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 2019 41st Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), IEEE, Berlin, Germany, pp. 2781-2784.
View/Download from: Publisher's site
View description>>
Studying dynamic characteristics of retinal vessels, as opposed to static measures, may provide additional insight into pathophysiological changes associated with local and systemic abnormalities such as glaucoma and hypertension. Various approaches have been developed to derive static biomarkers from retinal still images, but not many for dynamic analysis of video sequences. This study presents a novel method for the assessment of time-dependent diameter changes in high-speed videos (125 fps) from the rat retina. The proposed method is composed of a vessel segmentation and a diameter measurement module. The specificity and sensitivity of the segmentation method over 25 images were 95.1% and 97.3% respectively. The mean and standard deviation of the diameter measurement errors were -0.147±0.41 pixels over 100 measurements.
Salas, M, Castillo, WC, Juarez, LD, Zhang, C, Arias, A, Appenteng, K, Donneyong, MM, Thurin, N, Lopes, LC, Gomez Galicia, D, Burger, J, Ankrah, D, Ogunleye, O, Fadare, JO, Rueda, J-D, Lubbe, M, Kuzucan, A, Ejekam, CS, Garcia Estrada, MDC, Bernet, J, Alesso, L, Herrera Comoglio, R, Pont, L, Angelica Rodriguez, N & Truter, I 1970, 'Pharmacoepidemiology capacity building in the Latin American and African regions', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 547-548.
Schumacher, PM, Griese-Mammen, N, Botermann, L, Laufs, U & Schulz, M 1970, 'Medication discrepancies in patients with chronic heart failure', INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, SPRINGER, pp. 299-299.
Shariflou, S, Agar, A, Rose, KA & Golzan, M 1970, 'The accuracy of spontaneous venous pulsation assessment in discriminating glaucoma from glaucoma suspects', INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), ASSOC RESEARCH VISION OPHTHALMOLOGY INC, CANADA, Vancouver.
Shires, A 1970, 'British Association of Behavioural and Cognitive Psychology (BABCP) Conference 2019. Introduction to MiCBT workshop.', British Association of Behavioural and Cognitive Psychology (BABCP) Conference 2019, bath.
Shires, A 1970, 'Introduction to Mindfulness Integrated Cognitive Behavioural Therapy', British Assocation of Behavioural and Cognitive therapy, Bath UK.
Shires, A 1970, 'The trans diagnostic elements of Mindfulness-integrated Cognitive Behaviour therapy andtheir applications to crisis and comorbidity in clinical practice.psychology training.', International Conference on Mindfulness, Auckland New Zealnad.
Shires, A & Chui, J 1970, 'Mindfulness integrated Cognitive behaviour therapy in clinical psychology training.', International Conference on Mindfulness, Auckland New Zealand.
Teirlinck, CH, Verhagen, AP, Reijneveld-van de Vendel, EA, Runhaar, J, van Middelkoop, M, Hermsen, L, de Groot, IB & Bierma-Zeinstra, SM 1970, 'Responders to exercise therapy in patients with osteoarthritis of the hip: a systematic review and meta-analysis', Osteoarthritis and Cartilage, OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis, Elsevier BV, Toronto, CANADA, pp. S489-S490.
View/Download from: Publisher's site
van Reyk, D, Oliver, B, Capistrano, S, Komalla, V, Haghi, M & Zosky, G 1970, 'Pro-inflammatory effects of exposure of the combination of silicon- and iron-containing particles upon human lung fibroblasts', Airway cell biology and immunopathology, ERS International Congress 2019 abstracts, European Respiratory Society, Madrid, SPAIN.
View/Download from: Publisher's site
Verhagen, AP, Ferreira, M, Reijneveld-van de Vendel, E, Teirlinck, CH, Runhaar, J, van Middelkoop, M, Hermsen, L, de Groot, I & Bierma-Zeinstra, S 1970, 'No new trials on exercise are needed in knee osteoarthritis', Osteoarthritis and Cartilage, OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis, Elsevier BV, Toronto, CANADA, pp. S484-S484.
View/Download from: Publisher's site
Other
Bailey, PE & Leon, T 2019, 'A systematic review and meta-analysis of age-related differences in trust', Center for Open Science.
View/Download from: Publisher's site
Dineen-Griffin, S, Garcia Cardenas, V, Williams, K & Benrimoj, SI 2019, 'Evaluation of a collaborative protocolized approach by community pharmacies and general medical practitioners for an Australian minor ailments scheme: study protocol for a cluster-randomized controlled trial (Preprint)', JMIR Publications Inc., JMIR Publications Inc..
View/Download from: Publisher's site
View description>>
Internationally, governments have been investing in supporting pharmacists to take on an expanded role to support self-care for health system efficiency. There is consistent evidence that minor ailment schemes (MAS) promote efficiencies within the healthcare system. The cost savings and health outcomes demonstrated in the UK and Canada opens up new opportunities for pharmacists to effect sustainable changes through MAS delivery in Australia. This trial is evaluating the clinical, economic and humanistic impact of an Australian minor ailments service (AMAS), compared with usual pharmacy care in a cluster-randomized controlled trial in Western Sydney, Australia. The cluster-randomized controlled trial design has an intervention and a control group, comparing individuals receiving a structured intervention with those receiving usual care for specific common ailments. Participants will be community pharmacies, general practices and patients located in Western Sydney Primary Health Network region. 30 community pharmacies will be randomly assigned to either intervention or control group. Each will recruit 24 patients seeking, aged 18 years or older, presenting to the pharmacy in person with a symptom-based or product-based request for one of the following ailments (reflux, cough, common cold, headache (tension or migraine), primary dysmenorrhoea and low back pain). Intervention pharmacists will deliver protocolized care to patients using clinical treatment pathways with agreed referral points and collaborative systems boosting clinician-pharmacist communication. Patients recruited in control pharmacies will receive usual car... Fisher, G, de Oliveira, CQ, Gandevia, S & Kennedy, D 2019, 'Unilateral neglect is associated with poor proprioception after stroke – a systematic review', Cold Spring Harbor Laboratory. Miller, R, Iancu, C, Babineau, J & Newton-John, T 2019, 'Are residential rehabilitation clients representative of Australians who engage in problematic Alcohol and Other Drug use?'. Shires, A & Cayoun, B 2019, 'The transdiagnostic elements of Mindfulness-integrated Cogntive Behaviour therapy and their applicatons to crisis and comoborbidity in clinical practice'. Pre Conference workshop. International Mindfulness Conference 2019 Shires, A & Chui, J 2019, 'Mindfulness integrated Cognitive behaviour therapy in clinical psychology training'. Research presentation. International mindfulness Conference NZ 2019 Stark, BC, Dutta, M, Murray, L, Bryant, L, Fromm, D, MacWhinney, B, Ramage, AE, Roberts, A, Ouden, D-BD, Brock, K, MicKinney-Bock, K, Paek, EJ, Harmon, T, Yoon, SO, Themistocleous, C, Yoo, H, Aveni, K, Gutierrez, S & Sharma, S 2019, 'Standardizing assessment of spoken discourse in aphasia: A working group with deliverables', Center for Open Science.
View/Download from: Publisher's site
View description>>
View description>>
View/Download from: Publisher's site
UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.